: The AMEDEO Literature Guide

Home

HIV Medicine

FAQ

Unsubscribe

Change Email

Policy

About

Free Journals

The Best Medical Websites:
Amedeo's Golden Links

Bladder Cancer, January 2001

Free Subscription

Abstracts

Retrieve all available abstracts of the following 1215 articles:
HTML format

Single Articles

LO YK, Tang KY, Chang WN, Lu CH, Cheng JS, Lee KC et al
Effect of oleamide on Ca(2+) signaling in human bladder cancer cells(1).
Biochem Pharmacol 2001; 62: 1363-1369
Abstract Related articles

QURESHI KN, Griffiths TR, Robinson MC, Marsh C, Roberts JT, Lunec J et al
Combined p21(WAF1/CIP1) and p53 overexpression predict improved survival in muscle-invasive bladder cancer treated by radical radiotherapy.
Int J Radiat Oncol Biol Phys 2001; 51: 1234-40
Abstract Related articles

MICHAUD DOMS, Clinton SK, Rimm EB, Willett WC, Giovannucci E
Risk of bladder cancer by geographic region in a u.s. Cohort of male health professionals.
Epidemiology 2001; 12: 719-26
Abstract Related articles

KAYE JA, Wald Myers M, Jick H
Acetaminophen and the risk of renal and bladder cancer in the general practice research database.
Epidemiology 2001; 12: 690-4
Abstract Related articles

FRANZONE P, Sanguineti G, Tognoni P, Marcenaro M, Vitale V
Organ preservation for invasive bladder cancer: morbidity of chemoradiotherapy at very long follow-up.
Int J Radiat Oncol Biol Phys 2001; 51: 297
Abstract Related articles

POS FJ, Hulshof MC, van Tienhoven GT, Koedooder C, Gonzalez Gonzalez D
Escalated concomitant boost radiotherapy in bladder cancer.
Int J Radiat Oncol Biol Phys 2001; 51: 291
Abstract Related articles

KURT M, Ozkan L, Saran A, Cebelli GB, Cakir S, Unlu E et al
Efficacy of concomitant chemoradiotherapy in organ-preserving treatment of bladder cancer.
Int J Radiat Oncol Biol Phys 2001; 51: 283
Abstract Related articles

EAPEN L, Stewart D, Peterson R, E C, Aref I, Huan S et al
Efficacy of concurrent intra-arterial cisplatin and radiation in the treatment of bladder cancer presenting with hydronephrosis.
Int J Radiat Oncol Biol Phys 2001; 51: 274-275
Abstract Related articles

ROEDEL C, Grabenbauer GG, Kuhn R, Dunst J, Schrott KM, Sauer R
Selective organ preservation in patients with invasive bladder cancer: final results of a protocol of transurethral surgery, radiation therapy plus concurrent cisplatin and 5-fluorouracil.
Int J Radiat Oncol Biol Phys 2001; 51: 274
Abstract Related articles

SHIPLEY WU, Zietman AL, Kaufman DS, Zehr E, Heney NM, Lane SC et al
Selective bladder preservation by combined modality treatment of invasive bladder cancer: 10-Year outcome.
Int J Radiat Oncol Biol Phys 2001; 51: 13-14
Abstract Related articles

TAKAI D, Gonzales FA, Tsai YC, Thayer MJ, Jones PA
Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer.
Hum Mol Genet 2001; 10: 2619-2626
Abstract Related articles

KAGEYAMA Y, Kihara K
[Neoadjuvant chemotherapy for invasive bladder cancer]
Gan To Kagaku Ryoho 2001; 28: 1838-44
Abstract Related articles

ZHANG J, Zheng S, Fan Z, Gao Y, Di X, Wang D et al
A comparison between microsatellite analysis and cytology of urine for the detection of bladder cancer.
Cancer Lett 2001; 172: 55-8
Abstract Related articles

NERSESYAN AK
Re: biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine.
J Natl Cancer Inst 2001; 93: 1492
Abstract Related articles

HEMSTREET GP 3RD
Response: re: biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine.
J Natl Cancer Inst 2001; 93: 1492-3
Abstract Related articles

HALACHMI S, Madeb R, Kravtsov A, Moskovitz B, Halachmi N, Nativ O
Bladder cancer - genetic overview.
Med Sci Monit 2001; 7: 164-168
Abstract Related articles

DE CARVALHO DD, Schmitmeier S, Novello JC, Markland FS
Effect of BJcuL (a lectin from the venom of the snake Bothrops jararacussu) on adhesion and growth of tumor and endothelial cells.
Toxicon 2001; 39: 1471-6
Abstract Related articles

ZHU W, Chan EK, Li J, Hemmerich P, Tan EM
Transcription activating property of autoantigen SG2NA and modulating effect of WD-40 repeats.
Exp Cell Res 2001; 269: 312-21
Abstract Related articles

BALBI JC, Larrinaga MT, De Stefani E, Mendilaharsu M, Ronco AL, Boffetta P et al
Foods and risk of bladder cancer: a case-control study in Uruguay.
Eur J Cancer Prev 2001; 10: 453-458
Abstract Related articles

EKICI S, Sahin A, Ozen H
Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer.
J Endourol 2001; 15: 827-9
Abstract Related articles

ADAM BL, Vlahou A, Semmes OJ, Wright GL Jr
Proteomic approaches to biomarker discovery in prostate and bladder cancers.
Proteomics 2001; 1: 1264-70
Abstract Related articles

ZEEGERS MP, Swaen GM, Kant I, Goldbohm RA, van Den Brandt PA
Occupational risk factors for male bladder cancer: results from a population based case cohort study in the Netherlands.
Occup Environ Med 2001; 58: 590-6
Abstract Related articles

CHENG L, Bostwick DG, Li G, Zhang S, Vortmeyer AO, Zhuang Z
Conserved Genetic Findings in Metastatic Bladder Cancer.
Arch Pathol Lab Med 2001; 125: 1197-1199
Abstract Related articles

LARSSON PC, Beheshti B, Sampson HA, Jewett MA, Shipman R
Allelic deletion fingerprinting of urine cell sediments in bladder cancer.
Mol Diagn 2001; 6: 181-8
Abstract Related articles

LANGZAM L, Koren R, Gal R, Kugel V, Paz A, Farkas A et al
Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy.
Am J Clin Pathol 2001; 116: 377-85
Abstract Related articles

SCRIMGER RA, Murtha AD, Parliament MB, Venner PM, Hanson J, Houle G et al
Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors.
Int J Radiat Oncol Biol Phys 2001; 51: 23-30
Abstract Related articles

TOKUNAGA H, Shariat SF, Green AE, Brown RM, Zhou JH, Benedict WF et al
Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens.
Int J Radiat Oncol Biol Phys 2001; 51: 16-22
Abstract Related articles

PARONI R, Salonia A, Lev A, Da Pozzo LF, Cighetti G, Montorsi F et al
Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma.
Br J Clin Pharmacol 2001; 52: 273-8
Abstract Related articles

BORNMAN DM, Mathew S, Alsruhe J, Herman JG, Gabrielson E
Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals.
Am J Pathol 2001; 159: 831-5
Abstract Related articles

LIANG SX, Lakshmanan Y, Woda BA, Jiang Z
A high-grade primary leiomyosarcoma of the bladder in a survivor of retinoblastoma.
Arch Pathol Lab Med 2001; 125: 1231-4
Abstract Related articles

GOLKA K, Weistenhofer W, Jedrusik P, Geller F, Blaszkewicz M, Bolt HM
N-acetyltransferase 2 phenotype in painters with bladder cancer and controls.
Ann Acad Med Singapore 2001; 30: 464-7
Abstract Related articles

MATTER MJ, Gygi C, Gillet M, Gebhard S, Bouzourene H
Malacoplakia simulating organ invasion in a rectosigmoid adenocarcinoma: report of a case.
Dis Colon Rectum 2001; 44: 1371-5
Abstract Related articles

MILORD RA, Lecksell K, Epstein JI
An objective morphologic parameter to aid in the diagnosis of flat urothelial carcinoma in situ.
Hum Pathol 2001; 32: 997-1002
Abstract Related articles

WOLF HK, Stober C, Hohenfellner R, Leissner J
Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas.
Tumour Biol 2001; 22: 328-36
Abstract Related articles

ROIGAS J, Schulze G, Raytarowski S, Jung K, Schnorr D, Loening SA
Tumor M2 pyruvate kinase in plasma of patients with urological tumors.
Tumour Biol 2001; 22: 282-5
Abstract Related articles

PFAU P, Chak A
Detection of preinvasive cancer cells: early-warning changes in precancerous epithelial cells can now be spotted in situ and Endoscopic detection of dysplasia in patients with Barrett’s esophagus using light- scattered spectroscopy.
Gastrointest Endosc 2001; 54: 414-6
Abstract Related articles

GONTIJO AM, Elias FN, Salvadori DM, de Oliveira ML, Correa LA, Goldberg J et al
Single-cell gel (comet) assay detects primary DNA damage in nonneoplastic urothelial cells of smokers and ex-smokers.
Cancer Epidemiol Biomarkers Prev 2001; 10: 987-93
Abstract Related articles

UTTING M, Werner W, Muller G, Schubert J, Junker K
A possible noninvasive method for the detection of bladder cancer in patients: microsatellite analysis of free DNA in urine and blood.
Ann N Y Acad Sci 2001; 945: 31-5
Abstract Related articles

FISCHETTI G, Barrese F, Cuzari S, Marino C, Mariani S, Morello P
Neoadjuvant chemotherapy and conservative surgery in invasive bladder cancer. Personal experience.
Minerva Urol Nefrol 2001; 53: 119-23
Abstract Related articles

FAVRE B, Fontao L, Koster J, Shafaatian R, Jaunin F, Saurat JH et al
The hemidesmosomal protein bullous pemphigoid antigen 1 and the integrin beta 4 subunit bind to ERBIN. Molecular cloning of multiple alternative splice variants of ERBIN and analysis of their tissue expression.
J Biol Chem 2001; 276: 32427-36
Abstract Related articles

PUNTONI R, Ceppi M, Reggiardo G, Merlo F
Occupational exposure to carbon black and risk of bladder cancer.
Lancet 2001; 358: 562
Abstract Related articles

DEDI R, Bhandari S, Turney JH, Brownjohn AM, Eardley I
Lesson of the week: Causes of haematuria in adult polycystic kidney disease.
BMJ 2001; 323: 386-7
Abstract Related articles

KNOWLES MA
What we could do now: molecular pathology of bladder cancer.
Mol Pathol 2001; 54: 215-21
Abstract Related articles

FERRIES E, Connan F, Pages F, Gaston J, Hagnere A, Vieillefond A et al
Identification of p53 peptides recognized by CD8(+) T lymphocytes from patients with bladder cancer.
Hum Immunol 2001; 62: 791-798
Abstract Related articles

GUO JM, Zhang XY, Chen HL, Wang GM, Zhang YK
Structural alterations of sugar chains in urine fibronectin from bladder cancer patients and its enzymatic mechanism.
J Cancer Res Clin Oncol 2001; 127: 512-9
Abstract Related articles

RAFNSSON V
Incidence of cancer among bookbinders, printers, photoengravers, and typesetters.
Occup Environ Med 2001; 58: 523-7
Abstract Related articles

SCHLEGEL PN
What’s new in urology.
J Am Coll Surg 2001; 193: 179-201
Abstract Related articles

PITARD A, Brennan P, Clavel J, Greiser E, Lopez-Abente G, Chang-Claude J et al
Cigar, pipe, and cigarette smoking and bladder cancer risk in European men.
Cancer Causes Control 2001; 12: 551-6
Abstract Related articles

HARADA H, Omura K, Maeda A
A massive pleomorphic adenoma of the submandibular salivary gland accompanied by neurilemomas of the neck misdiagnosed as a malignant tumor: report of case.
J Oral Maxillofac Surg 2001; 59: 931-5
Abstract Related articles

MCKENNEY JK, Desai S, Cohen C, Amin MB
Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens.
Am J Surg Pathol 2001; 25: 1074-8
Abstract Related articles

WATANABE K, Baba K, Saito A, Hoshi N, Suzuki T
Pseudosarcomatous myofibroblastic tumor and myosarcoma of the urogenital tract.
Arch Pathol Lab Med 2001; 125: 1070-3
Abstract Related articles

OZER E, Yorukoglu K, Mungan MU, Ozkal S, Demirel D, Sagol O et al
Prognostic significance of nuclear morphometry in superficial bladder cancer.
Anal Quant Cytol Histol 2001; 23: 251-6
Abstract Related articles

FERNANDEZ-AYALA M, Nan DN, Farinas MC
Vertebral osteomyelitis due to Corynebacterium striatum.
Am J Med 2001; 111: 167
Abstract Related articles

SHOCHINA M, Fellig Y, Sughayer M, Pizov G, Vitner K, Podeh D et al
Nitric oxide synthase immunoreactivity in human bladder carcinoma.
Mol Pathol 2001; 54: 248-52
Abstract Related articles

BEKELE L, Vidal Vazquez M, Adjei AA
Systemic chemotherapy in patients with renal failure.
Am J Clin Oncol 2001; 24: 382-4
Abstract Related articles

UCHIDA T, Ohori M, Egawa S
[Minimally invasive therapy for bladder and prostate cancer]
Gan To Kagaku Ryoho 2001; 28: 1094-8
Abstract Related articles

NAKASHIRO KI, Hayashi Y, Kita A, Tamatani T, Chlenski A, Usuda N et al
Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells.
Am J Pathol 2001; 159: 591-7
Abstract Related articles

ROBB-NICHOLSON C
By the way, doctor. Can you tell me if hair dye can cause cancer?
Harv Womens Health Watch 2001; 8: 8
Abstract Related articles

DUNST J
[Long-term outcome of radical cystectomy in urinary bladder carcinoma]
Strahlenther Onkol 2001; 177: 437-8
Abstract Related articles

CHABANNES E, Fauconnet S, Bernardini S, Wallerand H, Adessi G, Bittard H
Protein kinase C signalling pathway is involved in the regulation of vascular endothelial growth factor expression in human bladder transitional carcinoma cells.
Cell Signal 2001; 13: 585-91
Abstract Related articles

MAEDA K, Nomata K, Noguchi M, Kanetake H
Angiogenin expression in superficial bladder cancer.
Hinyokika Kiyo 2001; 47: 547-52
Abstract Related articles

HARA S, Miyake H, Fujisawa M, Okada H, Arakawa S, Kamidono S et al
Prognostic variables in patients who have undergone radical cystectomy for transitional cell carcinoma of the bladder.
Jpn J Clin Oncol 2001; 31: 399-402
Abstract Related articles

KAMUHABWA AR, Agostinis PM, D’Hallewin MA, Baert L, de Witte PA
Cellular photodestruction induced by hypericin in AY-27 rat bladder carcinoma cells.
Photochem Photobiol 2001; 74: 126-32
Abstract Related articles

INAI H, Shimazui T, Yamamoto T, Yamauchi A, Uchida K, Takeshima H et al
[A case of transitional cell carcinoma of the urinary bladder with high serum level of CEA and CA19-9]
Hinyokika Kiyo 2001; 47: 583-6
Abstract Related articles

RUCHARDT A, Gruber B, Trenkwalder P
[Intrapulmonary tumor cell embolism from cancer of the bladder as the cause of a subacute cor pulmonale]
Dtsch Med Wochenschr 2001; 126: 847-50
Abstract Related articles

INOUE K, Yoshikawa T, Kawahito Y, Sano H
What is proper treatment for Wegener granulomatosis?
Arch Intern Med 2001; 161: 1777-8
Abstract Related articles

JIA L, Srinivasula SM, Liu FT, Newland AC, Fernandes-Alnemri T, Alnemri ES et al
Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells.
Blood 2001; 98: 414-21
Abstract Related articles

BAHRENBERG G, Brauers A, Joost HG, Jakse G
PSCA expression is regulated by phorbol ester and cell adhesion in the bladder carcinoma cell line RT112.
Cancer Lett 2001; 168: 37-43
Abstract Related articles

KIMOTO N, Hirose M, Futakuchi M, Iwata T, Kasai M, Shirai T
Site-dependent modulating effects of conjugated fatty acids from safflower oil in a rat two-stage carcinogenesis model in female Sprague- Dawley rats.
Cancer Lett 2001; 168: 15-21
Abstract Related articles

NEWMAN L
Bladder cancer chemotherapy trial generates more questions than it answers.
J Natl Cancer Inst 2001; 93: 973-5
Abstract Related articles

JACOBSEN GK
[Not god enough, Ugeskriftet--and not satisfactory in these quality- conscious times]
Ugeskr Laeger 2001; 163: 3817-8
Abstract Related articles

MUREN LP, Jebsen N, Gustafsson A, Dahl O
Can dose-response models predict reliable normal tissue complication probabilities in radical radiotherapy of urinary bladder cancer? The impact of alternative radiation tolerance models and parameters.
Int J Radiat Oncol Biol Phys 2001; 50: 627-37
Abstract Related articles

BALDI A, Santini D, Paggi MG
Association for Molecular Pathology: Sixth annual meeting in Denver, November 9-12, 2000.
J Cell Physiol 2001; 188: 139-42
Abstract Related articles

NOCITO A, Bubendorf L, Maria Tinner E, Suess K, Wagner U, Forster T et al
Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade.
J Pathol 2001; 194: 349-57
Abstract Related articles

KRAM A, Li L, Zhang RD, Yoon DS, Ro JY, Johnston D et al
Mapping and genome sequence analysis of chromosome 5 regions involved in bladder cancer progression.
Lab Invest 2001; 81: 1039-48
Abstract Related articles

BUBENDORF L, Grilli B, Sauter G, Mihatsch MJ, Gasser TC, Dalquen P
Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings.
Am J Clin Pathol 2001; 116: 79-86
Abstract Related articles

LATTERMANN R, Schricker T, Wachter U, Georgieff M, Goertz A
Understanding the mechanisms by which isoflurane modifies the hyperglycemic response to surgery.
Anesth Analg 2001; 93: 121-7
Abstract Related articles

CHAN TY, Epstein JI
In situ adenocarcinoma of the bladder.
Am J Surg Pathol 2001; 25: 892-9
Abstract Related articles

LEUSCHNER I, Harms D, Mattke A, Koscielniak E, Treuner J
Rhabdomyosarcoma of the urinary bladder and vagina: a clinicopathologic study with emphasis on recurrent disease: a report from the Kiel Pediatric Tumor Registry and the German CWS Study.
Am J Surg Pathol 2001; 25: 856-64
Abstract Related articles

JIANG J, Ulbright TM, Younger C, Sanchez K, Bostwick DG, Koch MO et al
Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis.
Arch Pathol Lab Med 2001; 125: 921-3
Abstract Related articles

BOARDMAN CH, Webb MJ, Cheville JC, Lerner SE, Zincke H
Transitional cell carcinoma of the bladder mimicking recurrent paget’s disease of the vulva: report of two cases, with one occurring in a myocutaneous flap.
Gynecol Oncol 2001; 82: 200-4
Abstract Related articles

VOLM T, Pfaff P, Gnann R, Kreienberg R
Bladder carcinoma associated with cyclophosphamide therapy for ovarian cancer occurring with a latency of 20 years.
Gynecol Oncol 2001; 82: 197-9
Abstract Related articles

AMLING CL
Diagnosis and management of superficial bladder cancer.
Curr Probl Cancer 2001; 25: 224-78
Abstract Related articles

KHALBUSS WE, Hossain M, Elhosseiny A
Primary malignant melanoma of the urinary bladder diagnosed by urine cytology: a case report.
Acta Cytol 2001; 45: 631-5
Abstract Related articles

YLAGAN LR, Humphrey PA
Micropapillary variant of transitional cell carcinoma of the urinary bladder: a report of three cases with cytologic diagnosis in urine specimens.
Acta Cytol 2001; 45: 599-604
Abstract Related articles

ZAHER A, Sheridan T
Tumor markers in the detection of recurrent transitional cell carcinoma of the bladder: a brief review.
Acta Cytol 2001; 45: 575-81
Abstract Related articles

PETRYLAK DP
Transitional cell carcinoma of the bladder: new approaches to the treatment of advanced disease.
Curr Oncol Rep 2001; 3: 285-6
Abstract Related articles

HUSSAIN SA, Moffitt DD, Glaholm JG, Peake D, Wallace DM, James ND
A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer.
Ann Oncol 2001; 12: 929-35
Abstract Related articles

FUKUI I, Yonese J, Tsukamoto T, Yoshida T, Kim T, Tohma T et al
Combination chemotherapy with ifosfamide, 5-fluorouracil, etoposide and cisplatin for metastatic urothelial cancer.
Cancer Chemother Pharmacol 2001; 48: 88-93
Abstract Related articles

DOTAN ZA, Mor Y, Aviel-Ronen S, Ramon J
[Nephrogenic adenoma--benign lesion of urinary tract system]
Harefuah 2001; 140: 600-2, 678
Abstract Related articles

TURNER SD, Tinwell H, Piegorsch W, Schmezer P, Ashby J
The male rat carcinogens limonene and sodium saccharin are not mutagenic to male Big Blue rats.
Mutagenesis 2001; 16: 329-32
Abstract Related articles

SARI R, Buyukberber S, Sevinc A, Mizrak B
Synchronous primary malignant neoplasms of colon and bladder.
Indian J Gastroenterol 2001; 20: 156-7
Abstract Related articles

SPAHN M, Portillo FJ, Grobholz R, Junemann KP, Alken P
[Fibromyxoid pseudosarcoma of the urinary bladder. Case report and review of the literature of a rare disease]
Urologe A 2001; 40: 315-8
Abstract Related articles

KUROMATSU I, Matsuo K, Takamura S, Kim G, Takebe Y, Kawamura J et al
Induction of effective antitumor immune responses in a mouse bladder tumor model by using DNA of an alpha antigen from mycobacteria.
Cancer Gene Ther 2001; 8: 483-90
Abstract Related articles

KIMURA M, Kashiwagi H, Furuta T, Otsuka K, Satou T, Hashimoto S et al
Carcinoma of the urinary bladder with a lymphomatous appearance.
Pathol Int 2001; 51: 555-9
Abstract Related articles

KHALED HM, Raafat A, Mokhtar N, Zekri AR, Gaballah H
Human papilloma virus infection and overexpression of p53 protein in bilharzial bladder cancer.
Tumori 2001; 87: 256-61
Abstract Related articles

WOLF K
[HIV-infected patient with macrohematuria. Urothelial carcinoma of the urinary bladder]
Schweiz Rundsch Med Prax 2001; 90: 1159-61
Abstract Related articles

LINDSEY JK
A general family of distributions for longitudinal dependence with special reference to event histories.
Stat Med 2001; 20: 1625-38
Abstract Related articles

VILLANUEVA CM, Kogevinas M, Grimalt JO
[Drinking water chlorination and adverse health effects: review of epidemiological studies]
Med Clin (Barc) 2001; : 27-35
Abstract Related articles

RANDAL J
Telomerase still ’investigational’ in its application to cancer management.
J Natl Cancer Inst 2001; 93: 800-1
Abstract Related articles

FUKUSHIMA S
Possible involvement of O6-methylguanine formation and p53 dysfunction in mouse urinary bladder carcinogenesis.
Mutat Res 2001; 477: 125-30
Abstract Related articles

LANE T
BCG immunotherapy for superficial bladder cancer.
J R Soc Med 2001; 94: 316
Abstract Related articles

NAKOPOULOU L, Gakiopoulou H, Zervas A, Giannopoulou I, Constantinides C, Lazaris AC et al
MMP-3 mRNA and MMP-3 and MMP-1 proteins in bladder cancer: a comparison with clinicopathologic features and survival.
Appl Immunohistochem Molecul Morphol 2001; 9: 130-7
Abstract Related articles

LA VECCHIA C, Tavani A
Hair dyes and bladder cancer: an update.
Eur J Cancer Prev 2001; 10: 205-8
Abstract Related articles

VAUGHN DJ, Malkowicz SB
Recent developments in chemotherapy for bladder cancer.
Oncology (Huntingt) 2001; : 763-71, 775
Abstract Related articles

BILLEREY C, Chopin D, Aubriot-Lorton MH, Ricol D, Gil Diez de Medina S, Van Rhijn B et al
Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors.
Am J Pathol 2001; 158: 1955-9
Abstract Related articles

GIOVAGNOLI MR, Rocchi M, Grillo L, Vecchione A
The significance of Urothelial dysplasia in the follow-up of patients who underwent surgery for bladder cancer.
Minerva Urol Nefrol 2001; 53: 93-7
Abstract Related articles

SUN HZ, Wu SF, Tu ZH
Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity.
Cell Res 2001; 11: 107-15
Abstract Related articles

GHALAYINI IF, Bani-Hani IH, Almasri NM
Osteosarcoma of the urinary bladder occurring simultaneously with prostate and bowel carcinomas: report of a case and review of the literature.
Arch Pathol Lab Med 2001; 125: 793-5
Abstract Related articles

KIMURA F, Florl AR, Steinhoff C, Golka K, Willers R, Seifert HH et al
Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder.
Mutat Res 2001; 458: 49-54
Abstract Related articles

METZE K, Cia EM, Trevisan MA
Clinical value of interphase argyrophilic nucleolar organiser regions in transitional cell bladder tumours.
Mol Pathol 2001; 54: 200
Abstract Related articles

KORKOLOPOULOU P, Konstantinidou AE, Kavantzas N, Patsouris E, Pavlopoulos PM, Christodoulou P et al
Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer.
Virchows Arch 2001; 438: 603-11
Abstract Related articles

CINA SJ, Epstein JI, Endrizzi JM, Harmon WJ, Seay TM, Schoenberg MP
Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder.
Hum Pathol 2001; 32: 630-7
Abstract Related articles

ALPERT M
A touch of poison.
Sci Am 2001; 284: 20-1
Abstract Related articles

LOPEZ-BELTRAN A, Luque RJ, Vicioso L, Anglada F, Requena MJ, Quintero A et al
Lymphoepithelioma-like carcinoma of the urinary bladder: a clinicopathologic study of 13 cases.
Virchows Arch 2001; 438: 552-7
Abstract Related articles

TATSURA H, Ogawa K, Sakata T, Okamura T
A nested variant of transitional cell carcinoma of the urinary bladder: a case report.
Jpn J Clin Oncol 2001; 31: 287-9
Abstract Related articles

MAASE H
Gemcitabine-containing regimens in bladder cancer: A new standard of care.
Semin Oncol 2001; 28: 1-3
Abstract Related articles

COOSEMANS W, Baert L, Kuypers D, Maes B, Messiaen T, Vanrenterghem Y et al
Renal transplantation onto abnormal urinary tract: ileal conduit urinary diversion.
Transplant Proc 2001; 33: 2493-4
Abstract Related articles

OZDEMIR BH, Ozdemir OG, Sertcelik A
The prognostic importance of the nucleolar organizer region (AgNOR), Ki- 67 and proliferating cell nuclear antigen (PCNA) in primary nonurachal bladder adenocarcinoma.
APMIS 2001; 109: 428-34
Abstract Related articles

BRENNAN P, Bogillot O, Greiser E, Chang-Claude J, Wahrendorf J, Cordier S et al
The contribution of cigarette smoking to bladder cancer in women (pooled European data).
Cancer Causes Control 2001; 12: 411-7
Abstract Related articles

CARLES J, Nogue M
Gemcitabine/carboplatin in advanced urothelial cancer.
Semin Oncol 2001; 28: 19-24
Abstract Related articles

KOCHAKARN W, Chaimuangraj S, Leenanupunth C, Muangman V
Risk factors of urethral involvement of bladder cancer after radical cystectomy with orthotopic neobladder in females.
J Med Assoc Thai 2001; 84: 889-92
Abstract Related articles

KAWANISHI H, Aoyama T, Yoshida T, Sasaki M, Itoh T
[Bladder carcinoma producing granulocyte colony-stimulating factor (G- CSF): a case report]
Hinyokika Kiyo 2001; 47: 429-32
Abstract Related articles

MARRERO E, Bulnes C, Sanchez LM, Palenzuela I, Stuart R, Jacobs F et al
Pteridium aquilinum (bracken fern) toxicity in cattle in the humid Chaco of Tarija, Bolivia.
Vet Hum Toxicol 2001; 43: 156-8
Abstract Related articles

KUZNETSOV DD, Alsikafi NF, O’Connor RC, Steinberg GD
Intravesical valrubicin in the treatment of carcinoma in situ of the bladder.
Expert Opin Pharmacother 2001; 2: 1009-13
Abstract Related articles

IMAOKA S, Yoneda Y, Sugimoto T, Ikemoto S, Hiroi T, Yamamoto K et al
Androgen regulation of CYP4B1 responsible for mutagenic activation of bladder carcinogens in the rat bladder: detection of CYP4B1 mRNA by competitive reverse transcription-polymerase chain reaction.
Cancer Lett 2001; 166: 119-23
Abstract Related articles

KOENIG F, Knittel J, Stepp H
Diagnosing cancer in vivo.
Science 2001; 292: 1401-3
Abstract Related articles

MAI KT, Yazdi HM, Farmer J
Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
Prostate 2001; 47: 172-82
Abstract Related articles

VAN TILBORG AA, de Vries A, Zwarthoff EC
The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer.
J Pathol 2001; 194: 76-80
Abstract Related articles

COZZI PJ, Malhotra S, McAuliffe P, Kooby DA, Federoff HJ, Huryk B et al
Intravesical oncolytic viral therapy using attenuated, replication- competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.
FASEB J 2001; 15: 1306-1308
Abstract Related articles

GROFF DB
Pelvic neoplasms in children.
J Surg Oncol 2001; 77: 65-71
Abstract Related articles

CINA SJ, Lancaster-Weiss KJ, Lecksell K, Epstein JI
Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia.
Arch Pathol Lab Med 2001; 125: 646-51
Abstract Related articles

LANGEN KM, Jones DT
Organ motion and its management.
Int J Radiat Oncol Biol Phys 2001; 50: 265-78
Abstract Related articles

GROB BM, Macchia RJ
Radical transurethral resection in the management of muscle-invasive bladder cancer.
J Endourol 2001; 15: 419-23
Abstract Related articles

NONOMURA N, Nishimura K, Okuyama A, Miki T, Kishimoto T, Kiyohara H et al
[Prophylactic effect of pirarubicin (THP) on postoperative recurrence of superficial bladder cancer in terms of intravesical retention time]
Hinyokika Kiyo 2001; 47: 315-9
Abstract Related articles

FUKUI Y, Samma S, Fujimoto K, Akiyama T, Yamaguchi A, Hirayama A
[Screening methods in the detection of bladder cancer: comparison of nuclear matrix protein-22, bladder tumor antigen and cytological examinations]
Hinyokika Kiyo 2001; 47: 311-4
Abstract Related articles

VOLANTE M, Tizzani A, Casetta G, Zitella A, Pacchioni D, Bussolati G
Progression from superficial to invasive carcinoma of the bladder: genetic evidence of either clonal heterogeneous events.
Hum Pathol 2001; 32: 468-74
Abstract Related articles

KASAI T, Moriyama K, Tsuji M, Uema K, Sakurai N
[A case of vaginal implantation of transitional cell carcinoma of the bladder]
Nippon Hinyokika Gakkai Zasshi 2001; 92: 538-41
Abstract Related articles

AKAGASHI K, Tanda H, Kato S, Ohnishi S, Nakajima H, Nanbu A et al
[Availability of NMP22 (nuclear matrix protein 22) for the diagnosis of urothelial cancer]
Hinyokika Kiyo 2001; 47: 307-10
Abstract Related articles

SALANITRI J, Smith P, Schlicht S
Multifocal malignant extra-adrenal paragangliomas of the Organ of Zuckerkandl and urinary bladder.
Australas Radiol 2001; 45: 229-32
Abstract Related articles

JAN CR, Yu CC, Huang JK
Dual effect of the antianginal drug fendiline on bladder female transitional carcinoma cells: mobilization of intracellular CA2+ and induction of cell death.
Pharmacology 2001; 62: 218-23
Abstract Related articles

TAUBER S, Liedl B, Schneede P, Liessmann F, Waidelich R, Hofstetter A
[Fluorescence cytology of the urinary bladder]
Urologe A 2001; 40: 217-21
Abstract Related articles

AKASAKA S, Suzuki S, Shimizu H, Igarashi T, Akimoto M, Shimada T
Suicide gene therapy for chemically induced rat bladder tumor entailing instillation of adenoviral vectors.
Jpn J Cancer Res 2001; 92: 568-75
Abstract Related articles

MURRAY A, Simms MS, Scholfield DP, Vincent RM, Denton G, Bishop MC et al
Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancer.
J Nucl Med 2001; 42: 726-32
Abstract Related articles

MCCLELLAN T, DeBord J, Franklin G, Tierney J
Small cell neuroendocrine carcinoma of the urinary bladder: case report of a rare primary tumor.
W V Med J 2001; 97: 151-2
Abstract Related articles

LLORET C, Segui A, Bueso E, Chorda D
[Bilateral ureteral pseudodiverticulosis with transitional cell tumour]
J Radiol 2001; 82: 586-8
Abstract Related articles

LIU CC, Chou YH, Huang CH, Tsai KB
Bladder wall calcification after intravesical chemotherapy with mitomycin C--a case report.
Kaohsiung J Med Sci 2001; 17: 274-7
Abstract Related articles

WEYER PJ, Cerhan JR, Kross BC, Hallberg GR, Kantamneni J, Breuer G et al
Municipal drinking water nitrate level and cancer risk in older women: the Iowa Women’s Health Study.
Epidemiology 2001; 12: 327-38
Abstract Related articles

TANG KY, Lu T, Chang CH, Lo YK, Cheng JS, Wang JL et al
Effect of fluoxetine on intracellular Ca2+ levels in bladder female transitional carcinoma (BFTC) cells.
Pharmacol Res 2001; 43: 503-8
Abstract Related articles

SHOENFELD Y, Aron-Maor A, Tanai A, Ehrenfeld M
Bcg and autoimmunity: another two-edged sword.
J Autoimmun 2001; 16: 235-40
Abstract Related articles

PIETROW PK, Smith JA Jr
Laser treatment for invasive and noninvasive carcinoma of the bladder.
J Endourol 2001; 15: 415-8
Abstract Related articles

DE COURTEN A, Irle C, Samson J, Lombardi T
Metastatic transitional cell carcinoma of the urinary bladder presenting as a mandibular gingival swelling.
J Periodontol 2001; 72: 688-90
Abstract Related articles

KOCHAKARN W, Kongchareonsombat W, Tirapanich W
Squamous cell carcinoma of the eviscerated bladder: a case report.
J Med Assoc Thai 2001; 84: 735-7
Abstract Related articles

KIM HC, Kim SH, Hwang SI, Lee HJ, Han JK
Isolated bladder metastases from stomach cancer: CT demonstration.
Abdom Imaging 2001; 26: 333-5
Abstract Related articles

BERNHARDT TM, Rapp-Bernhardt U
Virtual cystoscopy of the bladder based on CT and MRI data.
Abdom Imaging 2001; 26: 325-32
Abstract Related articles

CHANG HT, Huang JK, Wang JL, Cheng JS, Lee KC, Lo YK et al
Tamoxifen-induced Ca2+ mobilization in bladder female transitional carcinoma cells.
Arch Toxicol 2001; 75: 184-8
Abstract Related articles

STROHMER H, Roehlich M, Hafner E, Maier U
Leiomyoma of the vesicovaginal septum.
Arch Gynecol Obstet 2001; 265: 94-5
Abstract Related articles

BOSCH X
Bladder cancer risk higher for women smokers.
BMJ 2001; 322: 948B
Abstract Related articles

MONTIE JE
Intravesical Therapy for Bladder Cancer: Empiricism at the Helm.
J Natl Cancer Inst 2001; 93: 572-3
Abstract Related articles

AU JL, Badalament RA, Wientjes MG, Young DC, Warner JA, Venema PL et al
Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial.
J Natl Cancer Inst 2001; 93: 597-604
Abstract Related articles

MYDTSKOV M, Hansen KH
[Primary, small cell carcinoma of the urinary bladder]
Ugeskr Laeger 2001; 163: 2256
Abstract Related articles

PAO MM, Tsutsumi M, Liang G, Uzvolgyi E, Gonzales FA, Jones PA
The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells.
Hum Mol Genet 2001; 10: 903-10
Abstract Related articles

OZCELIK N, Kosar A, Soysal D
Ochratoxin A in human serum samples collected in Isparta-Turkey from healthy individuals and individuals suffering from different urinary disorders.
Toxicol Lett 2001; 121: 9-13
Abstract Related articles

CASTELAO JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS et al
Gender- and smoking-related bladder cancer risk.
J Natl Cancer Inst 2001; 93: 538-45
Abstract Related articles

EL MAWLA NG, El Bolkainy MN, Khaled HM
Bladder cancer in Africa: Update.
Semin Oncol 2001; 28: 174-8
Abstract Related articles

FARBER A, Grigoryants V, Palac DM, Chapman T, Cronenwett JL, Powell RJ
Primary aortoduodenal fistula in a patient with a history of intravesical therapy for bladder cancer with bacillus Calmette-Guerin: Review of primary aortoduodenal fistula without abdominal aortic aneurysm.
J Vasc Surg 2001; 33: 868-73
Abstract Related articles

MUREN LP, Hafslund R, Gustafsson A, Smaaland R, Dahl O
Partially wedged beams improve radiotherapy treatment of urinary bladder cancer.
Radiother Oncol 2001; 59: 21-30
Abstract Related articles

LIU J, Lee P, Galbiati F, Kitsis RN, Lisanti MP
Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation.
Am J Physiol Cell Physiol 2001; 280: C823-35
Abstract Related articles

KOGA S, Kondo Y, Komata T, Kondo S
Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA.
Gene Ther 2001; 8: 654-658
Abstract Related articles

CLIFFORD JL, Sabichi AL, Zou C, Yang X, Steele VE, Kelloff GJ et al
Effects of Novel Phenylretinamides on Cell Growth and Apoptosis in Bladder Cancer.
Cancer Epidemiol Biomarkers Prev 2001; 10: 391-395
Abstract Related articles

MOONEN L, Ong F, Gallee M, Verheij M, Horenblas S, Hart AA et al
Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.
Int J Radiat Oncol Biol Phys 2001; 49: 1305-10
Abstract Related articles

OHTA K, Sawamura A, Miyahara E, Kim R, Toge T
[A case of inoperable advanced gall bladder cancer responding to intra- arterial infusion of 5-fluorouracil (5-FU) and leucovorin (LV)]
Gan To Kagaku Ryoho 2001; 28: 516-9
Abstract Related articles

TSUSHIMA T, Kobashi K, Akebi N, Yamato T, Asahi T, Maki Y et al
[Early phase II study of amrubicin (SM-5887) for superficial bladder cancer: a dose-finding study for intravesical chemotherapy]
Gan To Kagaku Ryoho 2001; 28: 483-91
Abstract Related articles

OHMORI H, Yamato T, Asahi T
[Phase I study of amrubicin hydrochroride (SM-5887) for superficial bladder cancer in intravesical chemotherapy]
Gan To Kagaku Ryoho 2001; 28: 475-82
Abstract Related articles

NAKOPOULOU L, Zervas A, Lazaris AC, Constantinides C, Stravodimos C, Davaris P et al
Predictive value of topoisomerase II alpha immunostaining in urothelial bladder carcinoma.
J Clin Pathol 2001; 54: 309-13
Abstract Related articles

VERHAGEN PC, Nikkels PG, de Jong TP
Eosinophilic cystitis.
Arch Dis Child 2001; 84: 344-6
Abstract Related articles

VLAHOU A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L et al
Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine.
Am J Pathol 2001; 158: 1491-502
Abstract Related articles

VON DER MAASE H
Gemcitabine in advanced bladder cancer.
Semin Oncol 2001; 28: 11-4
Abstract Related articles

STERNBERG CN, Calabro F
Neo-adjuvant chemotherapy in invasive bladder cancer.
World J Urol 2001; 19: 94-8
Abstract Related articles

LEHMANN J, Retz M, Stockle M
The role of adjuvant chemotherapy for locally advanced bladder cancer.
World J Urol 2001; 19: 133-40
Abstract Related articles

ALSHEIKH A, Mohamedali Z, Jones E, Masterson J, Gilks CB
Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Mod Pathol 2001; 14: 267-72
Abstract Related articles

GALINKIN D, Katz S, Greenwald M, Fagelman D
Pseudotumor of the bladder as a manifestation of uncomplicated appendicitis.
J Clin Gastroenterol 2001; 32: 367-8
Abstract Related articles

KUROKAWA S, Morita T, Muraishi O, Tokue A
[Clinical evaluation of urinary nuclear matrix protein 22 as a marker for bladder cancer]
Hinyokika Kiyo 2001; 47: 247-50
Abstract Related articles

OHUCHI H, Noguchi S, Takase K, Kawakami S, Ikeda I, Saito K et al
[Study of neoadjuvant chemotherapy for invasive bladder cancer with MEC (methotrexate, epirubicin, cisplatin) therapy]
Hinyokika Kiyo 2001; 47: 241-6
Abstract Related articles

ZEEGERS MP, Dorant E, Goldbohm RA, van den Brandt PA
Are coffee, tea, and total fluid consumption associated with bladder cancer risk? Results from the Netherlands Cohort Study.
Cancer Causes Control 2001; 12: 231-8
Abstract Related articles

BITTORF B, Kessler H, Merkel S, Bruckl W, Wein A, Ballhausen WG et al
Multiple primary malignancies: An epidemiological and pedigree analysis of 57 patients with at least three tumours.
Eur J Surg Oncol 2001; 27: 302-13
Abstract Related articles

POGGIANI C, Teani M, Auriemma A, Bianchi P, Sadou Y
Sonographic detection of rhabdomyosarcoma of the urinary bladder.
Eur J Ultrasound 2001; 13: 35-9
Abstract Related articles

HASEGAWA M, Yagi K, Iwakawa S, Hirai M
Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells.
Jpn J Cancer Res 2001; 92: 459-66
Abstract Related articles

FUNFSTUCK R, Franke S, Hellberg M, Ott U, Knofel B, Straube E et al
Secretion of cytokines by uroepithelial cells stimulated by Escherichia coli and Citrobacter spp.
Int J Antimicrob Agents 2001; 17: 253-8
Abstract Related articles

AMANO T, Fukuda M, Imao T, Takemae K
[A case of septic shock due to ileal conduit obstruction]
Hinyokika Kiyo 2001; 47: 285-8
Abstract Related articles

SHIMASAKI N, Yamasaki I, Kamada M, Syuin T
[Two cases of successful treatments with steroid for local and systemic hypersensitivity reaction following intravesical instillation of Bacillus Calmette-Guerin]
Hinyokika Kiyo 2001; 47: 281-4
Abstract Related articles

UEMURA M, Inoue H, Nishimura K, Mizutani S, Miyoshi S
[Transitional cell carcinoma of the bladder in a young patient: a case report]
Hinyokika Kiyo 2001; 47: 277-9
Abstract Related articles

TAMURA K, Inoue K, Fukata S, Kamada M, Shuin T
[Small cell carcinoma of the urinary bladder with synchronous esophageal cancer and incidental lung cancer: a case report]
Hinyokika Kiyo 2001; 47: 273-6
Abstract Related articles

UEMURA M, Inoue H, Nishimura K, Mizutani S, Miyoshi S, Ota H
[A case of urothelial tumors which occurred simultaneously in bilateral upper urinary tracts and bladder presenting with anuria]
Hinyokika Kiyo 2001; 47: 269-71
Abstract Related articles

BUDGELL GJ, Mott JH, Logue JP, Hounsell AR
Clinical implementation of dynamic multileaf collimation for compensated bladder treatments.
Radiother Oncol 2001; 59: 31-8
Abstract Related articles

MADY EA
Cytokeratins as serum markers in egyptian bladder cancer. A comparison of CYFRA 21-1, TPA and TPS.
Int J Biol Markers 2001; 16: 130-5
Abstract Related articles

SUAREZ PINERA M, Alonso JC, Bittini A, Dominguez P, Almoguera I, Ortega A et al
[Urinary pheochromocytoma with normal hormone levels]
Rev Clin Esp 2001; 201: 226-7
Abstract Related articles

ZAMECNIK M, Michal M, Hes O, Velickinova H
Benign ectopic prostatic glands in subvesical skeletal muscle. A lesion resembling carcinoma.
Cesk Patol 2001; 37: 65-8
Abstract Related articles

LONGATTO FILHO A, Santinelli A, Montironi R
Cytometric investigations of bladder irrigation/washing and voided urine.
Pathologica 2001; 93: 164-7
Abstract Related articles

DARVISHIAN F, Teichberg S, Meyersfield S, Urmacher CD
Concurrent malakoplakia and papillary urothelial carcinoma of the urinary bladder.
Ann Clin Lab Sci 2001; 31: 147-50
Abstract Related articles

SCHAFFER M, Schaffer PM, Panzer M, Wilkowski R, Duhmke E
Porphyrias associated with malignant tumors: results of treatment with ionizing irradiation.
Onkologie 2001; 24: 170-2
Abstract Related articles

DIETRICH H, Dietrich B
Ludwig Rehn (1849-1930)--pioneering findings on the aetiology of bladder tumours.
World J Urol 2001; 19: 151-3
Abstract Related articles

COHEN EE, Stadler WM
Treatment of metastatic urothelial cancer in the post-MVAC era.
World J Urol 2001; 19: 126-32
Abstract Related articles

ROY MK, Islam MF, Kibria SA
Role of ultrasonography and urinary cytology in diagnosing recurrence of superficial urinary bladder cancer compared to cystoscopy.
Bangladesh Med Res Counc Bull 2001; 27: 23-32
Abstract Related articles

MAZUMDAR M, Fazzari M, Panageas KS
A standardization method to adjust for the effect of patient selection in phase II clinical trials.
Stat Med 2001; 20: 883-92
Abstract Related articles

HEMSTREET GP 3RD, Yin S, Ma Z, Bonner RB, Bi W, Rao JY et al
Biomarker Risk Assessment and Bladder Cancer Detection in a Cohort Exposed to Benzidine.
J Natl Cancer Inst 2001; 93: 427-436
Abstract Related articles

GAZDAR AF, Czerniak B
Filling the void: urinary markers for bladder cancer risk and diagnosis.
J Natl Cancer Inst 2001; 93: 413-4
Abstract Related articles

BEECKEN WD, Fernandez A, Joussen AM, Achilles EG, Flynn E, Lo KM et al
Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice.
J Natl Cancer Inst 2001; 93: 382-7
Abstract Related articles

COZZI PJ, Malhotra S, McAuliffe P, Kooby DA, Federoff HJ, Huryk B et al
Intravesical oncolytic viral therapy using attenuated, replication- competent, herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model.
FASEB J 2001; :
Abstract Related articles

PRIOLO G, Gontero P, Martinasso G, Mengozzi G, Formiconi A, Pelucelli G et al
Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer.
Clin Chim Acta 2001; 305: 47-53
Abstract Related articles

LAMM DL, Riggs DR
Enhanced immunocompetence by garlic: role in bladder cancer and other malignancies.
J Nutr 2001; 131: 1067S-70S
Abstract Related articles

MCKENNEY JK, Gomez JA, Desai S, Lee MW, Amin MB
Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion.
Am J Surg Pathol 2001; 25: 356-62
Abstract Related articles

GANAHA F, Yamada T, Ujita M, Irie T, Fukuda Y, Fukuda K
Intraarterial Low-dose Cisplatin via an Indwelling Port and Concurrent Radiotherapy for Invasive Bladder Cancer.
J Vasc Interv Radiol 2001; 12: 379-384
Abstract Related articles

LOCKYER CR, Gillatt DA
BCG immunotherapy for superficial bladder cancer.
J R Soc Med 2001; 94: 119-23
Abstract Related articles

Hair dye and cancer.
Health News 2001; 7: 8
Abstract Related articles

RISTIMAKI A, Nieminen O, Saukkonen K, Hotakainen K, Nordling S, Haglund C
Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder.
Am J Pathol 2001; 158: 849-53
Abstract Related articles

AL-MAGHRABI J, Kamel-Reid S, Jewett M, Gospodarowicz M, Wells W, Banerjee D
Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type arising in the urinary bladder: report of 4 cases with molecular genetic analysis.
Arch Pathol Lab Med 2001; 125: 332-6
Abstract Related articles

YAMAMOTO S
Bladder cancer mortality rates by prefectures in Japan.
Jpn J Clin Oncol 2001; 31: 130
Abstract Related articles

SHISHIDO T, Itou T, Ono Y, Arai Y, Miki M
[Adenocarcinoma of the renal pelvis and transitional cell carcinoma of the ureter occurring 11 years after radical cystectomy for bladder cancer: a case report]
Hinyokika Kiyo 2001; 47: 187-90
Abstract Related articles

BAITHUN SI, Naase M, Blanes A, Diaz-Cano SJ
Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications.
Virchows Arch 2001; 438: 289-97
Abstract Related articles

CHEN CC, Shieh B, Jin YT, Liau YE, Huang CH, Liou JT et al
Microarray profiling of gene expression patterns in bladder tumor cells treated with genistein.
J Biomed Sci 2001; 8: 214-22
Abstract Related articles

KUMAR NU, Dey P, Mondal AK, Singh SK, Vohra H
DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma.
Diagn Cytopathol 2001; 24: 153-6
Abstract Related articles

GRASSO M, Torelli F, Scannapieco G, Franzoso F, Lania C
Neoadiuvant treatment with intravesical interleukin-2 for recurrent superficial transitional bladder carcinoma Ta-T1/G1-2.
J Immunother 2001; 24: 184-7
Abstract Related articles

HAUTMANN SH, Schroeder GL, Civantos F, Duncan RC, Gnann R, Friedrich MG et al
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]
Urologe A 2001; 40: 121-6
Abstract Related articles

ABBAS F, Biyabani SR, Talati J
Orthotopic bladder replacement to the urethra following salvage radical cystoprostatectomy in men with failed radiation therapy.
Tech Urol 2001; 7: 20-6
Abstract Related articles

YANG CW, Park JH, Park JH, Cho SG, Kim YS, Bang BK
Acute graft dysfunction due to Kaposi sarcoma involving the bladder in a renal transplant recipient.
Nephrol Dial Transplant 2001; 16: 625-7
Abstract Related articles

BUSTO CATANON L, Sanchez Merino JM, Picallo Sanchez JA, Gelabert Mas A
[Clinical prognostic factors in superficial cancer of the urinary bladder]
Arch Esp Urol 2001; 54: 131-8
Abstract Related articles

GOLBANO ABLANQUE JM, Serrano Pascual A, Otero Tejero I, Merino Hernaez C, Chicharro Almarza J, Gonzalez-Permato Gutierrez P
[Detubularized ureterosigmoidostomy Mainz II: a diversion with a future?]
Arch Esp Urol 2001; 54: 123-8
Abstract Related articles

SKOPELITOU AS, Gloustianou G, Bai M, Huebner K
FHIT gene expression in human urinary bladder transitional cell carcinomas.
In Vivo 2001; 15: 169-73
Abstract Related articles

JIMENEZ ARISTU JI, Lozano Urunuela F, de Pablo Cardenas A, Pinos Paul MA, Jimenez Calvo J, Montesino Semper M et al
[Leiomyoma of the bladder. Report of a case]
Actas Urol Esp 2001; 25: 223-5
Abstract Related articles

PAEZ BORDA A, Lujan Galan M, Gomez de Vicente JM, Moreno Santurino A, Abate F, Berenguer Sanchez A
[Preliminary results of the treatment of high grade (T1G3) superficial tumors of the bladder with transurethral resection]
Actas Urol Esp 2001; 25: 187-92
Abstract Related articles

OJEA CALVO A, Nunez Lopez A, Alonso Rodrigo A, Rodriguez Iglesias B, Benavente Delgado J, Barros Rodriguez JM et al
[Value of a second transurethral resection in the assessment and treatment of patients with bladder tumor]
Actas Urol Esp 2001; 25: 182-6
Abstract Related articles

REICHER-REISS H, Jonas M, Goldbourt U, Boyko V, Modan B
Selectively increased risk of cancer in men with coronary heart disease.
Am J Cardiol 2001; 87: 459-62, A6
Abstract Related articles

NEGRI E, La Vecchia C
Epidemiology and prevention of bladder cancer.
Eur J Cancer Prev 2001; 10: 7-14
Abstract Related articles

RIEDEL I, Czernobilsky B, Lifschitz-Mercer B, Roth LM, Wu XR, Sun TT et al
Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Virchows Arch 2001; 438: 181-91
Abstract Related articles

ALLKEMPER T, Tombach B, Heindel W
[Gd-BOPTA enhanced excretory MR urography with administration of diuretics]
Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2001; 173: 115
Abstract Related articles

RODEL C, Dunst J, Grabenbauer GG, Kuhn R, Papadopoulos T, Schrott KM et al
Radiotherapy is an effective treatment for high-risk T1-bladder cancer.
Strahlenther Onkol 2001; 177: 82-8
Abstract Related articles

HOSHI S, Suzuki KI, Shintaku I, Sato K, Kaihou Y, Namima T et al
Two patients with N3 bladder cancer successfully treated by internal iliac arterial infusion chemotherapy and irradiation: case reports.
Am J Clin Oncol 2001; 24: 87-90
Abstract Related articles

PETROVICH Z, Jozsef G, Brady LW
Radiotherapy for carcinoma of the bladder: a review.
Am J Clin Oncol 2001; 24: 1-9
Abstract Related articles

DOBSON MJ, Carrington BM, Collins CD, Ryder WD, Read G, Hutchinson CE et al
The assessment of irradiated bladder carcinoma using dynamic contrast- enhanced MR imaging.
Clin Radiol 2001; 56: 94-8
Abstract Related articles

STERN MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA
DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk.
Cancer Epidemiol Biomarkers Prev 2001; 10: 125-31
Abstract Related articles

VAZIRI SA, Hughes NC, Sampson H, Darlington G, Jewett MA, Grant DM
Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects.
Pharmacogenetics 2001; 11: 7-20
Abstract Related articles

CHEUK W, Kwan MY, Suster S, Chan JK
Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas.
Arch Pathol Lab Med 2001; 125: 228-31
Abstract Related articles

KANAYAMA H
Matrix metalloproteinases and bladder cancer.
J Med Invest 2001; 48: 31-43
Abstract Related articles

VAN DER MEIJDEN AP
Non-specific immunotherapy with bacille Calmette-Guerin (BCG).
Clin Exp Immunol 2001; 123: 179-80
Abstract Related articles

LUO Y, Chen X, Han R, O’Donnell MA
Recombinant bacille Calmette-Guerin (BCG) expressing human interferon- alpha 2B demonstrates enhanced immunogenicity.
Clin Exp Immunol 2001; 123: 264-70
Abstract Related articles

DEBNATH D, Richards DG
A rare coincidence and recurrent urinary tract infections.
Postgrad Med J 2001; 77: 122, 129
Abstract Related articles

AKTAS D, Ozen H, Atsu N, Tekin A, Sozen S, Tuncbilek E
Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. a marker for invasive bladder cancer?
Cancer Genet Cytogenet 2001; 125: 1-4
Abstract Related articles

LEE KH
Evaluation of the NMP22 test and comparison with voided urine cytology in the detection of bladder cancer.
Yonsei Med J 2001; 42: 14-8
Abstract Related articles

TORABI-POUR N, Nouri AM, Perrett D, Oliver RT
Combination of HPLC and solid-phase binding assay for isolation and purification of MHC class I and associated peptides using a bladder tumour cell line.
Biomed Chromatogr 2001; 15: 18-24
Abstract Related articles

AOKI S, Tanaka K, Ohori T, Nishikawa E, Yamada Y, Honda N et al
[A case of transitional cell carcinoma of the bladder in a juvenile patient]
Hinyokika Kiyo 2001; 47: 99-103
Abstract Related articles

TAKEZAWA Y, Inoue M, Kurita S, Nakata S, Kobayashi M, Kosaku N et al
Pheochromocytoma of the urinary bladder: a case report.
Hinyokika Kiyo 2001; 47: 105-7
Abstract Related articles

HOEFFEL JC, Galloy MA
Additional cases of pseudotumoral eosinophilic cystitis.
Pediatr Radiol 2001; 31: 132-3
Abstract Related articles

DROLLER MJ
Maintenance therapy for superficial bladder cancer.
Oncology (Huntingt) 2001; : 239-41
Abstract Related articles

ROOKS V, Beecken WD, Iordanescu I, Taylor GA
Sonographic evaluation of orthotopic bladder tumors in mice treated with TNP-470, an angiogenic inhibitor.
Acad Radiol 2001; 8: 121-7
Abstract Related articles

MERRITT CR
Imaging the results of antiangiogenesis therapy.
Acad Radiol 2001; 8: 119-20
Abstract Related articles

KAMPHUIS JT, Buiting AG, Misere JF, van Berge Henegouwen DP, van Soolingen D, Rensma PL
BCG immunotherapy: be cautious of granulomas. Disseminated BCG infection and mycotic aneurysm as late complications of intravesical BCG instillations.
Neth J Med 2001; 58: 71-5
Abstract Related articles

MARINKOVIC SP, Badlani GH
Imaging of the lower urinary tract in adults.
J Endourol 2001; 15: 75-86
Abstract Related articles

LIN HY, Wu WJ, Jang MY, Shen JT, Tsai HN, Chou YH et al
Cystitis glandularis mimics bladder cancer--three case reports and literature review.
Kaohsiung J Med Sci 2001; 17: 102-6
Abstract Related articles

UYGUR MC, Altug U, Ozgur M, Erol D
The application of appendiceal Mitrofanoff principle to Stanford pouch.
Can J Urol 2001; 8: 1193-8
Abstract Related articles

SUR M, Cooper K, Allard U
Investigation of human papillomavirus in transitional cell carcinomas of the urinary bladder in South Africa.
Pathology 2001; 33: 17-20
Abstract Related articles

HERRANZ AMO F, Verdu Tartajo F, Diez Cordero JM, Bielsa Carrillo A, Garcia Burgos J, Subira Rios D et al
[Differences in survival of patients with bladder cancer depending on depth of muscle infiltration]
Actas Urol Esp 2001; 25: 110-4
Abstract Related articles

SHIMIZU K, Imaida K
Metastatic transitional cell carcinoma or nonsecretory multiple myeloma?
Clin Lab Haematol 2001; 23: 67
Abstract Related articles

SPECHT LK, Landberg T
[Cancer treatment in Skane and in Sjaelland. Do differences concerning examination and treatment explain reduced survival among Danish cancer patients?]
Ugeskr Laeger 2001; 163: 439-42
Abstract Related articles

WOLFENSBERGER UE, Bagot A, Hailemariam S, Garzoli E, Kubik-Huch RA
[Penile metastasis of carcinoma of the urinary bladder]
Schweiz Rundsch Med Prax 2001; 90: 69-71
Abstract Related articles

SMITH SD, Wheeler MA, Plescia J, Colberg JW, Weiss RM, Altieri DC
Urine detection of survivin and diagnosis of bladder cancer.
JAMA 2001; 285: 324-8
Abstract Related articles

ZHANG J, Fan Z, Gao Y, Xiao Z, Li C, An Q et al
Detecting bladder cancer in the Chinese by microsatellite analysis: ethnic and etiologic considerations.
J Natl Cancer Inst 2001; 93: 45-50
Abstract Related articles

BASELLI EC, Greenberg RE
Maintenance therapy for superficial bladder cancer.
Oncology (Huntingt) 2001; : 85-8
Abstract Related articles

SCHMITT WE, Stassar MJ, Schmitt W, Little M, Cochlovius B
In vitro induction of a bladder cancer-specific T-cell response by mRNA- transfected dendritic cells.
J Cancer Res Clin Oncol 2001; 127: 203-6
Abstract Related articles

HOGAN TF, Lamm DL, Riggs DR, Ducatman AM
Smoking and bladder cancer.
W V Med J 2001; 97: 29-31
Abstract Related articles

ITO M, Okumura K, Nishio Y
[A case of human chorionic gonadotropin-producing bladder cancer]
Hinyokika Kiyo 2001; 47: 47-9
Abstract Related articles

OEDA T, Manabe D
[The usefulness of urinary FDP in the diagnosis of bladder cancer: comparison with NMP22, BTA and cytology]
Nippon Hinyokika Gakkai Zasshi 2001; 92: 1-5
Abstract Related articles

FEKKAK H, Moufid K, Joual A, Bennani S, el Mrini M, Benjelloun S
[Leiomyoma of the urinary tract]
Ann Urol (Paris) 2001; : 47-50
Abstract Related articles

LIEBERMAN R
Chemoprevention of superficial bladder cancer.
Cancer Treat Res 2001; 106: 237-54
Abstract Related articles

HELPAP B, Kollermann J
Immunohistochemical analysis of the proliferative activity of neuroendocrine tumors from various organs. Are there indications for a neuroendocrine tumor-carcinoma sequence?
Virchows Arch 2001; 438: 86-91
Abstract Related articles

SHEPHERD JH, Woolas RP, Summerville K, Barton DP, Woodhouse CR
Conservative anterior exenteration with preservation of fertility potential and continent urinary diversion.
BJOG 2001; 108: 117-9
Abstract Related articles

BORZACCHIELLO G, Ambrosio V, Galati P, Poggiali F, Venuti A, Roperto F
The pagetoid variant of urothelial carcinoma in situ of urinary bladder in a cow.
Vet Pathol 2001; 38: 113-6
Abstract Related articles

COHEN S
What’s the truth about the health risks of sugar substitutes such as saccharin and aspartame?
Health News 2001; 7: 10
Abstract Related articles

RIEGER-CHRIST KM, Cain JW, Braasch JW, Dugan JM, Silverman ML, Bouyounes B et al
Expression of classic cadherins type I in urothelial neoplastic progression.
Hum Pathol 2001; 32: 18-23
Abstract Related articles

CHIU BC, Lynch CF, Cerhan JR, Cantor KP
Cigarette smoking and risk of bladder, pancreas, kidney, and colorectal cancers in Iowa.
Ann Epidemiol 2001; 11: 28-37
Abstract Related articles

ROSS JS, Cohen MB
Biomarkers for the detection of bladder cancer.
Adv Anat Pathol 2001; 8: 37-45
Abstract Related articles

BOFFETTA P, Silverman DT
A meta-analysis of bladder cancer and diesel exhaust exposure.
Epidemiology 2001; 12: 125-30
Abstract Related articles

LOPEZ-ABENTE G, Escolar A
Tobacco consumption and bladder cancer in non-coffee drinkers.
J Epidemiol Community Health 2001; 55: 68-70
Abstract Related articles

VAUGHN DJ, Malkowicz SB
Recent advances in bladder cancer chemotherapy.
Cancer Invest 2001; 19: 77-85
Abstract Related articles

DUNST J, Rodel C, Zietman A, Schrott KM, Sauer R, Shipley WU
Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy.
Semin Surg Oncol 2001; 20: 24-32
Abstract Related articles

TANAKA M, Fraizer GC, De La Cerda J, Cristiano RJ, Liebert M, Grossman HB
Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery.
Gene Ther 2001; 8: 139-48
Abstract Related articles

VILLANUEVA C, Kogevinas M, Grimalt J
[Chlorination of drinking water in Spain and bladder cancer]
Gac Sanit 2001; 15: 48-53
Abstract Related articles

DHAMBORVORN T, Tritipsatit S, Meemongkoldilok S
Actinomycosis of the urinary bladder.
J Med Assoc Thai 2001; 84: 109-12
Abstract Related articles

SHIAU AL, Lin CY, Tzai TS, Wu CL
Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma.
Cancer Gene Ther 2001; 8: 73-81
Abstract Related articles

WU TT, Lee YH, Huang JK
p53 mutation and bcl-2 expression in transitional cell carcinoma of the urinary bladder.
Zhonghua Yi Xue Za Zhi (Taipei) 2001; : 9-14
Abstract Related articles

POULAKIS V, Witzsch U, Kollias A, Becht E
[Antegrade percutaneous endoluminal therapy of nonmalignant strictures of ureterointestinal anastomoses after urinary diversion]
Urologe A 2001; 40: 29-37
Abstract Related articles

MATSUMOTO S, Nishioka T, Akiyama T, Park YC, Kurita T, Ishikawa Y
[A case of squamous cell carcinoma of the bladder that was successfully treated with multidisciplinary therapies]
Hinyokika Kiyo 2001; 47: 43-6
Abstract Related articles

KANEMATSU A, Tsuji Y, Kanba H, Noguchi T, Kamoto T, Okabe T
[The sensitivity and clinical implications of periodical bladder biopsy following transurethral resection of superficial bladder transitional cell carcinoma]
Hinyokika Kiyo 2001; 47: 1-4
Abstract Related articles

BELACEL N, Boulassel MR
Multicriteria fuzzy assignment method: a useful tool to assist medical diagnosis.
Artif Intell Med 2001; 21: 201-7
Abstract Related articles

YAMAMOTO S, Yamanaka N, Maeda T, Uchida Y, Yabe S, Nakano M et al
Ileal neobladder for urinary bladder replacement following total pelvic exenteration for rectal carcinoma.
Dig Surg 2001; 18: 67-72
Abstract Related articles

SONG JH, Francis IR, Platt JF, Cohan RH, Mohsin J, Kielb SJ et al
Bladder tumor detection at virtual cystoscopy.
Radiology 2001; 218: 95-100
Abstract Related articles

ROHREN EM
Tc-99m MDP uptake in a calcified bladder tumor.
Clin Nucl Med 2001; 26: 58-9
Abstract Related articles

CONRAD LK, Kirsh EJ, Steinberg G, Gerber GS, Rosello W, Pelizzari C et al
Comparative viewing modalities for CT cystography.
Abdom Imaging 2001; 26: 92-7
Abstract Related articles

CIANCIULLI AM, Bovani R, Leonardo C, Iori F, Coletta AM, Marzano R et al
DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH: prognostic implications.
Eur J Histochem 2001; 45: 65-71
Abstract Related articles

KUMAR S
Gall bladder cancer: a disease of indo-gangetic belt: the author replies.
Trop Gastroenterol 2001; 22: 52
Abstract Related articles

CONNOR RJ, Engler H, Machemer T, Philopena JM, Horn MT, Sutjipto S et al
Identification of polyamides that enhance adenovirus-mediated gene expression in the urothelium.
Gene Ther 2001; 8: 41-8
Abstract Related articles

BROCK JE, Ahmed A, Lofts FJ
Adenocarcinoma of the gall bladder presenting with haematuria.
Clin Oncol (R Coll Radiol) 2001; : 65-6
Abstract Related articles

ROBINSON AJ, Alcock CJ
Dermatomyositis in association with transitional cell carcinoma of the bladder.
Clin Oncol (R Coll Radiol) 2001; : 50-1
Abstract Related articles

NILSSON S, Ragnhammar P, Glimelius B, Nygren P
A systematic overview of chemotherapy effects in urothelial bladder cancer. SBU-group. Swedish Council of Technology Assessment in Health Care.
Acta Oncol 2001; 40: 371-90
Abstract Related articles

NUNEZ MORA C, Rios Gonzalez E, Garcia Mediero JM, Alvarez Ferriera J, Martinez-Pineiro Lorenzo L, Cisneros Ledo J et al
[Prognostic value of inverted papilloma of the lower urinary tract]
Arch Esp Urol 2001; 54: 35-42
Abstract Related articles

BUSTO CASTANON L, Sanchez Merino JM, Picallo Sanchez JA, Gelabert Mas A
[Expression of epidermal growth factor receptor and p53 protein in superficial cancer of the urinary bladder]
Arch Esp Urol 2001; 54: 13-21
Abstract Related articles

PLANZ B, Synek C, Deix T, Bocking A, Marberger M
Diagnosis of bladder cancer with urinary cytology, immunocytology and DNA-image-cytometry.
Anal Cell Pathol 2001; 22: 103-9
Abstract Related articles

FUJIWARA H, Emi M, Nagai H, Ohgaki K, Imoto I, Akimoto M et al
Definition of a 1-Mb homozygous deletion at 9q32-q33 in a human bladder- cancer cell line.
J Hum Genet 2001; 46: 372-7
Abstract Related articles

GELDMACHER H, Taube C, Markert U, Kirsten DK
Nearly fatal complications of cervical lymphadenitis following bcg immunotherapy for superficial bladder cancer.
Respiration 2001; 68: 420-1
Abstract Related articles

KRAVCHICK S, Gal R, Cytron S, Peled R, Weissman Y, Mukamel E et al
Increased incidence of diabetes mellitus in the patients with transitional cell carcinoma of urinary bladder.
Pathol Oncol Res 2001; 7: 56-9
Abstract Related articles

MOORE M
Urine detection of survivin and diagnosis of bladder cancer.
J Insur Med 2001; 33: 202-3
Abstract Related articles

CHEN Z, Zhang Y, Zhang X, Du G, Yang W, Hu Z et al
Expression of multidrug-associated protein, P-glycoprotein, P53 and Bcl- 2 proteins in bladder cancer and clinical implication.
J Tongji Med Univ 2001; 21: 56-8
Abstract Related articles

YE Z, Chen J, Zhang X, Li J, Zhou S, Yang W et al
Novel gelatin-adriamycin sustained drug release system for intravesical therapy of bladder cancer.
J Tongji Med Univ 2001; 21: 145-8
Abstract Related articles

BURGER MS, Torino JL, Swaminathan S
DNA damage in human transitional cell carcinoma cells after exposure to the proximate metabolite of the bladder carcinogen 4-aminobiphenyl.
Environ Mol Mutagen 2001; 38: 1-11
Abstract Related articles

EL-LAMIE IK
Preliminary experience with Mainz type II pouch in gynecologic oncology patients.
Eur J Gynaecol Oncol 2001; 22: 77-80
Abstract Related articles

HAYNE D, Johnson U, D’Souza D, Boulos PB, Payne H
Anorectal irradiation in pelvic radiotherapy: an assessment using in- vivo dosimetry.
Clin Oncol (R Coll Radiol) 2001; : 126-9
Abstract Related articles

BUDGELL GJ, Cowan RA, Hounsell AR
Prediction of scattered dose to the testes in abdominopelvic radiotherapy.
Clin Oncol (R Coll Radiol) 2001; : 120-5
Abstract Related articles

IRIE A, Uchida T, Ishida H, Matsumoto K, Iwamura M, Baba S
p53 Mutation in Bladder Cancer Patients in Japan and Inhibition of Growth by in Vitro Adenovirus-Mediated Wild-Type p53 Transduction in Bladder Cancer Cells.
Mol Urol 2001; 5: 53-58
Abstract Related articles

WADA Y, Gotoh A, Shirakawa T, Hamada K, Kamidono S
Gene Therapy for Bladder Cancer Using Adenoviral Vector.
Mol Urol 2001; 5: 47-52
Abstract Related articles

ONO Y, Nonomura N, Harada Y, Fukui T, Tokizane T, Sato E et al
Loss of p73 Induction in a Cisplatin-Resistant Bladder Cancer Cell Line.
Mol Urol 2001; 5: 25-30
Abstract Related articles

FUKUI T, Nonomura N, Tokizane T, Sato E, Ono Y, Harada Y et al
Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer.
Mol Urol 2001; 5: 19-23
Abstract Related articles

SHELLEY MD, Barber J, Mason MD
Surgery versus radiotherapy for muscle invasive bladder cancer (Cochrane Review).
Cochrane Database Syst Rev 2001; 3: CD002079
Abstract Related articles

KIM JC, Steinberg GD
Medical management of patients with refractory carcinoma in situ of the bladder.
Drugs Aging 2001; 18: 335-44
Abstract Related articles

PATRIARCA S, Gafa L, Ferretti S, Vitarelli S, Cesaraccio R, Crocetti E et al
Coding criteria of bladder cancer: effects on estimating survival.
Epidemiol Prev 2001; 25: 42-7
Abstract Related articles

VAN TILBORG AA, de Vries A, de Bont M, Groenfeld LE, van der Kwast TH, Zwarthoff EC
Molecular evolution of multiple recurrent cancers of the bladder.
Hum Mol Genet 2000; 9: 2973-80
Abstract Related articles

WATANABE T, Shinohara N, Sazawa A, Harabayashi T, Ogiso Y, Koyanagi T et al
An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies.
Cancer Gene Ther 2000; 7: 1575-1580
Abstract Related articles

SARLAK A, Gundes H, Ozkurkcugil C, Ozkara S, Gokalp A
Solitary calcaneal metastasis in superficial bladder carcinoma.
Int J Clin Pract 2000; 54: 681-2
Abstract Related articles

KAGEYAMA Y, Okada Y, Arai G, Hyochi N, Suzuki M, Masuda H et al
Preoperative concurrent chemoradiotherapy against muscle-invasive bladder cancer: results of partial cystectomy in elderly or high-risk patients.
Jpn J Clin Oncol 2000; 30: 553-6
Abstract Related articles

YANG MH, Yen CC, Chang YH, Hsieh RK, Liu JH, Chiou TJ et al
Single agent paclitaxel as a first-line therapy in advanced urothelial carcinoma: its efficacy and safety in patients even with pretreatment renal insufficiency.
Jpn J Clin Oncol 2000; 30: 547-52
Abstract Related articles

CAPPABIANCA S, Grassi R, D’Alessandro P, Del Vecchio A, Maioli A, Donofrio V
Metastasis to the male breast from carcinoma of the urinary bladder.
Br J Radiol 2000; 73: 1326-8
Abstract Related articles

GOTOH M, Mizutani K, Furukawa T, Kinukawa T, Ono Y, Ohshima S
Quality of micturition in male patients with orthotopic neobladder replacement.
World J Urol 2000; 18: 411-6
Abstract Related articles

LEE MY, Tsou MH, Cheng MH, Chang DS, Yang AL, Ko JS
Clinical application of NMP22 and urinary cytology in patients with hematuria or a history of urothelial carcinoma.
World J Urol 2000; 18: 401-5
Abstract Related articles

SERRA C, Bonfill X, Sunyer J, Urrutia G, Turuguet D, Bastus R et al
Bladder cancer in the textile industry.
Scand J Work Environ Health 2000; 26: 476-81
Abstract Related articles

WOLF H, Haeckel C, Roessner A
Inducible nitric oxide synthase expression in human urinary bladder cancer.
Virchows Arch 2000; 437: 662-6
Abstract Related articles

ARIEL I, Sughayer M, Fellig Y, Pizov G, Ayesh S, Podeh D et al
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.
Mol Pathol 2000; 53: 320-3
Abstract Related articles

SENGELOV L, Christensen M, von der Maase HD, Horn T, Marcussen N, Kamby C et al
Loss of heterozygosity at 1p, 8p, 10p, 13q, and 17p in advanced urothelial cancer and lack of relation to chemotherapy response and outcome.
Cancer Genet Cytogenet 2000; 123: 109-13
Abstract Related articles

CHENG CW, Chueh SC, Chern HD
Diagnosis of bladder cancer using telomerase activity in voided urine.
J Formos Med Assoc 2000; 99: 920-5
Abstract Related articles

ALLEN PW
Claud the careless castrator.
Ann Diagn Pathol 2000; 4: 411
Abstract Related articles

SNELLER MC
Cystitis, bladder cancer, and myelodysplasia in patients with Wegener’s granulomatosis: comment on the article by Reinhold-Keller et al.
Arthritis Rheum 2000; 43: 2853-5
Abstract Related articles

DESAI S, Lim SD, Jimenez RE, Chun T, Keane TE, McKenney JK et al
Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia.
Mod Pathol 2000; 13: 1315-23
Abstract Related articles

SALA M, Cordier S, Chang-Claude J, Donato F, Escolar-Pujolar A, Fernandez F et al
Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case-control studies in European countries.
Cancer Causes Control 2000; 11: 925-31
Abstract Related articles

KORKOLOPOULOU P, Konstantinidou AE, Thomas-Tsagli E, Christodoulou P, Kapralos P, Davaris P
WAF1/p21 protein expression is an independent prognostic indicator in superficial and invasive bladder cancer.
Appl Immunohistochem Molecul Morphol 2000; 8: 285-92
Abstract Related articles

TIRZAMAN O, Wahner-Roedler DL, Malek RS, Sebo TJ, Li CY, Kyle RA
Primary localized amyloidosis of the urinary bladder: a case series of 31 patients.
Mayo Clin Proc 2000; 75: 1264-8
Abstract Related articles

NAIK KS, Carrington BM, Yates W, Clarke NW
The post-cystectomy pseudotumour sign: MRI appearances of a modified chronic pelvic haematoma due to retained haemostatic gauze.
Clin Radiol 2000; 55: 970-4
Abstract Related articles

ABDUL-GHANI R, Ohana P, Matouk I, Ayesh S, Ayesh B, Laster M et al
Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells.
Mol Ther 2000; 2: 539-44
Abstract Related articles

INAGAKI T, Nagata M, Kaneko M, Amagai T, Iwakawa M, Watanabe T
Carcinosarcoma with rhabdoid features of the urinary bladder in a 2- year-old girl: possible histogenesis of stem cell origin.
Pathol Int 2000; 50: 973-8
Abstract Related articles

ZHU X, Kanai Y, Saito A, Kondo Y, Hirohashi S
Aberrant expression of beta-catenin and mutation of exon 3 of the beta- catenin gene in renal and urothelial carcinomas.
Pathol Int 2000; 50: 945-52
Abstract Related articles

SHIMIZU S, Shirato H, Kitamura K, Shinohara N, Harabayashi T, Tsukamoto T et al
Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers.
Int J Radiat Oncol Biol Phys 2000; 48: 1591-7
Abstract Related articles

MOMBELLI B, Gismondo MR
The use of probiotics in medical practice.
Int J Antimicrob Agents 2000; 16: 531-6
Abstract Related articles

BATTERMANN JJ
Feasibility of permanent implants for prostate cancer after previous radiotherapy in the true pelvis.
Radiother Oncol 2000; 57: 297-300
Abstract Related articles

SUNG JD, Koyle MA
Squamous cell carcinoma of the bladder in a pediatric patient.
J Pediatr Surg 2000; 35: 1838-9
Abstract Related articles

WHALLEY DG, Berrigan MJ
Anesthesia for radical prostatectomy, cystectomy, nephrectomy, pheochromocytoma, and laparoscopic procedures.
Anesthesiol Clin North America 2000; 18: 899-917, x
Abstract Related articles

HOGARTH MB, Thomas S, Seifert MH, Tariq SM
Reiter’s syndrome following intravesical BCG immunotherapy.
Postgrad Med J 2000; 76: 791-3
Abstract Related articles

SIBLEY K, Bell S, Knowles MA
Redefining a critical region of LOH on 4p16.3 in bladder cancer.
Genes Chromosomes Cancer 2000; 29: 378-9
Abstract Related articles

CERVELL FERRON JM, Asensio Egea L, Moreno Aviles J, Soler Fernandez J, Garcia Perez R
[Leiomyoma of the bladder]
Arch Esp Urol 2000; 53: 943-6
Abstract Related articles

RUBIO MUNOZ A, Bono Arino A, Berne Manero JM, Sanz Velez JI, Abad Roger J, Escusol Lorente R et al
[Leiomyoma of the bladder]
Arch Esp Urol 2000; 53: 934-7
Abstract Related articles

BORRELL PALANCA A, Chicote Perez F, Alcala-Santaella Casanova C, Cisnal Monsalve JM, Pastor Sempere F
[Studer-type orthotopic urinary bladder: our experience]
Arch Esp Urol 2000; 53: 893-9
Abstract Related articles

RIOS GONZALEZ E, Martinez-Pineiro Lorenzo L, Martinez-Pineiro Carames JA, de la Pena Barthel JJ
[Immunotherapy in superficial bladder carcinoma]
Arch Esp Urol 2000; 53: 879-92
Abstract Related articles

BIALKOWSKA-HOBRZANSKA H, Bowles L, Bukala B, Joseph MG, Fletcher R, Razvi H
Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
Mol Diagn 2000; 5: 267-77
Abstract Related articles

GNILORYBOV VG, Stoliarzh AB, Kulenkov AI, Dadashev EO, Gnilorybov DV
[A novel method of cystoplasty after cystectomy in cancer]
Voen Med Zh 2000; 321: 38-41, 96
Abstract Related articles

GOHIL K, Moy RK, Farzin S, Maguire JJ, Packer L
mRNA expression profile of a human cancer cell line in response to Ginkgo biloba extract: induction of antioxidant response and the Golgi system.
Free Radic Res 2000; 33: 831-49
Abstract Related articles

VECCHIOLI SCALDAZZA C, Giacomini G
[Repeated bladder metastases from renal cell carcinoma. Report of a case with particular attention to the use of immunomodulators]
Minerva Urol Nefrol 2000; 52: 215-8
Abstract Related articles

BILIM V, Kawasaki T, Takahashi K, Tomita Y
Adriamycin induced G2/M cell cycle arrest in transitional cell cancer cells with wt p53 and p21(WAF1/CIP1) genes.
J Exp Clin Cancer Res 2000; 19: 483-8
Abstract Related articles

HOSHI S, Shintaku I, Suzuki K, Takahashi T, Kaihou Y, Ishidoya S et al
Bladder preservation by internal iliac arterial infusion chemotherapy and irradiation in T3 bladder carcinoma patients over the age of 70 years.
Tohoku J Exp Med 2000; 192: 249-58
Abstract Related articles

LERCH M
[Erythema anulare--a facultative paraneoplastic syndrome?]
Schweiz Rundsch Med Prax 2000; 89: 1963-5
Abstract Related articles

MAXWELL SA, Davis GE
Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines.
Proc Natl Acad Sci U S A 2000; 97: 13009-14
Abstract Related articles

BURTON PB, Anderson CJ, Corbishly CM
Caspase 3 and p27 as predictors of invasive bladder cancer.
N Engl J Med 2000; 343: 1418-20
Abstract Related articles

IMAOKA S, Yoneda Y, Sugimoto T, Hiroi T, Yamamoto K, Nakatani T et al
CYP4B1 is a possible risk factor for bladder cancer in humans.
Biochem Biophys Res Commun 2000; 277: 776-80
Abstract Related articles

MITROPOULOS D, Deliconstantinos G, Zervas A, Giannopoulos A, Kyriakou G, Dimopoulos C
Oxidative stress of red blood cells during Bacillus Calmette-Guerin intravesical instillations.
In Vivo 2000; 14: 721-4
Abstract Related articles

SORRENTI S, Forte F, Foti N, Catania A, D’Andrea V, Iavarone C et al
[Inverted papilloma of the bladder: observation of 3 clinical cases and discussion on their clinico-pathologic characteristics]
Chir Ital 2000; 52: 707-11
Abstract Related articles

VALERO PUERTA JA, Medina Perez M, Garcia Carriazo M, Valpuesta Fernandez I, Sanchez Gonzalez M, Mompean FO
[Bladder metastasis of signet-ring cell adenocarcinoma from the stomach]
Arch Esp Urol 2000; 53: 839-41
Abstract Related articles

FERNANDEZ GOMEZ JM, Rodriguez Martinez JJ, Escaf Barmadah S, Perez Garcia J, Garcia J, Casasola Chamorro J
[Significance of random biopsies of healthy mucosa in superficial bladder tumor]
Arch Esp Urol 2000; 53: 785-97
Abstract Related articles

HAIE-MEDER C, Breton-Callu C, Oberlin O, Martelli H, Audry G, Valayer J et al
[Brachytherapy in the treatment of vesicoprostatic rhabdomyosarcomas in children]
Cancer Radiother 2000; 4 Suppl 1: 145s-149s
Abstract Related articles

TSUDA K, Narumi Y, Nakamura H, Nonomura I, Okuyama A
[Staging urinary bladder cancer with dynamic MR imaging]
Hinyokika Kiyo 2000; 46: 835-9
Abstract Related articles

TANASE K, Tawada M, Muranaka K, Sawada S, Matsuda K, Miwa Y et al
[Two cases of nephrogenic adenoma in the bladder diverticulum]
Hinyokika Kiyo 2000; 46: 815-7
Abstract Related articles

AMANO T, Fukuda M, Imao T, Takemae K
[A case of ileus as a late complication of an ileal conduit in a patient with primary signet ring cell carcinoma of the bladder]
Hinyokika Kiyo 2000; 46: 811-4
Abstract Related articles

YUMURA Y, Chiba K, Okada Y, Hirokawa M
[Brain metastasis of bladder carcinoma after total cystectomy: a case report]
Hinyokika Kiyo 2000; 46: 807-9
Abstract Related articles

BARENTSZ JO, Jager GJ, Witjes JA
MR imaging of the urinary bladder.
Magn Reson Imaging Clin N Am 2000; 8: 853-67
Abstract Related articles

RHA SE, Byun JY, Kim HH, Baek JH, Hwang TK, Kang SJ
Kaposi’s sarcoma involving a transplanted kidney, ureter and urinary bladder: ultrasound and CT findings.
Br J Radiol 2000; 73: 1221-3
Abstract Related articles

REEK C, Graefen M, Erbersdobler A, Haese A
[Mucinous adenocarcinoma of the urachus. Case report and review of the literature]
Urologe A 2000; 39: 572-5
Abstract Related articles

STEINHOFF C, Franke KH, Golka K, Thier R, Romer HC, Rotzel C et al
Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma.
Arch Toxicol 2000; 74: 521-6
Abstract Related articles

LIU J, Babaian DC, Liebert M, Steck PA, Kagan J
Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens.
Mol Carcinog 2000; 29: 143-50
Abstract Related articles

GENEGA EM, Hutchinson B, Reuter VE, Gaudin PB
Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
Mod Pathol 2000; 13: 1186-91
Abstract Related articles

PATTERSON-KANE JC, Tramontin RR, Giles RC Jr, Harrison LR
Transitional cell carcinoma of the urinary bladder in a Thoroughbred, with intra-abdominal dissemination.
Vet Pathol 2000; 37: 692-5
Abstract Related articles

PEYRIERE H, Klouche K, Beraud JJ, Blayac JP, Hillaire-Buys D
Fatal systemic reaction after multiple doses of intravesical bacillus Calmette-Guerin for polyposis.
Ann Pharmacother 2000; 34: 1279-82
Abstract Related articles

HARADA S, Sato R, Nakamura R, Oikawa H, Oikawa H, Ohgi S et al
The correlation between spontaneous and radiation-induced apoptosis in T3B bladder cancer (histological grade G3), and the precedence between the two kinds of apoptosis for predicting clinical prognosis.
Int J Radiat Oncol Biol Phys 2000; 48: 1059-67
Abstract Related articles

SAEZ C, Marquez C, Quiroga E, Borderas F, Alfaro J, Pineda G et al
Neuroblastoma of the urinary bladder in an infant clinically detected by hematuria.
Med Pediatr Oncol 2000; 35: 488-92
Abstract Related articles

MASSARD G, Ducrocq X, Beaufigeau M, Elia S, Kessler R, Herve J et al
Lung cancer following previous extrapulmonary malignancy.
Eur J Cardiothorac Surg 2000; 18: 524-8
Abstract Related articles

GEERAERTS T, Albaladejo P, Droupy S, Blanchet P, Le Baleur A, Benhamou D
Acute thrombosis of the external iliac artery after a short procedure in the high lithotomy position.
Anesthesiology 2000; 93: 1353-4
Abstract Related articles

FADL-ELMULA I, Gorunova L, Mandahl N, Elfving P, Lundgren R, Mitelman F et al
Karyotypic characterization of urinary bladder transitional cell carcinomas.
Genes Chromosomes Cancer 2000; 29: 256-65
Abstract Related articles

VALERO PUERTA JA, Medina Perez M, Monteagudo Parreno A, Enamorado Interiano R, Valpuesta Fernandez I, Sanchez Gonzalez M
[Spontaneous extraperitoneal bladder perforation caused by bladder carcinoma]
Actas Urol Esp 2000; 24: 817-9
Abstract Related articles

MOYANO CALVO JL, de Miguel Rodriguez M, Ortiz Gamiz A, Poyato Galan JM, Sanchez Sanchez E, Blanco Palenciano E et al
[DNA ploidy determination with flow cytometry, Ki-67 index, and overexpression of p53 protein in 121 T1 superficial bladder carcinoma. Retrospective study. Correlation with classic variables]
Actas Urol Esp 2000; 24: 785-95
Abstract Related articles

KRUSLIN B, Stanic G, Belicza M, Cupic H, Begic-Fehir J, Muic B et al
[Carcinoma of the urinary bladder resembling lymphoepithelioma]
Lijec Vjesn 2000; 122: 270-2
Abstract Related articles

SHIN KY, Moon HS, Park HY, Lee TY, Woo YN, Kim HJ et al
Effects of tumor necrosis factor-alpha and interferon-gamma on expressions of matrix metalloproteinase-2 and -9 in human bladder cancer cells.
Cancer Lett 2000; 159: 127-34
Abstract Related articles

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-2000. A 32-year-old man with a lesion of the urinary bladder.
N Engl J Med 2000; 343: 1105-11
Abstract Related articles

KAJITA Y, Habuchi T, Kamoto T, Okuno H, Terai A, Kakehi Y et al
[Long-term clinical results of 5 cases of urachal carcinoma]
Hinyokika Kiyo 2000; 46: 711-4
Abstract Related articles

IMAMURA M, Inoue K, Megumi Y, Nishimura M, Ohmori K, Nishimura K
[Clinical evaluation of urinary basic fetoprotein and the BTA test for detection of bladder cancer]
Hinyokika Kiyo 2000; 46: 705-9
Abstract Related articles

TORRES LOBATON A, Cruz Ortiz H, Rojo Herrera G, Avila Medrano L
[Sarcomas of the vulva. Report of 2 cases]
Ginecol Obstet Mex 2000; 68: 429-34
Abstract Related articles

CABALLERO GOMEZ M, Marino del Real J, Asuar Aydillo SS, Abengozar Garcia Moreno A, Mateos Blanco J, Murillo Mirat J et al
[Primary signet ring cell adenocarcinoma of the bladder. Report of a case]
Actas Urol Esp 2000; 24: 749-52
Abstract Related articles

ALVAREZ KINDELAN J, Lopez Beltran A, Requena Tapia MJ
[Urothelial papillary neoplasms of low malignant potential. Retrospective studies]
Actas Urol Esp 2000; 24: 743-8
Abstract Related articles

GUTIERREZ BANOS JL, Rebollo Rodrigo MH, Antolin Juarez F, Martin Garcia B, Hernandez Rodriguez R, Portillo Martin JA et al
[NMP-22 in the diagnosis of bladder cancer]
Actas Urol Esp 2000; 24: 715-20
Abstract Related articles

GRINO GARRETA J, Bielsa Gali O, Cortadellas Angel R, Arango Toro O, Gelabert-Mas A
[Incidental diagnosis of bladder carcinoma]
Arch Esp Urol 2000; 53: 709-12
Abstract Related articles

KAJIO K, Hasegawa Y, Ihara K, Harada S, Kawauchi S, Fukuda T et al
[Granulocyte colony-stimulating factor producing undifferentiated carcinoma of urinary bladder: a case report]
Nippon Hinyokika Gakkai Zasshi 2000; 91: 679-82
Abstract Related articles

TSAI SC, Kao CH, Lin WY, Wang SJ
Unusual intestinal and urinary tract accumulation on bone scan: a case with Indiana pouch.
Semin Nucl Med 2000; 30: 310-2
Abstract Related articles

ZAYYAN KS, See WA
Their initial experience with laparoscopy-assisted cystectomy.
World J Surg 2000; 24: 1282-3
Abstract Related articles

GARDINER RA
Molecular and reconstructive urology: a coming together.
World J Surg 2000; 24: 1163-6
Abstract Related articles

HEHR T
[Role of primary radiotherapy plus deep regional hyperthermia in advanced stage FIGO IIb-IV cervical carcinoma]
Strahlenther Onkol 2000; 176: 485-6
Abstract Related articles

STEP DL, Streeter RN, Confer AW, Kirkpatrick JG, Sundberg JP, Arnold CS et al
Urinary bladder transitional cell papilloma in a shorthorn heifer.
Can Vet J 2000; 41: 794-7
Abstract Related articles

ISAAC J, Lowichik A, Cartwright P, Rohr R
Inverted papilloma of the urinary bladder in children: case report and review of prognostic significance and biological potential behavior.
J Pediatr Surg 2000; 35: 1514-6
Abstract Related articles

DECENSI A, Torrisi R, Bruno S, Costantini M, Curotto A, Nicolo G et al
Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.
Cancer Epidemiol Biomarkers Prev 2000; 9: 1071-8
Abstract Related articles

FLORL AR, Franke KH, Niederacher D, Gerharz CD, Seifert HH, Schulz WA
DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder.
Lab Invest 2000; 80: 1513-22
Abstract Related articles

BRAUERS A, Jakse G
Epidemiology and biology of human urinary bladder cancer.
J Cancer Res Clin Oncol 2000; 126: 575-83
Abstract Related articles

CARDONA F, Bagan JV, Perez A
Mandibular metastasis of bladder transitional cell carcinoma.
J Oral Maxillofac Surg 2000; 58: 1154-8
Abstract Related articles

YOSHIOKA Y, Nose T, Yoshida K, Inoue T, Yamazaki H, Tanaka E et al
High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial.
Int J Radiat Oncol Biol Phys 2000; 48: 675-81
Abstract Related articles

NOURI AM, Thompson C, Cannell H, Symes M, Purkiss S, Amirghofran Z
Profile of epidermal growth factor receptor (EGFr) expression in human malignancies: effects of exposure to EGF and its biological influence on established human tumour cell lines.
Int J Mol Med 2000; 6: 495-500
Abstract Related articles

EISSA S, Ali-Labib R, Khalifa A
Deletion of p16 and p15 genes In schistosomiasis-associated bladder cancer (SABC).
Clin Chim Acta 2000; 300: 159-69
Abstract Related articles

RISCHMANN P
[Current treatment of bladder cancer: from epidemiology to surgical treatment]
Anticancer Drugs 2000; 11 Suppl 1: S3-8
Abstract Related articles

KAWAKAMI K, Oka K, Kato M, Shiku H
Whole-bladder irradiation and doxorubicin-containing chemotherapy as successful treatment for a primary mucosa-associated lymphoid tissue lymphoma of the bladder.
Int J Hematol 2000; 72: 346-8
Abstract Related articles

STAKHOVS&RSQUO;KYI EO, Karpenko VS, Vukalovych PS, Voilenko OA, Romaniuk IP
[Radical cystectomy with ileoneocystoplasty]
Klin Khir 2000; : 47-50
Abstract Related articles

PFISTER C, Dunet F, Moussu J, Laquerriere A, Heintz JF, Grise P
Results of concomitant radio-chemotherapy for invasive bladder tumors.
Can J Urol 2000; 7: 1110-5
Abstract Related articles

BAHRENBERG G, Brauers A, Joost HG, Jakse G
Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors.
Biochem Biophys Res Commun 2000; 275: 783-8
Abstract Related articles

PERISSEL B, Giollant M, Dastugue N, Penault-Llorca F, Jaffray JY, Guy L et al
New cytogenetic data on bladder carcinoma cell line (CHA89) revealed by M-FISH analysis.
Cancer Genet Cytogenet 2000; 121: 228-9
Abstract Related articles

NATALE RB
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer.
Curr Oncol Rep 2000; 2: 386-93
Abstract Related articles

EDELMAN MJ
New approaches to treatment of metastatic bladder cancer.
Curr Oncol Rep 2000; 2: 379-85
Abstract Related articles

ISHIOKA J, Sugiura S, Chiba K, Kitami K, Hirokawa M
[A case of urachal abscess mimicking a tumor in the retrovesical space]
Hinyokika Kiyo 2000; 46: 635-7
Abstract Related articles

ALVAREZ KINDELAN J, Lopez-Beltran A, Requena Tapia MJ
[Molecular biology in bladder cancer]
Actas Urol Esp 2000; 24: 604-25
Abstract Related articles

FUJITA T, Masui N, Suyama K, Ao T, Mukai N, Koshiba K
[Two cases of primary carcinoma developed in a vesical diverticulum treated with ileal neobladder for total bladder replacement]
Nippon Hinyokika Gakkai Zasshi 2000; 91: 645-8
Abstract Related articles

BOHME H, Tauber R
[Continent cutaneous urinary diversion of ileal neobladders by transverse tubularized ileum segments (Yang- or Monti-principle)]
Urologe A 2000; 39: 436-9
Abstract Related articles

BURTON JL, Goepel JR, Lee JA
Demand management in urine cytology: a single cytospin slide is sufficient.
J Clin Pathol 2000; 53: 718-9
Abstract Related articles

HERRANZ AMO F, Diez Cordero JM, Verdu Tartajo F, Bielsa Carrillo A, Garcia Burgos J, Subira Rios D et al
[Radical cystectomy in the treatment of cancer of the bladder]
Arch Esp Urol 2000; 53: 619-24
Abstract Related articles

VICENTE RODRIGUEZ J
[Randomized biopsies (R.B.) in initial superficial bladder tumors (I.S.B.T.). Why?]
Arch Esp Urol 2000; 53: 575-8
Abstract Related articles

HATTORI M, Ohno E, Kuramoto H
Immunocytochemistry of collagenase expression in transitional cell carcinoma of the bladder.
Acta Cytol 2000; 44: 771-7
Abstract Related articles

AURIAULT ML, Comoz F, Bottet P, Bensadoun H
[A diagnostic pitfall in the pathology of bladder tumors: the nested variant of urothelial carcinoma]
Ann Pathol 2000; 20: 400-1
Abstract Related articles

ROCHA TA, Mauldin GN, Patnaik AK, Bergman PJ
Prognostic factors in dogs with urinary bladder carcinoma.
J Vet Intern Med 2000; 14: 486-90
Abstract Related articles

RUBOCKI RJ, Duffy KJ, Shepard KL, McCue BJ, Shepherd SJ, Wisecarver JL
Loss of heterozygosity detected in a short tandem repeat (STR) locus commonly used for human DNA identification.
J Forensic Sci 2000; 45: 1087-9
Abstract Related articles

ELKABANI M, Greene JN, Vincent AL, VanHook S, Sandin RL
Disseminated Mycobacterium bovis after intravesicular bacillus calmette- Gu rin treatments for bladder cancer.
Cancer Control 2000; 7: 476-81
Abstract Related articles

ROY C, Tuchmann C, Guth S, Saussine C
[Vesical diseases: accuracy of imaging modalities]
J Radiol 2000; 81: 1099-111
Abstract Related articles

SUTTON MA, Freund CT, Berkman SA, Dang TD, Kattan MW, Wheeler TM et al
In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer.
Mol Ther 2000; 2: 211-7
Abstract Related articles

FERGIE N, Murty GE
Second primary neoplasms in patients with laryngeal carcinoma.
Laryngoscope 2000; 110: 1586-7
Abstract Related articles

GRIPPO PJ, Sandgren EP
Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model.
Am J Pathol 2000; 157: 805-13
Abstract Related articles

RICHTER J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U et al
High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer.
Am J Pathol 2000; 157: 787-94
Abstract Related articles

PHILIP AT, Amin MB, Tamboli P, Lee TJ, Hill CE, Ro JY
Intravesical adipose tissue: a quantitative study of its presence and location with implications for therapy and prognosis.
Am J Surg Pathol 2000; 24: 1286-90
Abstract Related articles

ORDONEZ NG
Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas.
Am J Surg Pathol 2000; 24: 1217-23
Abstract Related articles

GRAU JM, Perea M
Dermatomyositis with the features of inclusion body myositis associated with carcinoma of the bladder: a true association?
Br J Dermatol 2000; 143: 671
Abstract Related articles

JOHNS LE, Houlston RS
Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: a meta-analysis.
Mutagenesis 2000; 15: 399-404
Abstract Related articles

GRIFFITH TS, Anderson RD, Davidson BL, Williams RD, Ratliff TL
Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis.
J Immunol 2000; 165: 2886-94
Abstract Related articles

VRIESEMA JL, van der Poel HG, Debruyne FM, Schalken JA, Kok LP, Boon ME
Neural network-based digitized cell image diagnosis of bladder wash cytology.
Diagn Cytopathol 2000; 23: 171-9
Abstract Related articles

JACKSON P, Millar D, Kingsley E, Yardley G, Ow K, Clark S et al
Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines.
Cancer Lett 2000; 157: 169-76
Abstract Related articles

TSAO JL, Yatabe Y, Markl ID, Hajyan K, Jones PA, Shibata D
Bladder cancer genotype stability during clinical progression.
Genes Chromosomes Cancer 2000; 29: 26-32
Abstract Related articles

RADOSAVLJEVIC D, Popov I, Jelic S, Nikolic-Tomasevic Z
[Chemotherapy of carcinoma of the urinary bladder]
Srp Arh Celok Lek 2000; 128: 340-6
Abstract Related articles

HODDER SL, Mahmoud AA, Sorenson K, Weinert DM, Stein RL, Ouma JH et al
Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection.
Am J Trop Med Hyg 2000; 63: 133-8
Abstract Related articles

DUDIEV SM
[Laparoscopic pelvic lymphadenectomy in patients with cancer of the bladder and prostate]
Urol Nefrol (Mosk) 2000; : 52-4
Abstract Related articles

AL&RSQUO;-SHUKRI SK, Danil’chenko DI, Kenig F, Shnorr D
[ALA fluorescent diagnosis of bladder cancer]
Urol Nefrol (Mosk) 2000; : 48-50
Abstract Related articles

ZYRIANOV BN, Selivanov SP
[Bladder wall permeability to to topically administered cisplatin]
Urol Nefrol (Mosk) 2000; : 28-30
Abstract Related articles

BANET G, Bibi O, Matouk I, Ayesh S, Laster M, Kimber KM et al
Characterization of human and mouse H19 regulatory sequences.
Mol Biol Rep 2000; 27: 157-65
Abstract Related articles

RICHON VM, Sandhoff TW, Rifkind RA, Marks PA
Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.
Proc Natl Acad Sci U S A 2000; 97: 10014-9
Abstract Related articles

BERCIANO J, Garcia A, Figols J, Munoz R, Berciano MT, Lafarga M
Perineurium contributes to axonal damage in acute inflammatory demyelinating polyneuropathy.
Neurology 2000; 55: 552-9
Abstract Related articles

OYAMA M, Ohigashi T, Hoshi M, Nakashima J, Tachibana M, Murai M et al
Intravesical and intravenous therapy of human bladder cancer by the herpes vector G207.
Hum Gene Ther 2000; 11: 1683-93
Abstract Related articles

SOKOLOVA IA, Halling KC, Jenkins RB, Burkhardt HM, Meyer RG, Seelig SA et al
The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.
J Mol Diagn 2000; 2: 116-23
Abstract Related articles

JUAN VIDAL O, de Paz Arias L, Catala Barcelo J, Garcia Escrig M
[Meningeal carcinomatosis as first manifestation of carcinoma of the bladder: report of 2 cases]
An Med Interna 2000; 17: 425-8
Abstract Related articles

MIZUNO R, Sato A, Ikeuchi K
[Rhabdomyolysis complicated with a fistula between ileal neobladder and intestine: a case report]
Hinyokika Kiyo 2000; 46: 557-9
Abstract Related articles

ABE T, Konari S, Obara W, Okamoto T, Fujioka T
[A case of squamous cell carcinoma arising in the urinary bladder diverticulum]
Hinyokika Kiyo 2000; 46: 553-5
Abstract Related articles

YAMADA T
[Study on recombinant BCG]
Kekkaku 2000; 75: 517-20
Abstract Related articles

WERNER W, Smesny S, Schubert J
[Modern follow-up strategies for the treatment of patients with superficial bladder carcinoma]
Z Arztl Fortbild Qualitatssich 2000; 94: 519-27
Abstract Related articles

BEN REJEB A, Mahjoub A, Berraies N, Tissaoui K
[Prognostic study of cell proliferative markers ki67, PCNA and p53 oncoprotein in bladder tumors]
Ann Urol (Paris) 2000; : 240-8
Abstract Related articles

KAEFER M, Rink RC
Genitourinary rhabdomyosarcoma. Treatment options.
Urol Clin North Am 2000; 27: 471-87
Abstract Related articles

PARK SS, Kim BK, Kim CJ, Kim WS, Kim IO, Park KW et al
Colorectal adenocarcinoma as a second malignant neoplasm following rhabdomyosarcoma of the urinary bladder: a case report.
J Korean Med Sci 2000; 15: 475-7
Abstract Related articles

MCMANUS R, BoAbbas Y, Lampe H, Holliday R, Shum D
Maxillary giant cell granuloma, pheochromocytoma, and hyperparathyroidism without medullary thyroid carcinoma.
Ear Nose Throat J 2000; 79: 590-3
Abstract Related articles

SADETZKI S, Bensal D, Blumstein T, Novikov I, Modan B
Selected risk factors for transitional cell bladder cancer.
Med Oncol 2000; 17: 179-82
Abstract Related articles

PRZYBOJEWSKA B, Jagiello A, Jalmuzna P
H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers.
Cancer Genet Cytogenet 2000; 121: 73-7
Abstract Related articles

DODD PM, McCaffrey JA, Mazumdar M, Icasiano E, Higgins G, Herr H et al
Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinoma.
Invest New Drugs 2000; 18: 247-51
Abstract Related articles

TAVANI A, La Vecchia C
Coffee and cancer: a review of epidemiological studies, 1990-1999.
Eur J Cancer Prev 2000; 9: 241-56
Abstract Related articles

FLEMING DR, Glisson SD, Bhupalam L, Michelson GD, Goldsmith GH, LaRocca RV
Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies.
Am J Clin Oncol 2000; 23: 349-52
Abstract Related articles

KRIEG RC, Fickweiler S, Wolfbeis OS, Knuechel R
Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro.
Photochem Photobiol 2000; 72: 226-33
Abstract Related articles

YOSHIDA T, Matsumoto T, Sasaki A, Morii Y, Ishio T, Bandoh T et al
Laparoscopic cholecystectomy in the treatment of patients with gall bladder cancer.
J Am Coll Surg 2000; 191: 158-63
Abstract Related articles

COHEN-JONATHAN E, Muschel RJ, Gillies McKenna W, Evans SM, Cerniglia G, Mick R et al
Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS.
Radiat Res 2000; 154: 125-32
Abstract Related articles

BASCHINSKY DY, Chen JH, Vadmal MS, Lucas JG, Bahnson RR, Niemann TH
Carcinosarcoma of the urinary bladder--an aggressive tumor with diverse histogenesis. A clinicopathologic study of 4 cases and review of the literature.
Arch Pathol Lab Med 2000; 124: 1172-8
Abstract Related articles

IWAKAWA K, Kizu J, Hosaka Y, Yamamoto K
"Cephem-induced vancomycin resistance" observed in phenotypically methicillin-sensitive Staphylococcus aureus isolated from a patient treated with vancomycin and cephems.
Jpn J Infect Dis 2000; 53: 167-9
Abstract Related articles

GREENLAND JD, Bauman GS, Winquis E, Shepherd RR
Palliative chemoirradiation for transitional carcinoma of the bladder: a case report.
Can J Urol 2000; 7: 1085-7
Abstract Related articles

LWALEED BA, Francis JL, Chisholm M
Monocyte tissue factor levels in cancer patients.
Saudi Med J 2000; 21: 722-9
Abstract Related articles

LOPATKIN NA, Kamalov AA, Kudriavtsev IV, Tokarev FV
[Fluorescent diagnostics of urinary bladder cancer]
Urologiia 2000; : 3-6
Abstract Related articles

DELBECQUE K, Smitz S, Delvenne P, Boniver J
[Clinical case of the month. Abdominal wall hematoma and macroscopic hematuria in a 95 year-old patient]
Rev Med Liege 2000; 55: 705-7
Abstract Related articles

MATTIOLI S, Seregni E, Caperna L, Botti C, Savelli G, Bombardieri E
BTA-TRAK combined with urinary cytology is a reliable urinary indicator of recurrent transitional cell carcinoma (TCC) of the bladder.
Int J Biol Markers 2000; 15: 219-25
Abstract Related articles

VARO SOLIS C, Bachiller Burgos J, Baez JM, Estudillo F, Gonzalez Moreno D, Alvarez-Ossorio Fernandez JL et al
[Glandular cystic cystitis]
Actas Urol Esp 2000; 24: 594-8
Abstract Related articles

ANGLADA CURADO FJ, Lopez Beltran A, Prieto Castro R, Regueiro Lopez JC, Leva Vallejo M, Alameda Aragoneses V et al
[Malignant fibrohistiocytoma of the bladder]
Actas Urol Esp 2000; 24: 581-3
Abstract Related articles

SENOVILLA PEREZ JL, Resel Estevez L, Moreno Sierra J, Fernandez Perez C, Gonzalez Larriba JL, Blanco Jimenez E et al
[Neoadjuvant chemotherapy MVAC in the treatment of infiltrating bladder carcinoma]
Actas Urol Esp 2000; 24: 536-41
Abstract Related articles

MENENDEZ LOPEZ V, Molina Porto R, Alcaraz Asensio A, Gutierrez del Pozo R, Alcover Garcia JA
[Relationship between tumor recurrence and the expression of the p53 gene in primary superficial transitional carcinoma of the bladder]
Actas Urol Esp 2000; 24: 530-5
Abstract Related articles

VICENTE RODRIGUEZ J, Salvador Bayarri J, Chechile Toniolo G, Millan Rodriguez F, Palou Redorta J
[Initial superficial bladder tumors: our experience. Our criteria. Study Group of Bladder Tumors]
Actas Urol Esp 2000; 24: 522-9
Abstract Related articles

SYLVESTER R, Sternberg C
The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why.
Ann Oncol 2000; 11: 851-6
Abstract Related articles

TAKESHI Y
[Study on recombinant BCG to prevent infections of intracellular pathogens]
Nihon Hansenbyo Gakkai Zasshi 2000; 69: 71-5
Abstract Related articles

ICHIKAWA T, Nakayama Y, Yamada D, Saegusa M, Asano S, Aramaki K
[Clinical evaluation of basic fetoprotein in bladder cancer]
Nippon Hinyokika Gakkai Zasshi 2000; 91: 579-83
Abstract Related articles

AWAKURA Y, Yamamoto M, Itoh N, Fukuyama T, Higuchi K, Okamoto E
[Small cell carcinoma of the urinary bladder: a case report]
Hinyokika Kiyo 2000; 46: 479-81
Abstract Related articles

YAMADA T, Kamei S, Miwa K, Nishida Y, Takahashi Y, Deguchi T
[Small cell carcinoma of the urinary bladder: a case report]
Hinyokika Kiyo 2000; 46: 475-7
Abstract Related articles

TOUYAMA H, Kamimura T, Miyazato M, Niimura K, Hatano T, Ogawa Y
[A case of metachronous adenocarcinoma of the urinary bladder and the right upper urinary tract]
Hinyokika Kiyo 2000; 46: 471-3
Abstract Related articles

MOULIN JJ, Clavel T, Buclez B, Laffitte-Rigaud G
A mortality study among workers in a French aluminium reduction plant.
Int Arch Occup Environ Health 2000; 73: 323-30
Abstract Related articles

IOACHIM E, Charchanti A, Stavropoulos NE, Skopelitou A, Athanassiou ED, Agnantis NJ
Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma.
Histol Histopathol 2000; 15: 721-7
Abstract Related articles

BOHM M, Grigoleit U
[Ileal conduit bleeding in portal hypertension. A rare complication]
Urologe A 2000; 39: 348-51
Abstract Related articles

BAZARBASHI S, Raja MA, El Sayed A, Ezzat A, Ibrahim E, Kattan S et al
Prospective phase II trial of alternating intravesical Bacillus Calmette-Guerin (BCG) and interferon alpha IIB in the treatment and prevention of superficial transitional cell carcinoma of the urinary bladder: preliminary results.
J Surg Oncol 2000; 74: 181-4
Abstract Related articles

HEICAPPELL R, Schostak M, Muller M, Miller K
Evaluation of urinary bladder cancer antigen as a marker for diagnosis of transitional cell carcinoma of the urinary bladder.
Scand J Clin Lab Invest 2000; 60: 275-82
Abstract Related articles

HUNCHAREK M, Geschwind JF, Witherspoon B, McGarry R, Adcock D
Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials.
J Clin Epidemiol 2000; 53: 676-80
Abstract Related articles

VINEIS P, Kogevinas M, Simonato L, Brennan P, Boffetta P
Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation.
Mutat Res 2000; 463: 103-10
Abstract Related articles

VEYS CA
PBN as a possible bladder carcinogen.
Occup Environ Med 2000; 57: 500
Abstract Related articles

MUELLER J, Steiner C, Hofler H
Stromelysin-3 expression in noninvasive and invasive neoplasms of the urinary bladder.
Hum Pathol 2000; 31: 860-5
Abstract Related articles

SATHIAKUMAR N, Delzell E
An updated mortality study of workers at a dye and resin manufacturing plant.
J Occup Environ Med 2000; 42: 762-71
Abstract Related articles

MUSCHECK M, Sukosd F, Pesti T, Kovacs G
High density deletion mapping of bladder cancer localizes the putative tumor suppressor gene between loci D8S504 and D8S264 at chromosome 8p23.3.
Lab Invest 2000; 80: 1089-93
Abstract Related articles

GILDEA JJ, Harding MA, Gulding KM, Theodorescu D
Transmembrane motility assay of transiently transfected cells by fluorescent cell counting and luciferase measurement.
Biotechniques 2000; 29: 81-6
Abstract Related articles

MISRA V, Gupta SC, Tandon SP, Gupta AK, Sircar S
Cytohistological study of urinary bladder neoplasms.
Indian J Pathol Microbiol 2000; 43: 303-9
Abstract Related articles

KATUSIN D, Poka Z, Mlinac-Lucijanic M, Kriz M, Klaric-Vucinic S, Ilijanic J
[Carcinoma in situ in the urinary bladder]
Lijec Vjesn 2000; 122: 177-9
Abstract Related articles

MASUDA A, Kikuchi YY, Kawamura N
Mutation analysis of the p53 tumor suppressor gene using paraffin- embedded specimens of human transitional cell carcinomas by the direct sequencing method.
Tokai J Exp Clin Med 2000; 25: 69-77
Abstract Related articles

TAN KY, Yip SK, Tan PH
Clinics in diagnostic imaging (50). Leiomyosarcoma of bladder.
Singapore Med J 2000; 41: 301-4
Abstract Related articles

CALOMINO N, Oliva G, Malerba M, Gattuso A, Giovannelli V, Clemente ML et al
[Is total parenteral nutrition necessary in patients subjected to radical cystectomy?] .
Minerva Urol Nefrol 2000; 52: 57-61
Abstract Related articles

GIROLDI LA, Shimazui T, Schalken JA, Yamasaki H, Bringuier PP
Classical cadherins in urological cancers.
Morphologie 2000; 84: 31-8
Abstract Related articles

SEGAL AJ, Amis ES Jr, Bigongiari LR, Bluth EI, Bush WH Jr, Choyke PL et al
Follow-up imaging of bladder carcinoma. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000; 215 Suppl: 765-72
Abstract Related articles

BIGONGIARI LR, Amis ES Jr, Bluth EI, Bush WH Jr, Choyke PL, Fritzsche P et al
Pretreatment staging of invasive transitional cell carcinoma of the bladder. American College of Radiology. ACR Appropriateness Criteria.
Radiology 2000; 215 Suppl: 697-702
Abstract Related articles

CARDILLO MR, Castagna G, Memeo L, De Bernardinis E, Di Silverio F
Epidermal growth factor receptor, MUC-1 and MUC-2 in bladder cancer.
J Exp Clin Cancer Res 2000; 19: 225-33
Abstract Related articles

SEKSIK P, Nahon S, Lesgourgues B, Cadranel JF, Mariaud De Serre N, Lenoble M et al
[Efficacity of treatment with lamivudine in two patients with severe reactivation of hepatitis B after withdrawal of chemotherapy]
Gastroenterol Clin Biol 2000; 24: 671-4
Abstract Related articles

CHOI SK, Choi YD, Cheon SH, Byun Y, Cho SW
Inflammatory pseudotumor of the urinary bladder in a child.
Yonsei Med J 2000; 41: 401-3
Abstract Related articles

JAIDANE M, Slama A, Ben Sorba N, Yacoubi T, Ghammed S, Elleuch A et al
[Bladder leiomyosarcoma: report of a case]
Ann Urol (Paris) 2000; : 179-83
Abstract Related articles

ILBEY O, Apaydin E, Gursan A, Cikili N
Bladder leiomyoma: a rare cause of urinary stress incontinence.
Arch Ital Urol Androl 2000; 72: 85-7
Abstract Related articles

POPKEN G, Schultze-Seemann W, Seiler KU, Birkel M, Wetterauer U
Intravesical administration of 5-aminolevulinic acid (5-ALA). Safety and pharmacokinetics of 5-ALA and its metabolite protoporphyrin IX.
Eur J Clin Pharmacol 2000; 56: 241-6
Abstract Related articles

RASO AM, Bellan A, Rispoli P, Conforti M, Barile G, Cassatella R et al
Surgical repair of abdominal aortic or iliac aneurysms associated with treatment of urological neoplasias.
J Cardiovasc Surg (Torino) 2000; : 469-74
Abstract Related articles

AUDIGIER C, Nesme P, Perol M, Guerin JC
[Rare pulmonary complication in intravesical BCG treatment]
Rev Mal Respir 2000; 17: 679-81
Abstract Related articles

KOREN R, Langzam L, Paz A, Livne PM, Gal R, Sampson SR
Protein kinase C (PKC) isoenzymes immunohistochemistry in lymph node revealing solution-fixed, paraffin-embedded bladder tumors.
Appl Immunohistochem Molecul Morphol 2000; 8: 166-71
Abstract Related articles

NAKATA S, Takahashi H, Takezawa Y, Kobayashi M, Suzuki T, Kawashima K
[Clinical features of multiple primary cancers including prostate cancer]
Hinyokika Kiyo 2000; 46: 385-91
Abstract Related articles

KAWAMURA K, Ikeda R, Suzuki K
[The relationships among DNA ploidy type determined by laser scanning cytometry, the overexpression of p53 protein and the numerical aberrations of chromosome 7 in bladder cancer]
Hinyokika Kiyo 2000; 46: 377-83
Abstract Related articles

SCHEIDLER J, Reiser MF
MRI of the female and male pelvis: current and future applications of contrast enhancement.
Eur J Radiol 2000; 34: 220-8
Abstract Related articles

METTS MC, Metts JC, Milito SJ, Thomas CR Jr
Bladder cancer: a review of diagnosis and management.
J Natl Med Assoc 2000; 92: 285-94
Abstract Related articles

NAKAMOTO T, Kasaoka Y, Ikegami Y, Usui T
Invasive bladder cancer after cyclophosphamide administration for nephrotic syndrome--a case report.
Hiroshima J Med Sci 2000; 49: 121-3
Abstract Related articles

BEYERSDORFF D, Taupitz M, Giessing M, Turk I, Schnorr D, Loening S et al
[The staging of bladder tumors in MRT: the value of the intravesical application of an iron oxide-containing contrast medium in combination with high-resolution T2-weighted imaging]
Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2000; 172: 504
Abstract Related articles

OPOLSKI A, Kuduk-Jaworska J, Wietrzyk J, Wojdat E, Waszkiewicz K, Romaniewska A et al
Antiproliferative activity in vitro of new malatoplatinum(ll) complexes.
Anticancer Drugs 2000; 11: 363-8
Abstract Related articles

BATES AW, Norton AJ, Baithun SI
Malignant lymphoma of the urinary bladder: a clinicopathological study of 11 cases.
J Clin Pathol 2000; 53: 458-61
Abstract Related articles

KAMBA M, Ohuchi Y, Ogawa T, Ohata R
Intraosseous pneumatocyst of the scapula.
Br J Radiol 2000; 73: 658-60
Abstract Related articles

ALEXANDROFF AB, Jackson AM, Paterson T, Haley JL, Ross JA, Longo DL et al
Role for CD40-CD40 ligand interactions in the immune response to solid tumours.
Mol Immunol 2000; 37: 515-26
Abstract Related articles

CORELLA D, Herranz C, Calatayud A, Font G, Celma C, Laborda R
Cancer mortality and exposure to chemical carcinogens in the work place: an ecological study in the Valencian Community, Spain (1981- 1995).
Eur J Epidemiol 2000; 16: 401-9
Abstract Related articles

GARCIA MONTES F, Lorenzo Gomez MF, Boyd J
[Does primary melanoma of the bladder exist?]
Actas Urol Esp 2000; 24: 433-6
Abstract Related articles

MONGE MIRALLAS JM, Asensio Lahoz A, Martinez Bretones F, Acinas Garcia O
[Report of 2 new cases of bladder inverted papilloma, one with them complicated with acute urinary obstruction]
Actas Urol Esp 2000; 24: 419-22
Abstract Related articles

ARIAS FUNEZ F, Burgos Revilla FJ, Jimenez Cidre M, Cruz Guerra N, Cuesta Roca C, Escudero Barrilero A
[Diffuse bladder hemangioma]
Actas Urol Esp 2000; 24: 416-8
Abstract Related articles

WHITTLESTONE TH, Persad R
Radical cystectomy and bladder substitution.
Hosp Med 2000; 61: 336-40
Abstract Related articles

SUNG MT, Lin JW, Chen WJ
Villous adenomas of the urinary tract: report of two cases.
Changgeng Yi Xue Za Zhi 2000; 23: 291-5
Abstract Related articles

ORDONEZ NG, Mackay B
Brenner tumor of the ovary: a comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder.
Ultrastruct Pathol 2000; 24: 157-67
Abstract Related articles

MATVEEV BP, Kudashev BV, Bukharkin BV, Romanov VA, Rubanov IV
[Role of fluorescent control in raising radicality of surgical treatment for superficial bladder cancer]
Urologiia 2000; : 22-4
Abstract Related articles

LACHAINE J, Valiquette L, Crott R
Economic evaluation of NMP22 in the management of bladder cancer.
Can J Urol 2000; 7: 974-80
Abstract Related articles

WATANABE T, Shinohara N, Moriya K, Sazawa A, Kobayashi Y, Ogiso Y et al
Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines.
IUBMB Life 2000; 49: 317-20
Abstract Related articles

FICHERA E, Liang S, Xu Z, Guo N, Mineo R, Fujita-Yamaguchi Y
A quantitative reverse transcription and polymerase chain reaction assay for human IGF-II allows direct comparison of IGF-II mRNA levels in cancerous breast, bladder, and prostate tissues.
Growth Horm IGF Res 2000; 10: 61-70
Abstract Related articles

WERMENSKI K, Kopys-Wiszniewska I
[Value of diagnostic imaging for assessment of unsuccessful treatment of children with neoplastic diseases. Introductory comments based on personal examinations]
Med Wieku Rozwoj 2000; 4: 103-13
Abstract Related articles

RYAN CW, Vogelzang NJ
Gemcitabine in the treatment of bladder cancer.
Expert Opin Pharmacother 2000; 1: 547-53
Abstract Related articles

MARTOV AG, Sysoev PA
[Treatment of bladder superficial neoplasm]
Urologiia 2000; : 44-9
Abstract Related articles

KAMYSHAN IS, Klimenko IA, Kirichenko SA
[Urinary bladder cancer in patients with tuberculous and post- tuberculous cystitis]
Urologiia 2000; : 21-4
Abstract Related articles

SCHIEFELBEIN F
[Bladder cancer--diagnosis and therapy]
Krankenpfl J 2000; 38: 64-8
Abstract Related articles

SAWCZUK IS, Burchardt T, Shabsigh A, de la Taille A, Burchardt M
Bladder cancer markers. Current availability and the future standard of care.
MLO Med Lab Obs 2000; 32: 30-3, 36, 38 passim
Abstract Related articles

WESTER K, Wahlund E, Sundstrom C, Ranefall P, Bengtsson E, Russell PJ et al
Paraffin section storage and immunohistochemistry. Effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen.
Appl Immunohistochem Molecul Morphol 2000; 8: 61-70
Abstract Related articles

SHOTEMOR SS, Churaiants VV, Bozhko OV, Ol’kina OV
[Small pelvic MRI on "Ellipse" low-adz tomograph made in Russia]
Vestn Rentgenol Radiol 2000; : 36-9
Abstract Related articles

HARDT J, Filipas D, Hohenfellner R, Egle UT
Quality of life in patients with bladder carcinoma after cystectomy: first results of a prospective study.
Qual Life Res 2000; 9: 1-12
Abstract Related articles

LEBLANC B, Duclos AJ, Benard F, Valiquette L, Paquin JM, Lapointe S et al
Long term follow-up of intravesical Bacillus Calmette-Guerin for the treatment of bladder transitional cell carcinoma.
Can J Urol 2000; 7: 944-8
Abstract Related articles

PARMAR MS
A false-positive tuberculin test result.
CMAJ 2000; 162: 19
Abstract Related articles

LEONARDI E, Dalla Palma P, Reich A, Caffo O, Luciani L
Biological characterisation of superficial bladder cancer by bivariate cytokeratin 7/DNA analysis, flow cytometric assessment of MIB- 1, and an immunohistochemical study.
Anal Cell Pathol 2000; 21: 21-33
Abstract Related articles

SCHNAKENBERG E, Breuer R, Werdin R, Dreikorn K, Schloot W
Susceptibility genes: GSTM1 and GSTM3 as genetic risk factors in bladder cancer.
Cytogenet Cell Genet 2000; 91: 234-8
Abstract Related articles

YAMADA T
[Studies on molecular mechanism of drug resistance of mycobacteria and recombinant BCG to prevent infection of intracellular pathogens]
Nippon Saikingaku Zasshi 2000; 55: 613-27
Abstract Related articles

GROSSMAN HB, Schmitz-Drager B, Fradet Y, Tribukait B
Use of markers in defining urothelial premalignant and malignant conditions.
Scand J Urol Nephrol Suppl 2000; : 94-104
Abstract Related articles

CORDON-CARDO C, Cote RJ, Sauter G
Genetic and molecular markers of urothelial premalignancy and malignancy.
Scand J Urol Nephrol Suppl 2000; : 82-93
Abstract Related articles

MURPHY WM, Busch C, Algaba F
Intraepithelial lesions of urinary bladder: morphologic considerations.
Scand J Urol Nephrol Suppl 2000; : 67-81
Abstract Related articles

DROLLER MJ, Malmstrom PU
Premalignant lesions and carcinoma in situ in bladder neoplasia: introduction and overview.
Scand J Urol Nephrol Suppl 2000; : 62-6
Abstract Related articles

WIJKSTROM H, Cohen SM, Gardiner RA, Kakizoe T, Schoenberg M, Steineck G et al
Prevention and treatment of urothelial premalignant and malignant lesions.
Scand J Urol Nephrol Suppl 2000; : 116-35
Abstract Related articles

COHEN SM, Shirai T, Steineck G
Epidemiology and etiology of premalignant and malignant urothelial changes.
Scand J Urol Nephrol Suppl 2000; : 105-15
Abstract Related articles

BIRO E, Kalina I, Salagovic J, Habalova V, Hriv ak M, Valansky L
p53 single nucleotide polymorphisms and bladder cancer.
Neoplasma 2000; 47: 303-6
Abstract Related articles

KAUFMAN DS, Winter KA, Shipley WU, Heney NM, Chetner MP, Souhami L et al
The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder
Oncologist 2000; 5: 471-6
Abstract Related articles

HOEKX L
[Bladder cancers]
Acta Urol Belg 2000; 68: 34-6
Abstract Related articles

LAMM DL, Allaway M
Current trends in bladder cancer treatment.
Ann Chir Gynaecol 2000; 89: 234-41
Abstract Related articles

TSUKINO R, Sasaki M
[Monosomy 13q syndrome]
Ryoikibetsu Shokogun Shirizu 2000; : 329-31
Abstract Related articles

BUBENIK J
Cross-contamination of cell lines in culture.
Folia Biol (Praha) 2000; : 163-4
Abstract Related articles

LITYNSKA A, Przybylo M, Ksiazek D, Laidler P
Differences of alpha3beta1 integrin glycans from different human bladder cell lines.
Acta Biochim Pol 2000; 47: 427-34
Abstract Related articles

GARCIA FIGUEIRAS R, Sousa Escandon A, Garcia Figueiras A, Gonzalez Rodriguez AA, Pazos Gonzalez G, Armesto Fernandez M et al
Unusual retrovesical masses in men.
Eur Radiol 2000; 10: 1639-43
Abstract Related articles

FERNANDEZ MA, Ruiz-Cabello F, Oliva MR, Cabrera T, Jimenez P, Lopez Nevot MA et al
Beta2-microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumors.
Int J Clin Lab Res 2000; 30: 87-92
Abstract Related articles

CERVENAKOV I, Szoldova K, Mardiak J, Chovan D, Mala M, Slavov D
Alpha 2-b interferon and farmarubicin in the prophylaxis of recurrence of superficial transitional cell carcinoma of the urinary bladder.
Bratisl Lek Listy 2000; 101: 317-20
Abstract Related articles

DODD PM, McCaffrey JA, Mazumdar M, Scher H, Higgins G, Boyle MG et al
Evaluation of drug delivery and survival impact of dose-intense relative to conventional-dose methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in urothelial cancer.
Cancer Invest 2000; 18: 626-34
Abstract Related articles

SHELLEY MD, Court JB, Kynaston H, Wilt TJ, Fish RG, Mason M
Intravesical Bacillus Calmette-Guerin in Ta and T1 Bladder Cancer (Cochrane Review).
Cochrane Database Syst Rev 2000; : CD001986
Abstract Related articles

SCHNEEWEISS S
Sensitivity analysis of the diagnostic value of endoscopies in cross- sectional studies in the absence of a gold standard.
Int J Technol Assess Health Care 2000; 16: 834-41
Abstract Related articles

KNAPP DW, Glickman NW, Widmer WR, DeNicola DB, Adams LG, Kuczek T et al
Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer.
Cancer Chemother Pharmacol 2000; 46: 221-6
Abstract Related articles

DORFFEL WV, Reitzig P, Dorffel Y, Possinger K
[Secondary malignant neoplasms in patients with breast cancer]
Zentralbl Gynakol 2000; 122: 419-27
Abstract Related articles

CIANCIULLI AM, Bovani R, Leonardo F, Antenucci A, Gandolfo GM, Giannarelli D et al
Interphase cytogenetics of bladder cancer progression: relationship between aneusomy, DNA ploidy pattern, histopathology, and clinical outcome.
Int J Clin Lab Res 2000; 30: 5-11
Abstract Related articles

SIMEONOVA PP, Luster MI
Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?
J Environ Pathol Toxicol Oncol 2000; 19: 281-6
Abstract Related articles

FILOV VA, Reztsova VV, Kil’maeva NE, Petukhov DV, Pinchuk BT
[An experimental study of the antitumor properties of olipifat]
Vopr Onkol 2000; 46: 332-6
Abstract Related articles

TASU JP, Geffroy D, Rocher L, Eschwege P, Strohl D, Benoit G et al
Primary malignant lymphoma of the urinary bladder: report of three cases and review of the literature.
Eur Radiol 2000; 10: 1261-4
Abstract Related articles

BARON A, Mastroeni F, Moore PS, Bonetti F, Orlandini S, Manfrin E et al
Detection of bladder cancer by semi-automated microsatellite analysis of urine sediment.
Adv Clin Path 2000; 4: 19-24
Abstract Related articles

MEYER S, Bruce J, Kelsey A, Eden OB
Pseudosarcoma of the bladder associated with residual urachus in a 3- year-old girl.
Pediatr Surg Int 2000; 16: 604-6
Abstract Related articles

FONTANIERE B, Ranchere D, Michot JP, Barfety-Michot B, Genna L, Charles N et al
[BTA test (Bard test) and urinary cytology]
Ann Pathol 2000; 20 Suppl: S88-91
Abstract Related articles

SEIGNEURIN D
["Immunocyt" technique]
Ann Pathol 2000; 20 Suppl: S87-8
Abstract Related articles

SEIGNEURIN D
[Cytometry]
Ann Pathol 2000; 20 Suppl: S86-7
Abstract Related articles

FONTANIERE B, Ranchere D, Michot JP, Barfety-Michot B, Genna L, Charles N et al
[Thin layer technique in the detection of exposed persons]
Ann Pathol 2000; 20 Suppl: S85-6
Abstract Related articles

ZERBIB M
[What do clinicians look for in urinary cytology?]
Ann Pathol 2000; 20 Suppl: S71-2
Abstract Related articles

WAKAI K, Takashi M, Okamura K, Yuba H, Suzuki K, Murase T et al
Foods and nutrients in relation to bladder cancer risk: a case-control study in Aichi Prefecture, Central Japan.
Nutr Cancer 2000; 38: 13-22
Abstract Related articles

JAN CR, Yu CC, Huang JK
Clomiphene, an ovulation-inducing agent, mobilizes intracellular Ca2+ and causes extracellular Ca2+ influx in bladder female transitional carcinoma cells.
Horm Res 2000; 54: 143-8
Abstract Related articles

STOEHR R, Hartmann A, Hiendlmeyer E, Murle K, Wieland W, Knuechel R
Oligoclonality of early lesions of the urothelium as determined by microdissection-supported genetic analysis.
Pathobiology 2000; 68: 165-72
Abstract Related articles

VELTRI RW, Partin AW, Miller MC
Quantitative nuclear grade (QNG): a new image analysis-based biomarker of clinically relevant nuclear structure alterations.
J Cell Biochem 2000; Suppl 35: 151-7
Abstract Related articles

DAVIDO T, Getzenberg RH
Nuclear matrix proteins as cancer markers.
J Cell Biochem 2000; Suppl 35: 136-41
Abstract Related articles

NEFYODOV LI, Uglyanitsa KN, Nechiporenko NA, Smirnov VY, Brzosko W, Karavay NL
New biochemical mechanisms of the anticancer effect of Ukrain in the treatment of cancer of the urinary bladder.
Drugs Exp Clin Res 2000; 26: 195-9
Abstract Related articles

SERAJ MJ, Harding MA, Gildea JJ, Welch DR, Theodorescu D
The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.
Clin Exp Metastasis 2000; 18: 519-25
Abstract Related articles

ZHANG H, Zelterman D
Binary regression for risks in excess of subject-specific thresholds.
Biometrics 1999; 55: 1247-51
Abstract Related articles

MANDAL AK
Follicular cystitis--a case report.
Indian J Pathol Microbiol 1999; 42: 503-4
Abstract Related articles

MOHANTY R, Gondal, Dash, Bhat, Chawal SC
Diffuse cavernous haemangioma of the rectosigmoid with bladder involvement--a case report.
Indian J Pathol Microbiol 1999; 42: 487-9
Abstract Related articles

USTUN MO, Onal B, Tugyan N, Rezanko T
Lymph node revealing solution: is it effective on detecting minute lymph nodes?
Adv Clin Path 1999; 3: 135-8
Abstract Related articles

GUAN YF, Zhang YH, Breyer RM, Davis L, Breyer MD
Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Neoplasia 1999; 1: 330-9
Abstract Related articles

VARENTSOV GI, Zakhmatov IM, Kornev AI, Otvetchikov IN
[Polyarthritis as a rare complication in BCG immunoprophylaxis of urinary bladder cancer]
Urologiia 1999; : 29-30
Abstract Related articles

STERNBERG CN
A critical review of the management of bladder cancer.
Crit Rev Oncol Hematol 1999; 31: 193-207
Abstract Related articles

GROUTZ A, Gillon G, Konichezky M, Shimonov M, Winkler H, Livne PM et al
Involvement of internal genitalia in female patients undergoing radical cystectomy for bladder cancer: a clinicopathologic study of 37 cases.
Int J Gynecol Cancer 1999; 9: 302-306
Abstract Related articles

Drink fluids to lower cancer risk.
Health News 1999; 5: 6
Abstract Related articles

LEIBOVICI D, Zisman A, Lindner A
[BCG in the treatment of superficial transitional cell carcinoma of the urinary bladder]
Harefuah 1999; 136: 628-33
Abstract Related articles

RIBEIRO JC, Barnetson AR, Jackson P, Ow K, Links M, Russell PJ
Caffeine-increased radiosensitivity is not dependent on a loss of G2/M arrest or apoptosis in bladder cancer cell lines.
Int J Radiat Biol 1999; 75: 481-92
Abstract Related articles

VLAOVIC P, Jewett MA
Cyclophosphamide-induced bladder cancer.
Can J Urol 1999; 6: 745-748
Abstract Related articles

KOLASSA JE, Tanner MA
Approximate Monte Carlo conditional inference in exponential families.
Biometrics 1999; 55: 246-51
Abstract Related articles

TSIKONOV I, Yeshurun D, Naschitz JE
[Multisystem disease caused by BCG imitating miliary tuberculosis]
Harefuah 1999; 136: 271-3, 339
Abstract Related articles

SELLA A, Flex D, Gafni D, Rabinovitz O, Sulkes A, Baniel J
[Combination chemotherapy with M-VAC protocol in metastatic urothelial cancer]
Harefuah 1999; 136: 268-71, 340, 339
Abstract Related articles

RAJARATNAM S, Seshadri MS, Gopalakrishnan G, Chandi SM
Phaeochromocytoma of the urinary bladder.
J Assoc Physicians India 1999; 47: 246-7
Abstract Related articles

WALLNER G, Zajaczkowski K
Vesico-intestinal fistulas, vesico-sigmoid fistula in the course of sigmoid cancer.
Ann Univ Mariae Curie Sklodowska [Med] 1999; 54: 373-8
Abstract Related articles

SPENCER RP
Bladder cancer mortality with aging: male/female comparison with autocorrelation and time frame shift.
J Nutr Health Aging 1999; 3: 186
Abstract Related articles

LOPATKIN NA, Martov AG, Darenkov SP, Kamalov AA, Kudriavtsev IV
[Surgical treatment of urinary bladder cancer]
Urol Nefrol (Mosk) 1999; : 26-31
Abstract Related articles

KURASHIGE S, Akuzawa Y, Endo F
Effects of astragali radix extract on carcinogenesis, cytokine production, and cytotoxicity in mice treated with a carcinogen, N-butyl- N’-butanolnitrosoamine.
Cancer Invest 1999; 17: 30-5
Abstract Related articles

DZAMIC Z, Hadzi-Djokic J, Tulic C, Vuksanovic A, Lalic N, Acimovic M et al
[Quality of life in patients with a modified Mainz-pouch II urinary diversion]
Acta Chir Iugosl 1999; 46: 11-3
Abstract Related articles

SZABO F, Simon Z, Arato G
Eosinophilic cystitis in view of two cases.
Acta Chir Hung 1999; 38: 253-60
Abstract Related articles

CONLY J, Phillips A, Campbell I, Dedier H, Cork L
Stability of reconstituted freeze-dried Bacille Calmette-Guerin used for intravesical immunotherapy for bladder cancer.
Can J Urol 1998; 5: 608-610
Abstract Related articles

ZULFIQAR MA, Zaleha AM, Zulkifli I, Chia WY, Samad SA
Tumoral cystitis in children.
Med J Malaysia 1998; 53: 284-7
Abstract Related articles

ZHAO T, Wang J, Jiang X
[The value of MRI for diagnosis of recurrence of rectal carcinoma after surgical resection]
Zhonghua Zhong Liu Za Zhi 1998; 20: 377-9
Abstract Related articles

CANTOR KP
Invited commentary: arsenic and cancer of the urinary tract.
Am J Epidemiol 2001; 153: 422-3
Abstract Related articles

CHIOU HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML et al
Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan.
Am J Epidemiol 2001; 153: 411-8
Abstract Related articles

ZEEGERS MP, Volovics A, Dorant E, Goldbohm RA, van den Brandt PA
Alcohol consumption and bladder cancer risk: results from The Netherlands Cohort Study.
Am J Epidemiol 2001; 153: 38-41
Abstract Related articles

MICHAUD DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci E
Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men.
Am J Epidemiol 2000; 152: 1145-53
Abstract Related articles

STEINMAUS CM, Nunez S, Smith AH
Diet and bladder cancer: a meta-analysis of six dietary variables.
Am J Epidemiol 2000; 151: 693-702
Abstract Related articles

SANCHEZ-CARBAYO M, Urrutia M, Romani R, Herrero M, Gonzalez de Buitrago JM, Navajo JA
Serial urinary IL-2, IL-6, IL-8, TNFalpha, UBC, CYFRA 21-1 and NMP22 during follow-up of patients with bladder cancer receiving intravesical BCG.
Anticancer Res 2001; 21: 3041-7
Abstract Related articles

IOACHIM EE, Charchanti AV, Stavropoulos NE, Athanassiou ED, Michael MC, Agnantis NJ
Localization of metallothionein in urothelial carcinoma of the human urinary bladder: an immunohistochemical study including correlation with HLA-DR antigen, p53, and proliferation indices.
Anticancer Res 2001; 21: 1757-61
Abstract Related articles

STAVROPOULOS NE, Ioachim E, Charchanti A, Michael MC, Kitsiou E, Mihailidis I et al
Tumor markers in stage P1 bladder cancer.
Anticancer Res 2001; 21: 1495-8
Abstract Related articles

LAVEZZI AM, Biondo B, Cazzullo A, Giordano F, Pallotti F, Turconi P et al
The role of different biomarkers (DNA, PCNA, apoptosis and karyotype) in prognostic evaluation of superficial transitional cell bladder carcinoma.
Anticancer Res 2001; 21: 1279-84
Abstract Related articles

MAZZUCCHELLI R, Santinelli A, Colanzi P, Streccioni M, Lopez-Beltran A, Scarpelli M et al
Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading.
Anticancer Res 2001; 21: 1157-62
Abstract Related articles

KAWAKAMI S, Kageyama Y, Fujii Y, Kihara K, Oshima H
Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells.
Anticancer Res 2001; 21: 213-9
Abstract Related articles

SHIGEMATSU N, Kawata T, Ihara N, Kawaguchi O, Kutsuki S, Ishibashi R et al
Effect of combined treatment with radiation and low dose etoposide on cell survival.
Anticancer Res 2001; 21: 325-8
Abstract Related articles

HUNCHAREK M, McGarry R, Kupelnick B
Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
Anticancer Res 2001; 21: 765-9
Abstract Related articles

HSU CH, Chen J, Wu CY, Cheng AL, Pu YS
Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
Anticancer Res 2001; 21: 711-5
Abstract Related articles

YOUNES M, Juarez D, Lechago LV, Lerner SP
Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival.
Anticancer Res 2001; 21: 575-8
Abstract Related articles

CARDILLO MR, Sale P, Di Silverio F
Heat shock protein-90, IL-6 and IL-10 in bladder cancer.
Anticancer Res 2000; 20: 4579-83
Abstract Related articles

NAKOPOULOU L, Zervas A, Gakiopoulou-Givalou H, Constantinides C, Doumanis G, Davaris P et al
Prognostic value of E-cadherin, beta-catenin, P120ctn in patients with transitional cell bladder cancer.
Anticancer Res 2000; 20: 4571-8
Abstract Related articles

JAN CR, Yu CC, Huang JK
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride) (W-7) causes increases in intracellular free Ca2+ levels in bladder female transitional carcinoma (BFTC) cells.
Anticancer Res 2000; 20: 4355-9
Abstract Related articles

HIRANO Y, Kageyama S, Ushiyama T, Suzuki K, Fujita K
Thymidine phosphorylase activity in transitional cell cancer: relation to histological parameters and chemosensitivity to fluorouracil-related drugs.
Anticancer Res 2000; 20: 4315-8
Abstract Related articles

KRAUSE FS, Feil G, Bichler KH
Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
Anticancer Res 2000; 20: 5023-8
Abstract Related articles

KRAUSE FS, Feil G, Zumbragel A, Bichler KH
Molecular genetic methods in the diagnosis of invasive bladder cancer.
Anticancer Res 2000; 20: 5015-21
Abstract Related articles

MENGS U, Schwarz T, Bulitta M, Weber K
Antitumoral effects of an intravesically applied aqueous mistletoe extract on urinary bladder carcinoma MB49 in mice.
Anticancer Res 2000; 20: 3565-8
Abstract Related articles

HOUR TC, Chen J, Huang CY, Guan JY, Lu SH, Hsieh CY et al
Characterization of chemoresistance mechanisms in a series of cisplatin- resistant transitional carcinoma cell lines.
Anticancer Res 2000; 20: 3221-5
Abstract Related articles

FREUND CT, Tong XW, Block A, Contant CF, Kieback DG, Rowley DR et al
Adenovirus-mediated suicide gene therapy for bladder cancer: comparison of the cytomegalovirus- and Rous sarcoma virus-promoter.
Anticancer Res 2000; 20: 2811-6
Abstract Related articles

KAMUHABWA AR, Agostinis P, D’Hallewin MA, Kasran A, de Witte PA
Photodynamic activity of hypericin in human urinary bladder carcinoma cells.
Anticancer Res 2000; 20: 2579-84
Abstract Related articles

PAPATHOMA AS, Petraki C, Grigorakis A, Papakonstantinou H, Karavana V, Stefanakis S et al
Prognostic significance of matrix metalloproteinases 2 and 9 in bladder cancer.
Anticancer Res 2000; 20: 2009-13
Abstract Related articles

FREUND CT, Sutton MA, Dang T, Contant CF, Rowley D, Lerner SP
Adenovirus-mediated combination suicide and cytokine gene therapy for bladder cancer.
Anticancer Res 2000; 20: 1359-65
Abstract Related articles

PATTISON S, Choong S, Corbishley CM, Bailey MJ
Squamous cell carcinoma of the bladder, intermittent self- catheterization and urinary tract infection--is there an association?
BJU Int 2001; 88: 441
Abstract Related articles

DRYHURST DJ, Fowler CG
Flexible cystodiathermy can be rendered painless by using 2% lignocaine solution to provide intravesical anaesthesia.
BJU Int 2001; 88: 437-8
Abstract Related articles

BONFIL RD, Gonzalez AD, Siguelboim D, Cuello Carrion FD, Ciocca DR, Villaronga A et al
Immunohistochemical analysis of Ki-67, p21waf1/cip1 and apoptosis in marker lesions from patients with superficial bladder tumours treated with vinorelbine intravesical therapy in a preliminary phase I trial.
BJU Int 2001; 88: 425-31
Abstract Related articles

SHELLEY MD, Kynaston H, Court J, Wilt TJ, Coles B, Burgon K et al
A systematic review of intravesical bacillus Calmette-Guerin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer.
BJU Int 2001; 88: 209-16
Abstract Related articles

ROTTERUD R, Berner A, Holm R, Skovlund E, Fossa SD
p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder.
BJU Int 2001; 88: 202-8
Abstract Related articles

WESTENEND PJ, Stoop JA, Hendriks JG
Human papillomaviruses 6/11, 16/18 and 31/33/51 are not associated with squamous cell carcinoma of the urinary bladder.
BJU Int 2001; 88: 198-201
Abstract Related articles

WOODHAMS SD, Greenwell TJ, Smalley T, Mundy AR
Factors causing variation in urinary N-nitrosamine levels in enterocystoplasties.
BJU Int 2001; 88: 187-91
Abstract Related articles

YU DS, Hsieh DS, Chang SY
Detection of chromosomal alterations in bladder cancer by comparative genomic hybridization.
BJU Int 2001; 87: 889-93
Abstract Related articles

WADA T, Louhelainen J, Hemminki K, Adolfsson J, Wijkstrom H, Norming U et al
The prevalence of loss of heterozygosity in chromosome 3, including FHIT, in bladder cancer, using the fluorescent multiplex polymerase chain reaction.
BJU Int 2001; 87: 876-881
Abstract Related articles

KATO H, Kiyokawa H, Igawa Y, Nishizawa O
The serous-lined tunnel principle for urinary reconstruction: a more rational method.
BJU Int 2001; 87: 783-8
Abstract Related articles

SMEULDERS N, Woodhouse CR
Neoplasia in adult exstrophy patients.
BJU Int 2001; 87: 623-8
Abstract Related articles

DAWAM D, Kalayi GD, Osuide JA, Muhammad I, Garg SK
Haematuria in Africa: is the pattern changing?
BJU Int 2001; 87: 326-30
Abstract Related articles

OOSTERLINCK W
The management of superficial bladder cancer.
BJU Int 2001; 87: 135-40
Abstract Related articles

CONSTANTINIDES C, Giannopoulos A, Kyriakou G, Androulaki A, Ioannou M, Dimopoulos M et al
Lymphoepithelioma-like carcinoma of the bladder.
BJU Int 2001; 87: 121-2
Abstract Related articles

HUGHES OD, Perkins AC, Frier M, Wastie ML, Denton G, Price MR et al
Imaging for staging bladder cancer: a clinical study of intravenous 111indium-labelled anti-MUC1 mucin monoclonal antibody C595.
BJU Int 2001; 87: 39-46
Abstract Related articles

KEEGAN PE
Re: A prospective pilot evaluation of urinary and immunohistochemical markers as predictors of clinical stage of urothelial carcinoma of the bladder.
BJU Int 2000; 86: 1096
Abstract Related articles

YIP SK, Peh WC
Re: Are dedicated bladder films necessary as part of intravenous urography for haematuria.
BJU Int 2000; 86: 1095
Abstract Related articles

NABI G
Re: Extravesical transitional cell carcinoma as a result of implantation after perforation of the bladder.
BJU Int 2000; 86: 1094-5
Abstract Related articles

CROOK TJ, Hall IS, Solomon LZ, Birch BR, Cooper AJ
A model of superficial bladder cancer using fluorescent tumour cells in an organ-culture system.
BJU Int 2000; 86: 886-93
Abstract Related articles

YAMAMOTO Y, Nasu Y, Saika T, Akaeda T, Tsushima T, Kumon H
The absorption of pirarubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer.
BJU Int 2000; 86: 802-4
Abstract Related articles

FILIADIS I, Hrouda D
Genetic factors in chemically-induced transitional cell bladder cancer.
BJU Int 2000; 86: 794-801
Abstract Related articles

DUGGAN B, Kelly J, Keane PF, Williamson K, Johnston SR
Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy.
BJU Int 2000; 86: 757
Abstract Related articles

YONO M, Yoshida M, Takahashi W, Inadome A, Ueda S
Comparison of the effects of novel antimuscarinic drugs on human detrusor smooth muscle.
BJU Int 2000; 86: 719-25
Abstract Related articles

CLIFF AM, Heatherwick B, Scoble J, Parr NJ
The effect of fasting or desmopressin before treatment on the concentration of mitomycin C during intravesical administration.
BJU Int 2000; 86: 644-7
Abstract Related articles

SHACKLEY DC, Whitehurst C, Moore JV, George NJ, Betts CD, Clarke NW
Light penetration in bladder tissue: implications for the intravesical photodynamic therapy of bladder tumours.
BJU Int 2000; 86: 638-43
Abstract Related articles

BRIERLY RD, Hindley RG, Thomas PJ
Focal changes in nerve, muscle and connective tissue in normal and unstable human bladder.
BJU Int 2000; 86: 407
Abstract Related articles

EL-SHERBINY MT, El-Mekresh MH, El-Baz MA, Ghoneim MA
Paediatric lower urinary tract rhabdomyosarcoma: a single-centre experience of 30 patients.
BJU Int 2000; 86: 260-7
Abstract Related articles

MACVICAR AD
Bladder cancer staging.
BJU Int 2000; 86 Suppl 1: 111-22
Abstract Related articles

KOURIEFS C, Leris AC, Mokbel K, Carpenter R
The role of urine cytology in the assessment of lower urinary tract symptoms.
BJU Int 2000; 85: 1155
Abstract Related articles

CHOUDRY GA, Stewart PA, Double JA, Krul MR, Naylor B, Flannigan GM et al
A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9.
Br J Cancer 2001; 85: 1137-46
Abstract Related articles

ZEEGERS MP, Goldbohm RA, Brandt PA
Are retinol, vitamin C, vitamin E, folate and carotenoids intake associated with bladder cancer risk? Results from the Netherlands Cohort Study.
Br J Cancer 2001; 85: 977-83
Abstract Related articles

RAITANEN MP, Kaasinen E, Rintala E, Hansson E, Nieminen P, Aine R et al
Prognostic utility of human complement factor H related protein test (the BTA stat Test).
Br J Cancer 2001; 85: 552-6
Abstract Related articles

THYKJAER T, Christensen M, Clark AB, Hansen LR, Kunkel TA, Orntoft TF
Functional analysis of the mismatch repair system in bladder cancer.
Br J Cancer 2001; 85: 568-75
Abstract Related articles

BERGGREN P, Steineck G, Adolfsson J, Hansson J, Jansson O, Larsson P et al
p53 mutations in urinary bladder cancer.
Br J Cancer 2001; 84: 1505-11
Abstract Related articles

WYLD L, Reed MW, Brown NJ
Differential cell death response to photodynamic therapy is dependent on dose and cell type.
Br J Cancer 2001; 84: 1384-6
Abstract Related articles

KAMAI T, Takagi K, Asami H, Ito Y, Oshima H, Yoshida KI
Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
Br J Cancer 2001; 84: 1242-51
Abstract Related articles

PERABO FG, Kamp S, Schmidt D, Lindner H, Steiner G, Mattes RH et al
Bladder cancer cells acquire competent mechanisms to escape Fas- mediated apoptosis and immune surveillance in the course of malignant transformation.
Br J Cancer 2001; 84: 1330-8
Abstract Related articles

SEDDIGHZADEH M, Steineck G, Jansson O, Larsson P, Wijkstrom H, Adolfsson J et al
Low interleukin-1alpha messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma.
Br J Cancer 2001; 84: 329-34
Abstract Related articles

KASSEM HS, Varley JM, Hamam SM, Margison GP
Immunohistochemical analysis of expression and allelotype of mismatch repair genes (hMLH1 and hMSH2) in bladder cancer.
Br J Cancer 2001; 84: 321-8
Abstract Related articles

FUJIYAMA C, Jones A, Fuggle S, Bicknell R, Cranston D, Harris AL
Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion.
Br J Cancer 2001; 84: 558-64
Abstract Related articles

TUT VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK
Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Br J Cancer 2001; 84: 270-5
Abstract Related articles

MULATERO C, McClaren BR, Mason M, Oliver RT, Gallagher CJ
Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma.
Br J Cancer 2000; 83: 1612-6
Abstract Related articles

SHINOHARA H, Zhou J, Yoshikawa K, Yazumi S, Ko K, Yamaoka Y et al
Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis.
Br J Cancer 2000; 83: 1039-46
Abstract Related articles

OYA M, Schulz WA
Decreased expression of p57(KIP2)mRNA in human bladder cancer.
Br J Cancer 2000; 83: 626-31
Abstract Related articles

GREEN J, Banks E, Berrington A, Darby S, Deo H, Newton R
N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction.
Br J Cancer 2000; 83: 412-7
Abstract Related articles

CASTELAO JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK
Non-steroidal anti-inflammatory drugs and bladder cancer prevention.
Br J Cancer 2000; 82: 1364-9
Abstract Related articles

VAN RHIJN BW, Lurkin I, Kirkels WJ, van der Kwast TH, Zwarthoff EC
Microsatellite analysis--DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial.
Cancer 2001; 92: 768-75
Abstract Related articles

MIZUTANI Y, Wada H, Ogawa O, Yoshida O, Fukushima M, Nonomura N et al
Prognostic significance of thymidylate synthase activity in bladder carcinoma.
Cancer 2001; 92: 510-8
Abstract Related articles

MIZUTANI Y, Hongo F, Sato N, Ogawa O, Yoshida O, Miki T
Significance of serum soluble Fas ligand in patients with bladder carcinoma.
Cancer 2001; 92: 287-93
Abstract Related articles

MILLIKAN RE, Plunkett WK, Smith TL, Williams DL, Logothetis CJ
Gemcitabine modulation of alkylator therapy: a phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicin.
Cancer 2001; 92: 194-9
Abstract Related articles

SHIRAHAMA T, Arima J, Akiba S, Sakakura C
Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder.
Cancer 2001; 92: 188-93
Abstract Related articles

XU X, Sun TT, Gupta PK, Zhang P, Nasuti JF
Uroplakin as a marker for typing metastatic transitional cell carcinoma on fine-needle aspiration specimens.
Cancer 2001; 93: 216-21
Abstract Related articles

PRESCOTT JL, Montie J, Pugh TW, McHugh T, Veltri RW
Clinical sensitivity of p53 mutation detection in matched bladder tumor, bladder wash, and voided urine specimens.
Cancer 2001; 91: 2127-35
Abstract Related articles

PRESTIGIACOMO CJ, Balmaceda C, Dalmau J
Anti-Ri-associated paraneoplastic opsoclonus-ataxia syndrome in a man with transitional cell carcinoma.
Cancer 2001; 91: 1423-8
Abstract Related articles

COBLENTZ TR, Mills SE, Theodorescu D
Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
Cancer 2001; 91: 1284-90
Abstract Related articles

ELSASSER-BEILE U, Ruhnau T, Freudenberg N, Wetterauer U, Mengs U
Antitumoral effect of recombinant mistletoe lectin on chemically induced urinary bladder carcinogenesis in a rat model.
Cancer 2001; 91: 998-1004
Abstract Related articles

MAITRA A, Rathi A, Gazdar AF, Sagalowsky A, Ashfaq R
Expression of the RNA component of human telemorase (hTR) in ThinPrep preparations from bladder washings.
Cancer 2001; 93: 73-9
Abstract Related articles

PROUT GR JR, Wesley MN, Greenberg RS, Chen VW, Brown CC, Miller AW et al
Bladder cancer: race differences in extent of disease at diagnosis.
Cancer 2000; 89: 1349-58
Abstract Related articles

JAHNSON S, Karlsson MG
Tumor mapping of regional immunostaining for p21, p53, and mdm2 in locally advanced bladder carcinoma.
Cancer 2000; 89: 619-29
Abstract Related articles

SOMJI S, Sens MA, Lamm DL, Garrett SH, Sens DA
Metallothionein isoform 1 and 2 gene expression in the human bladder: evidence for upregulation of MT-1X mRNA in bladder cancer.
Cancer Detect Prev 2001; 25: 62-75
Abstract Related articles

LIN S, Hirschowitz SL, Williams C, Shintako P, Said J, Rao JY
Cytokeratin 20 as an immunocytochemical marker for detection of urothelial carcinoma in atypical cytology: preliminary retrospective study on archived urine slides.
Cancer Detect Prev 2001; 25: 202-9
Abstract Related articles

BAGLIETTO L, Torrisi R, Arena G, Tosetti F, Gonzaga AG, Pasquetti W et al
Ocular effects of fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancer.
Cancer Detect Prev 2000; 24: 369-75
Abstract Related articles

SAWCZUK IS, Bagiella E, Sawczuk AT, Yun EJ
Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder.
Cancer Detect Prev 2000; 24: 364-8
Abstract Related articles

BRAUERS A, Manegold E, Buettner R, Baron JM, Merk HF, Jakse G
Cytochrome P450 isoenzyme mRNA expression pattern in human urinary bladder malignancies and normal urothelium.
Cancer Detect Prev 2000; 24: 356-63
Abstract Related articles

SHIINA H, Igawa M, Urakami S, Shigeno K, Yoneda T, Terashima M et al
Alterations of beta- and gamma-Catenin in N-Butyl-N-(-4- hydroxybutyl)nitrosamine-induced Murine Bladder Cancer.
Cancer Res 2001; 61: 7101-7109
Abstract Related articles

ROMANENKO A, Vozianov A, Morimura K, Fukushima S
Correspondence re: W. Paile’s letter to the editor. Cancer Res., 60: 1146, 2000.
Cancer Res 2001; 61: 6964-5
Abstract Related articles

LEE MG, Kim HY, Byun DS, Lee SJ, Lee CH, Kim JI et al
Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Cancer Res 2001; 61: 6688-92
Abstract Related articles

OKEGAWA T, Pong RC, Li Y, Bergelson JM, Sagalowsky AI, Hsieh JT
The Mechanism of the Growth-inhibitory Effect of Coxsackie and Adenovirus Receptor (CAR) on Human Bladder Cancer: A Functional Analysis of CAR Protein Structure.
Cancer Res 2001; 61: 6592-6600
Abstract Related articles

VAN BOKHOVEN A, Varella-Garcia M, Korch C, Miller GJ
TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin.
Cancer Res 2001; 61: 6340-4
Abstract Related articles

THOGERSEN VB, Sorensen BS, Poulsen SS, Orntoft TF, Wolf H, Nexo E
A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients.
Cancer Res 2001; 61: 6227-33
Abstract Related articles

MARKL ID, Cheng J, Liang G, Shibata D, Laird PW, Jones PA
Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time.
Cancer Res 2001; 61: 5875-84
Abstract Related articles

CASCORBI I, Roots I, Brockmoller J
Association of nat1 and nat2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with nat1*10.
Cancer Res 2001; 61: 5051-6
Abstract Related articles

CORALLI C, Cemazar M, Kanthou C, Tozer GM, Dachs GU
Limitations of the reporter green fluorescent protein under simulated tumor conditions.
Cancer Res 2001; 61: 4784-90
Abstract Related articles

KURASHIGE T, Noguchi Y, Saika T, Ono T, Nagata Y, Jungbluth A et al
Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade.
Cancer Res 2001; 61: 4671-4
Abstract Related articles

AMARA N, Palapattu GS, Schrage M, Gu Z, Thomas GV, Dorey F et al
Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
Cancer Res 2001; 61: 4660-5
Abstract Related articles

SIMON R, Richter J, Wagner U, Fijan A, Bruderer J, Schmid U et al
High-throughput tissue microarray analysis of 3p25 (raf1) and 8p12 (fgfr1) copy number alterations in urinary bladder cancer.
Cancer Res 2001; 61: 4514-9
Abstract Related articles

PENG XY, Won JH, Rutherford T, Fujii T, Zelterman D, Pizzorno G et al
The Use of the L-Plastin Promoter for Adenoviral-mediated, Tumor- specific Gene Expression in Ovarian and Bladder Cancer Cell Lines.
Cancer Res 2001; 61: 4405-4413
Abstract Related articles

PIAZZA GA, Thompson WJ, Pamukcu R, Alila HW, Whitehead CM, Liu L et al
Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis.
Cancer Res 2001; 61: 3961-8
Abstract Related articles

THYKJAER T, Workman C, Kruhoffer M, Demtroder K, Wolf H, Andersen LD et al
Identification of gene expression patterns in superficial and invasive human bladder cancer.
Cancer Res 2001; 61: 2492-9
Abstract Related articles

MATIN SF, Rackley RR, Sadhukhan PC, Kim MS, Novick AC, Bandyopadhyay SK
Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells.
Cancer Res 2001; 61: 2261-6
Abstract Related articles

VAN RHIJN BW, Lurkin I, Radvanyi F, Kirkels WJ, van der Kwast TH, Zwarthoff EC
The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate.
Cancer Res 2001; 61: 1265-8
Abstract Related articles

SLOVAK ML, Tcheurekdjian L, Zhang FF, Murata-Collins JL
Simultaneous detection of multiple genetic aberrations in single cells by spectral fluorescence in situ hybridization.
Cancer Res 2001; 61: 831-6
Abstract Related articles

JUAN G, Cordon-Cardo C
Intranuclear compartmentalization of cyclin E during the cell cycle: disruption of the nucleoplasm-nucleolar shuttling of cyclin E in bladder cancer.
Cancer Res 2001; 61: 1220-6
Abstract Related articles

SIMON R, Eltze E, Schafer KL, Burger H, Semjonow A, Hertle L et al
Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells.
Cancer Res 2001; 61: 355-62
Abstract Related articles

WYKOFF CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A et al
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
Cancer Res 2000; 60: 7075-83
Abstract Related articles

AN G, Ng AY, Meka CS, Luo G, Bright SP, Cazares L et al
Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers.
Cancer Res 2000; 60: 7014-20
Abstract Related articles

PRIMDAHL H, von der Maase H, Christensen M, Wolf H, Orntoft TF
Allelic deletions of cell growth regulators during progression of bladder cancer.
Cancer Res 2000; 60: 6623-9
Abstract Related articles

BROWN NS, Jones A, Fujiyama C, Harris AL, Bicknell R
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
Cancer Res 2000; 60: 6298-302
Abstract Related articles

RAUCHWERGER DR, Firby PS, Hedley DW, Moore MJ
Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity.
Cancer Res 2000; 60: 6075-9
Abstract Related articles

GRUBBS CJ, Lubet RA, Koki AT, Leahy KM, Masferrer JL, Steele VE et al
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
Cancer Res 2000; 60: 5599-602
Abstract Related articles

LIANG G, Robertson KD, Talmadge C, Sumegi J, Jones PA
The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells.
Cancer Res 2000; 60: 4907-12
Abstract Related articles

SCHNEIDER A, Borgnat S, Lang H, Regine O, Lindner V, Kassem M et al
Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer.
Cancer Res 2000; 60: 4617-22
Abstract Related articles

BRUCH J, Schulz WA, Haussler J, Melzner I, Bruderlein S, Moller P et al
Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines.
Cancer Res 2000; 60: 4526-30
Abstract Related articles

MUTO S, Horie S, Takahashi S, Tomita K, Kitamura T
Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer.
Cancer Res 2000; 60: 4021-5
Abstract Related articles

SARKAR S, Julicher KP, Burger MS, Della Valle V, Larsen CJ, Yeager TR et al
Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
Cancer Res 2000; 60: 3862-71
Abstract Related articles

KAWANO K, Gomi S, Tanaka K, Tsuda N, Kamura T, Itoh K et al
Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer.
Cancer Res 2000; 60: 3550-8
Abstract Related articles

PARK BJ, Lee SJ, Kim JI, Lee SJ, Lee CH, Chang SG et al
Frequent alteration of p63 expression in human primary bladder carcinomas.
Cancer Res 2000; 60: 3370-4
Abstract Related articles

OLESEN SH, Thykjaer T, Orntoft TF
Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity.
Carcinogenesis 2001; 22: 813-5
Abstract Related articles

TORINO JL, Burger MS, Reznikoff CA, Swaminathan S
Role of TP53 in repair of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human transitional cell carcinoma of the urinary bladder.
Carcinogenesis 2001; 22: 147-54
Abstract Related articles

FRENCH JE, Lacks GD, Trempus C, Dunnick JK, Foley J, Mahler J et al
Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
Carcinogenesis 2001; 22: 99-106
Abstract Related articles

HULLA JE, French JE, Dunnick JK
Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice.
Carcinogenesis 2001; 22: 89-98
Abstract Related articles

MUSCHECK M, Abol-Enein H, Chew K, Moore D 2nd, Bhargava V, Ghoneim MA et al
Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization.
Carcinogenesis 2000; 21: 1721-6
Abstract Related articles

SLATON JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J et al
Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Clin Cancer Res 2001; 7: 2840-53
Abstract Related articles

DALBAGNI G, Ren ZP, Herr H, Cordon-Cardo C, Reuter V
Genetic alterations in tp53 in recurrent urothelial cancer: a longitudinal study.
Clin Cancer Res 2001; 7: 2797-801
Abstract Related articles

OHTA JI, Miyoshi Y, Uemura H, Fujinami K, Mikata K, Hosaka M et al
Fluorescence in Situ Hybridization Evaluation of c-erbB-2 Gene Amplification and Chromosomal Anomalies in Bladder Cancer.
Clin Cancer Res 2001; 7: 2463-7
Abstract Related articles

JIMENEZ RE, Hussain M, Bianco FJ Jr, Vaishampayan U, Tabazcka P, Sakr WA et al
Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors.
Clin Cancer Res 2001; 7: 2440-7
Abstract Related articles

CHOW NH, Chan SH, Tzai TS, Ho CL, Liu HS
Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.
Clin Cancer Res 2001; 7: 1957-62
Abstract Related articles

STADLER WM, Steinberg G, Yang X, Hagos F, Turner C, Olopade OI
Alterations of the 9p21 and 9q33 Chromosomal Bands in Clinical Bladder Cancer Specimens by Fluorescence in Situ Hybridization.
Clin Cancer Res 2001; 7: 1676-1682
Abstract Related articles

SERAJ MJ, Thomas AR, Chin JL, Theodorescu D
Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder.
Clin Cancer Res 2001; 7: 1516-22
Abstract Related articles

GAN Y, Mo Y, Kalns JE, Lu J, Danenberg K, Danenberg P et al
Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors.
Clin Cancer Res 2001; 7: 1313-9
Abstract Related articles

JONES A, Fujiyama C, Blanche C, Moore JW, Fuggle S, Cranston D et al
Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia- inducible factor-2 alpha in human bladder tumors and cell lines.
Clin Cancer Res 2001; 7: 1263-72
Abstract Related articles

GAZZANIGA P, Gandini O, Giuliani L, Magnanti M, Gradilone A, Silvestri I et al
Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients.
Clin Cancer Res 2001; 7: 577-83
Abstract Related articles

SHIRAHAMA T, Sakakura C
Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder.
Clin Cancer Res 2001; 7: 558-61
Abstract Related articles

GERHARDS S, Jung K, Koenig F, Daniltchenko D, Hauptmann S, Schnorr D et al
Correspondence re: C. F. M. Sier et al., Enhanced urinary gelatinase activities (matrix metalloproteinases 2 and 9) are associated with early-stage bladder carcinoma: a comparison with clinically used tumor
Clin Cancer Res 2001; 7: 445-7
Abstract Related articles

NISHIYAMA T, Tachibana M, Horiguchi Y, Nakamura K, Ikeda Y, Takesako K et al
Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.
Clin Cancer Res 2001; 7: 23-31
Abstract Related articles

LI ML, Horn L, Firby PS, Moore MJ
Pharmacological determinants of 9-aminocamptothecin cytotoxicity.
Clin Cancer Res 2001; 7: 168-74
Abstract Related articles

INOUE K, Slaton JW, Karashima T, Yoshikawa C, Shuin T, Sweeney P et al
The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.
Clin Cancer Res 2000; 6: 4866-73
Abstract Related articles

TADA Y, Wada M, Kuroiwa K, Kinugawa N, Harada T, Nagayama J et al
MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment.
Clin Cancer Res 2000; 6: 4618-27
Abstract Related articles

INOUE K, Slaton JW, Perrotte P, Davis DW, Bruns CJ, Hicklin DJ et al
Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.
Clin Cancer Res 2000; 6: 4874-84
Abstract Related articles

INOUE K, Perrotte P, Wood CG, Slaton JW, Sweeney P, Dinney CP
Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.
Clin Cancer Res 2000; 6: 4422-31
Abstract Related articles

CHEN SA, Tsai MH, Wu FT, Hsiang A, Chen YL, Lei HY et al
Induction of antitumor immunity with combination of HER2/neu DNA vaccine and interleukin 2 gene-modified tumor vaccine.
Clin Cancer Res 2000; 6: 4381-8
Abstract Related articles

GALA JL, Loric S, Guiot Y, Denmeade SR, Gady A, Brasseur F et al
Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value?
Clin Cancer Res 2000; 6: 4049-54
Abstract Related articles

CHOW NH, Liu HS, Chan SH
The role of nm23-H1 in the progression of transitional cell bladder cancer.
Clin Cancer Res 2000; 6: 3595-9
Abstract Related articles

SANCHEZ-CARBAYO M, Urrutia M, Gonzalez de Buitrago JM, Navajo JA
Evaluation of two new urinary tumor markers: bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer.
Clin Cancer Res 2000; 6: 3585-94
Abstract Related articles

LU JJ, Kakehi Y, Takahashi T, Wu XX, Yuasa T, Yoshiki T et al
Detection of circulating cancer cells by reverse transcription- polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
Clin Cancer Res 2000; 6: 3166-71
Abstract Related articles

MIGALDI M, Sgambato A, Garagnani L, Ardito R, Ferrari P, De Gaetani C et al
Loss of p21Waf1 expression is a strong predictor of reduced survival in primary superficial bladder cancers.
Clin Cancer Res 2000; 6: 3131-8
Abstract Related articles

LARCHIAN WA, Horiguchi Y, Nair SK, Fair WR, Heston WD, Gilboa E
Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer.
Clin Cancer Res 2000; 6: 2913-20
Abstract Related articles

GELMINI S, Crisci A, Salvadori B, Pazzagli M, Selli C, Orlando C
Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
Clin Cancer Res 2000; 6: 2771-6
Abstract Related articles

INOUE K, Slaton JW, Davis DW, Hicklin DJ, McConkey DJ, Karashima T et al
Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
Clin Cancer Res 2000; 6: 2635-43
Abstract Related articles

KONETY BR, Nguyen TS, Dhir R, Day RS, Becich MJ, Stadler WM et al
Detection of bladder cancer using a novel nuclear matrix protein, BLCA- 4.
Clin Cancer Res 2000; 6: 2618-25
Abstract Related articles

DE KOK JB, van Balken MR, Ruers TJ, Swinkels DW, Klein Gunnewiek JM
Detection of telomerase activity in urine as a tool for noninvasive detection of recurrent bladder tumors is poor and cannot be improved by timing of sampling.
Clin Chem 2000; 46: 2014-5
Abstract Related articles

DE KOK JB, van Balken MR, Roelofs RW, van Aarssen YA, Swinkels DW, Klein Gunnewiek JM
Quantification of hTERT mRNA and telomerase activity in bladder washings of patients with recurrent urothelial cell carcinomas.
Clin Chem 2000; 46: 2003-7
Abstract Related articles

WIKMAN FP, Lu ML, Thykjaer T, Olesen SH, Andersen LD, Cordon-Cardo C et al
Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples.
Clin Chem 2000; 46: 1555-61
Abstract Related articles

DIAMANDIS EP
Sequencing with microarray technology--a powerful new tool for molecular diagnostics.
Clin Chem 2000; 46: 1523-5
Abstract Related articles

RAMON J, Ben-Haim M, Shabtai M, Rubinstein E
Transepithelial intestinal excretion of ciprofloxacin in humans.
Clin Infect Dis 2001; 32: 822-3
Abstract Related articles

Bacillus Calmette-Guerin in the Treatment of Tuberculosis and Bladder Cancer: Clinical Use and Immunologic Response. Reports of a workshop. Toronto, Canada, 11-13 July 1994.
Clin Infect Dis 2000; 31 Suppl 3: S59-121
Abstract Related articles

WITTES RC
Bacille Calmette-Guerin vaccine.
Clin Infect Dis 2000; 31 Suppl 3: S115-21
Abstract Related articles

DE BOER EC, De Reijke TM, Vos PC, Kurth KH, Schamhart DH
Immunostimulation in the urinary bladder by local application of Nocardia rubra cell-wall skeletons (Rubratin) and bacillus Calmette- Guerin as therapy for superficial bladder cancer: a comparative study.
Clin Infect Dis 2000; 31 Suppl 3: S109-14
Abstract Related articles

RATLIFF TL
Role of animal models in understanding intravesical therapy with bacille Calmette-Guerin.
Clin Infect Dis 2000; 31 Suppl 3: S106-8
Abstract Related articles

BOHLE A, Thanhauser A, Ernst M, Flad HD, Rusch-Gerdes S, Jocham D et al
Reduction of side effects of intravesical therapy with bacille Calmette- Guerin by pentoxifylline?--an in vitro approach.
Clin Infect Dis 2000; 31 Suppl 3: S101-5
Abstract Related articles

BRANDAU S, Bohle A, Thanhauser A, Ernst M, Mattern T, Ulmer AJ et al
In vitro generation of bacillus Calmette-Guerin-activated killer cells.
Clin Infect Dis 2000; 31 Suppl 3: S94-S100
Abstract Related articles

PRESCOTT S, Jackson AM, Hawkyard SJ, Alexandroff AB, James K
Mechanisms of action of intravesical bacille Calmette-Guerin: local immune mechanisms.
Clin Infect Dis 2000; 31 Suppl 3: S91-3
Abstract Related articles

LAMM DL
Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancer.
Clin Infect Dis 2000; 31 Suppl 3: S86-90
Abstract Related articles

BUU N, Sanchez F, Schurr E
The Bcg host-resistance gene.
Clin Infect Dis 2000; 31 Suppl 3: S81-5
Abstract Related articles

WITTES RC
Immunology of bacille Calmette-Guerin and related topics.
Clin Infect Dis 2000; 31 Suppl 3: S59-63
Abstract Related articles

BELLMUNT J, Albiol S
New chemotherapy combinations for advanced bladder cancer.
Curr Opin Urol 2001; 11: 517-22
Abstract Related articles

OOSTERLINCK W
Recent clinical trials in superficial bladder cancer.
Curr Opin Urol 2001; 11: 511-5
Abstract Related articles

Current world literature. Oncology: bladder and testis.
Curr Opin Urol 2001; 11: 553-61
Abstract Related articles

STERNBERG CN
Second-line treatment of advanced transitional cell carcinoma of the urothelial tract.
Curr Opin Urol 2001; 11: 523-9
Abstract Related articles

VAN DER POEL HG, Debruyne FM
Can biological markers replace cystoscopy? An update.
Curr Opin Urol 2001; 11: 503-9
Abstract Related articles

BRUSH JP
Positron emission tomography in urological malignancy.
Curr Opin Urol 2001; 11: 175-9
Abstract Related articles

Bibliography. Current world literature. Oncology: bladder and testis.
Curr Opin Urol 2000; 10: 528-37
Abstract Related articles

BASSI P
Outcome of radical cystectomy for invasive bladder cancer.
Curr Opin Urol 2000; 10: 459-63
Abstract Related articles

AKAZA H
Advances in chemotherapy of invasive bladder cancer.
Curr Opin Urol 2000; 10: 453-7
Abstract Related articles

MALMSTROM PU
Management of superficial bladder cancer: what is new?
Curr Opin Urol 2000; 10: 447-51
Abstract Related articles

FRADET Y, Lacombe L
Can biological markers predict recurrence and progression of superficial bladder cancer?
Curr Opin Urol 2000; 10: 441-5
Abstract Related articles

HASSEN W, Droller MJ
Current concepts in assessment and treatment of bladder cancer.
Curr Opin Urol 2000; 10: 291-9
Abstract Related articles

ELEUTERI P, Grollino MG, Pomponi D, De Vita R
Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma.
Eur J Cancer 2001; 37: 1496-503
Abstract Related articles

SU S, Lai M, Yeh T, Chow N
Overexpression of HER-2/neu enhances the sensitivity of human bladder cancer cells to urinary isoflavones.
Eur J Cancer 2001; 37: 1413-8
Abstract Related articles

FORSTI A, Louhelainen J, Soderberg M, Wijkstrom H, Hemminki K
Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer.
Eur J Cancer 2001; 37: 1372-80
Abstract Related articles

MIZUTANI Y, Wada H, Fukushima M, Yoshida O, Ukimura O, Kawauchi A et al
The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer.
Eur J Cancer 2001; 37: 569-575
Abstract Related articles

BELLMUNT J, de Wit R, Albanell J, Baselga J
A feasibility study of carboplatin with fixed dose of gemcitabine in ’unfit’ patients with advanced bladder cancer.
Eur J Cancer 2001; 37: 2212-5
Abstract Related articles

ABEN KK, Witjes JA, van Dijck JA, Schalken JA, Verbeek AL, Kiemeney LA
Lower incidence of urothelial cell carcinoma due to the concept of a clonal origin.
Eur J Cancer 2000; 36: 2385-9
Abstract Related articles

NOURI AM, Cannell H, Dagini B, Dabare AA, Habib N, Fowler CG
Profile of p53 expression in bladder and oral tumours. Effects of in vitro manipulations of p53 on the behaviour of established human tumour cell lines.
Eur J Cancer 2000; 36: 1853-62
Abstract Related articles

ROSTOM YA, Chapet O, Russo SM, Dubernard P, Marechal JM, Sentenac I et al
Intra-operative electron radiotherapy as a conservative treatment for infiltrating bladder cancer.
Eur J Cancer 2000; 36: 1781-7
Abstract Related articles

KHALED HM, Hamza MR, Mansour O, Gaafar R, Zaghloul MS
A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinoma.
Eur J Cancer 2000; 36 Suppl 2: 34-7
Abstract Related articles

BELLMUNT J, Guillem V, Paz-Ares L, Gonzalez-Larriba JL, Carles J, Albanell J et al
Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer.
Eur J Cancer 2000; 36 Suppl 2: 17-25
Abstract Related articles

VON DER MAASE H
Gemcitabine and cisplatin in locally advanced and/or metastatic bladder cancer.
Eur J Cancer 2000; 36 Suppl 2: 13-6
Abstract Related articles

RAGHAVAN D
Advanced bladder and urothelial cancers.
Eur J Cancer 2000; 36 Suppl 2: 1-6
Abstract Related articles

HUGUET-PEREZ J, Palou J, Millan-Rodriguez F, Salvador-Bayarri J, Villavicencio-Mavrich H, Vicente-Rodriguez J
Upper tract transitional cell carcinoma following cystectomy for bladder cancer.
Eur Urol 2001; 40: 318-23
Abstract Related articles

HENNINGSOHN L, Wijkstrom H, Dickman PW, Bergmark K, Steineck G
Distressful symptoms after radical cystectomy with urinary diversion for urinary bladder cancer: a swedish population-based study.
Eur Urol 2001; 40: 151-62
Abstract Related articles

NEWLING DW, Hetherington J, Sundaram SK, Robinson MR, Kisbenedek L
The use of valrubicin for the chemoresection of superficial bladder cancer - a marker lesion study.
Eur Urol 2001; 39: 643-7
Abstract Related articles

SAAD A, Hanbury DC, McNicholas TA, Boustead GB, Woodman AC
The early detection and diagnosis of bladder cancer: a critical review of the options.
Eur Urol 2001; 39: 619-33
Abstract Related articles

RETZ M, Lehmann J, Roder C, Weichert-Jacobsen K, Loch T, Romahn E et al
Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients.
Eur Urol 2001; 39: 507-17
Abstract Related articles

KAUSCH I, Bohle A
Bladder Cancer. ii. molecular aspects and diagnosis.
Eur Urol 2001; 39: 498-506
Abstract Related articles

BRANDAU S, Bohle A
Bladder Cancer. i. molecular and genetic basis of carcinogenesis.
Eur Urol 2001; 39: 491-7
Abstract Related articles

GAME X, Soulie M, Seguin P, Vazzoler N, Tollon C, Pontonnier F et al
Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality.
Eur Urol 2001; 39: 525-9
Abstract Related articles

BRANDAU S, Bohle A
Activation of natural killer cells by Bacillus Calmette-Guerin.
Eur Urol 2001; 39: 518-24
Abstract Related articles

WILLIAMS SG, Gandour-Edwards R, Deitch AD, Toscano S, Fan JJ, Sternberg CN et al
Differences in gene expression in muscle-invasive bladder cancer: a comparison of italian and american patients.
Eur Urol 2001; 39: 430-7
Abstract Related articles

CONRAD S, Hautmann SH, Henke RP, Erbersdobler A, Simon J, Straub M et al
Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients.
Eur Urol 2001; 39 Suppl 4: 25-9
Abstract Related articles

CORTI B, Carella R, Gabusi E, D’Errico A, Martorana G, Grigioni WF
Solitary fibrous tumour of the urinary bladder with expression of bcl- 2, CD34, and insulin-like growth factor type II.
Eur Urol 2001; 39: 484-8
Abstract Related articles

LEISSNER J, Hohenfellner R, Thuroff JW, Koppen C, Wolf HK
Prognostic significance of histopathological grading and immunoreactivity for p53 and p21/WAF1 in grade 2 pTa transitional cell carcinoma of the urinary bladder.
Eur Urol 2001; 39: 438-45
Abstract Related articles

CHAMPELOVIER P, Besse A, Boucard N, Simon A, Leroux D, Pinel N et al
Dag-1 carcinoma cell in studying the mechanisms of progression and therapeutic resistance in bladder cancer.
Eur Urol 2001; 39: 343-8
Abstract Related articles

TOPSAKAL M, Karadeniz T, Anac M, Donmezer S, Besisik A
Assessment of fibrin-fibrinogen degradation products (accu-dx) test in bladder cancer patients.
Eur Urol 2001; 39: 287-91
Abstract Related articles

KIRKALI G, Tuzel E, Guler C, Gezer S, Kirkali Z
Significance of tissue laminin P(1) elastase and fibronectin levels in transitional cell carcinoma of the bladder.
Eur Urol 2001; 39: 292-9
Abstract Related articles

KORKOLOPOULOU P, Christodoulou P, Lazaris A, Thomas-Tsagli E, Kapralos P, Papanikolaou A et al
Prognostic implications of aberrations in p16/pRb pathway in urothelial bladder carcinomas: a multivariate analysis including p53 expression and proliferation markers.
Eur Urol 2001; 39: 167-77
Abstract Related articles

FRIEDRICH MG, Riethdorf S, Erbersdobler A, Tiemer C, Schwaibold H, Solter JK et al
Relevance of p53 gene alterations for tumor recurrence in patients with superficial transitional cell carcinoma of the bladder.
Eur Urol 2001; 39: 159-66
Abstract Related articles

COLOMBO R, Brausi M, Da Pozzo L, Salonia A, Montorsi F, Scattoni V et al
Thermo-chemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication. a pilot study on marker lesion.
Eur Urol 2001; 39: 95-100
Abstract Related articles

KHALED HM, Abdel-Salam I, Abdel-Gawad M, Metwally A, El-Demerdash S, El-Didi M et al
Evaluation of the BTA tests for the detection of bilharzial related bladder cancer: the Cairo experience.
Eur Urol 2001; 39: 91-4
Abstract Related articles

TRIAS I, Algaba F, Condom E, Espanol I, Segui J, Orsola I et al
Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases.
Eur Urol 2001; 39: 85-90
Abstract Related articles

TORELLI F, Catanzaro F, Conti G, Comeri CG, Risi O, Pino R et al
High-dose epirubicin in the prophylactic treatment of T1G2 superficial bladder tumors.
Eur Urol 2001; 39 Suppl 2: 11-4
Abstract Related articles

JAROLIM L, Babjuk M, Pecher SM, Grim M, Nanka O, Tichy M et al
Causes and treatment of residual urine volume after orthotopic bladder replacement in women.
Eur Urol 2000; 38: 748-52
Abstract Related articles

SCHMITZ-DRAGER BJ, Goebell PJ, Ebert T, Fradet Y
p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?
Eur Urol 2000; 38: 691-9
Abstract Related articles

CHAUTARD D, Daver A, Bocquillon V, Verriele V, Colls P, Bertrand G et al
Comparison of the Bard Trak test with voided urine cytology in the diagnosis and follow-up of bladder tumors.
Eur Urol 2000; 38: 686-90
Abstract Related articles

MURPHY WM
The term ’superficial bladder cancer’ should be abandoned.
Eur Urol 2000; 38: 597-9
Abstract Related articles

ERBERSDOBLER A, Kaiser H, Friedrich MG, Henke RP
Numerical aberrations of chromosome 8 and allelic loss at 8p in non- muscle-invasive urothelial carcinomas of the urinary bladder.
Eur Urol 2000; 38: 590-6
Abstract Related articles

BUE P, Holmberg AR, Marquez M, Westlin JE, Nilsson S, Malmstrom PU
Intravesical administration of EGF- dextran conjugates in patients with superficial bladder cancer.
Eur Urol 2000; 38: 584-9
Abstract Related articles

SACHS MD, Schlechte H, Lenk VS, Brenner S, Schnorr D, Fleige B et al
Genetic analysis of Tp53 from urine sediment as a tool for diagnosing recurrence and residual of bladder carcinoma.
Eur Urol 2000; 38: 426-33
Abstract Related articles

SERRETTA V, Pomara G, Rizzo I, Esposito E
Urinary BTA-stat, BTA-trak and NMP22 in surveillance after TUR of recurrent superficial transitional cell carcinoma of the bladder.
Eur Urol 2000; 38: 419-25
Abstract Related articles

GUMUS E, Miroglu C, Saporta L, Basaran G, Horasanli K, Tanriverdi O et al
Rectodynamic and radiological assessment in modified mainz pouch II cases.
Eur Urol 2000; 38: 316-22
Abstract Related articles

SIRACUSANO S, Liguori G, Trombetta C, d’Aloia G, Belgrano E
Modified Ghoneim’s technique using a single serous-lined extramural tunnel in detubularized orthotopic ileal W-bladde
Eur Urol 2000; 38: 313-5
Abstract Related articles

GONTERO P, Casetta G, Zitella A, Ballario R, Pacchioni D, Magnani C et al
Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.
Eur Urol 2000; 38: 287-96
Abstract Related articles

COOKE PW, Dunn JA, Latief T, Bathers S, James ND, Wallace DM
Long-term risk of salvage cystectomy after radiotherapy for muscle- invasive bladder cancer.
Eur Urol 2000; 38: 279-86
Abstract Related articles

SHIRAKAWA T, Sasaki R, Gardner TA, Kao C, Zhang ZJ, Sugimura K et al
Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug- sensitive cells.
Int J Cancer 2001; 94: 282-9
Abstract Related articles

VON KNOBLOCH R, Hegele A, Brandt H, Olbert P, Heidenreich A, Hofmann R
Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis.
Int J Cancer 2001; 94: 67-72
Abstract Related articles

GOHJI K, Hirano H, Okamoto M, Kitazawa S, Toyoshima M, Dong J et al
Expression of three extracellular matrix degradative enzymes in bladder cancer.
Int J Cancer 2001; 95: 295-301
Abstract Related articles

VRIESEMA JL, Aben KK, Witjes JA, Kiemeney LA, Schalken JA
Superficial and metachronous invasive bladder carcinomas are clonally related.
Int J Cancer 2001; 93: 699-702
Abstract Related articles

GEOFFROY-PEREZ B, Cordier S
Fluid consumption and the risk of bladder cancer: Results of a multicenter case-control study.
Int J Cancer 2001; 93: 880-7
Abstract Related articles

HERNANDO E, Orlow I, Liberal V, Nohales G, Benezra R, Cordon-Cardo C
Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer.
Int J Cancer 2001; 95: 223-7
Abstract Related articles

MIYAKE H, Hara S, Arakawa S, Kamidono S, Hara I
Overexpression of bcl-2 regulates sodium butyrate- and/or docetaxel- induced apoptosis in human bladder cancer cells both in vitro and in vivo.
Int J Cancer 2001; 93: 26-32
Abstract Related articles

JUNGBLUTH AA, Chen YT, Stockert E, Busam KJ, Kolb D, Iversen K et al
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues.
Int J Cancer 2001; 92: 856-60
Abstract Related articles

FADL-ELMULA I, Kytola S, Pan Y, Lui WO, Derienzo G, Forsberg L et al
Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis.
Int J Cancer 2001; 92: 824-31
Abstract Related articles

WATANABE T, Shinohara N, Sazawa A, Takimoto M, Hashimoto A, Koyanagi T et al
Adenovirus-mediated gene therapy for bladder cancer in an orthotopic model using a dominant negative H-ras mutant.
Int J Cancer 2001; 92: 712-7
Abstract Related articles

BRANDAU S, Riemensberger J, Jacobsen M, Kemp D, Zhao W, Zhao X et al
NK cells are essential for effective BCG immunotherapy.
Int J Cancer 2001; 92: 697-702
Abstract Related articles

SEIDL J, Rauch J, Krieg RC, Appel S, Baumgartner R, Knuechel R
Optimization of differential photodynamic effectiveness between normal and tumor urothelial cells using 5-aminolevulinic acid-induced protoporphyrin IX as sensitizer.
Int J Cancer 2001; 92: 671-7
Abstract Related articles

MATULLO G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L et al
DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study.
Int J Cancer 2001; 92: 562-7
Abstract Related articles

DONG C, Hemminki K
Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families.
Int J Cancer 2001; 92: 144-50
Abstract Related articles

GAGO-DOMINGUEZ M, Castelao JE, Yuan JM, Yu MC, Ross RK
Use of permanent hair dyes and bladder-cancer risk.
Int J Cancer 2001; 91: 575-9
Abstract Related articles

GIULIANI L, Gazzaniga P, Caporuscio F, Ciotti M, Frati L, Agliano AM
Can down-regulation of UDP-glucuronosyltransferases in the urinary bladder tissue impact the risk of chemical carcinogenesis?
Int J Cancer 2001; 91: 141-3
Abstract Related articles

CHOW NH, Cairns P, Eisenberger CF, Schoenberg MP, Taylor DC, Epstein JI et al
Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer.
Int J Cancer 2000; 89: 514-8
Abstract Related articles

ABDEL MOHSEN MA, Hassan AA, El-Sewedy SM, Aboul-Azm T, Magagnotti C, Fanelli R et al
Human bladder cancer, schistosomiasis, N-nitroso compounds and their precursors.
Int J Cancer 2000; 88: 682-3
Abstract Related articles

WANG DS, Rieger-Christ K, Latini JM, Moinzadeh A, Stoffel J, Pezza JA et al
Molecular analysis of PTEN and MXI1 in primary bladder carcinoma.
Int J Cancer 2000; 88: 620-5
Abstract Related articles

ABEN KK, Cloos J, Koper NP, Braakhuis BJ, Witjes JA, Kiemeney LA
Mutagen sensitivity in patients with familial and non-familial urothelial cell carcinoma.
Int J Cancer 2000; 88: 493-6
Abstract Related articles

BOSTROM PJ, Ravanti L, Reunanen N, Aaltonen V, Soderstrom KO, Kahari VM et al
Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder.
Int J Cancer 2000; 88: 417-23
Abstract Related articles

ZAPATERO A, Martin de Vidales C, Marin A, Cerezo L, Arellano R, Rabadan M et al
Invasive bladder cancer: a single-institution experience with bladder- sparing approach.
Int J Cancer 2000; 90: 287-94
Abstract Related articles

NICHOLS RC JR, Sweetser MG, Mahmood SK, Malamud FC, Dunn NP, Adams JP et al
Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: a well- tolerated combination.
Int J Cancer 2000; 90: 281-6
Abstract Related articles

ZLOTTA AR, Van Vooren JP, Denis O, Drowart A, Daffe M, Lefevre P et al
What are the immunologically active components of bacille Calmette- Guerin in therapy of superficial bladder cancer?
Int J Cancer 2000; 87: 844-52
Abstract Related articles

TORRISI R, Mezzetti M, Johansson H, Barreca A, Pigatto F, Robertson C et al
Time course of fenretinide-induced modulation of circulating insulin- like growth factor (IGF)-i, IGF-II and IGFBP-3 in a bladder cancer chemoprevention trial.
Int J Cancer 2000; 87: 601-5
Abstract Related articles

LOUHELAINEN J, Wijkstrom H, Hemminki K
Allelic losses demonstrate monoclonality of multifocal bladder tumors.
Int J Cancer 2000; 87: 522-7
Abstract Related articles

BOHM M, Kleine-Besten R, Wieland I
Loss of heterozygosity analysis on chromosome 5p defines 5p13-12 as the critical region involved in tumor progression of bladder carcinomas.
Int J Cancer 2000; 89: 194-7
Abstract Related articles

SATOH M, Ito A, Nojiri H, Handa K, Numahata K, Ohyama C et al
Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells.
Int J Oncol 2001; 19: 723-31
Abstract Related articles

TOMOVSKA S, Richter J, Suess K, Wagner U, Rozenblum E, Gasser TC et al
Molecular cytogenetic alterations associated with rapid tumor cell proliferation in advanced urinary bladder cancer.
Int J Oncol 2001; 18: 1239-44
Abstract Related articles

ZUPKO I, Kamuhabwa AR, D’Hallewin MA, Baert L, De Witte PA
In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
Int J Oncol 2001; 18: 1099-105
Abstract Related articles

SCHAFFER AA, Simon R, Desper R, Richter J, Sauter G
Tree models for dependent copy number changes in bladder cancer.
Int J Oncol 2001; 18: 349-54
Abstract Related articles

LOUHELAINEN J, Wijkstrom H, Hemminki K
Multiple regions with allelic loss at chromosome 3 in superficial multifocal bladder tumors.
Int J Oncol 2001; 18: 203-10
Abstract Related articles

SIMON R, Burger H, Semjonow A, Hertle L, Terpe HJ, Bocker W
Patterns of chromosomal imbalances in muscle invasive bladder cancer.
Int J Oncol 2000; 17: 1025-9
Abstract Related articles

SJOSTROM A, Bue P, Malmstrom P, Carlsson J
Binding of 125I after administration of 125I-EGF-dextran, 125I-EGF or 125I to human bladder cancer spheroids.
Int J Oncol 2000; 17: 559-64
Abstract Related articles

SAIKA T, Suyama B, Murata T, Manabe D, Kurashige T, Nasu Y et al
Orthotopic neobladder reconstruction in elderly bladder cancer patients.
Int J Urol 2001; 8: 533-538
Abstract Related articles

LI S, Nomata K, Sawase K, Noguchi M, Kanda S, Kanetake H
Prognostic significance of platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in stage pT1 G3 bladder cancer.
Int J Urol 2001; 8: 478-82
Abstract Related articles

MIYAKAWA M, Tachibana M, Miyakawa A, Yoshida K, Shimada N, Murai M et al
Re-evaluation of the latent period of bladder cancer in dyestuff-plant workers in Japan.
Int J Urol 2001; 8: 423-430
Abstract Related articles

GURBUZ YS, Muezzinoglu B, Cimen K, Dillioglugil O
Synchronous occurrence of bladder carcinosarcoma and testicular seminoma.
Int J Urol 2001; 8: 404-7
Abstract Related articles

MORIOKA M, Jo Y, Furukawa Y, Kinugawa K, Sone A, Matsuki T et al
Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract.
Int J Urol 2001; 8: 366-73
Abstract Related articles

YAMADA Y, Honda N, Hibi H, Taki T, Mitsui K, Fukatsu H
Holmium:YAG laser endoureterotomy in the treatment of ureteroenteric stricture following Indiana urinary diversion.
Int J Urol 2001; 8: 326-9
Abstract Related articles

AYGUN C, Tekin MI, Tarhan C, Ozdemir H, Peskircioglu L, Ozkardes H
Neurofibroma of the bladder wall in von Recklinghausen’s disease.
Int J Urol 2001; 8: 249-53
Abstract Related articles

SAKAMOTO N, Naito S, Kumazawa J, Ariyoshi A, Osada Y, Omoto T et al
Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study.
Int J Urol 2001; 8: 212-6
Abstract Related articles

ARISAWA C, Takeuchi S, Wakui M
Appendiceal carcinoma invading the urinary bladder.
Int J Urol 2001; 8: 196-8
Abstract Related articles

YAMAMOTO S, Ito T, Akiyama A, Miki M, Tachibana M, Takase M et al
Primary signet-ring cell carcinoma of the urinary bladder inducing renal failure.
Int J Urol 2001; 8: 190-3
Abstract Related articles

KASAHARA K, Inoue K, Shuin T
Advanced adenocarcinoma of the urinary bladder successfully treated by the combination of cisplatinum, mitomycin-C, etoposide and tegafur- uracil chemotherapy.
Int J Urol 2001; 8: 133-6
Abstract Related articles

HASHIMOTO H, Tokumitsu M, Saga Y, Okuyama M, Yachiku S
Immunohistochemical expression of P-glycoprotein in the rat urinary bladder and the effect of verapamil on intravesical chemotherapy.
Int J Urol 2001; 8: 118-23
Abstract Related articles

WADA S, Yoshimura R, Masuda C, Hase T, Ikemoto S, Kishimoto T et al
Are tobacco use and urine pH indicated as risk factors for bladder carcinoma?
Int J Urol 2001; 8: 106-9
Abstract Related articles

YOSHIDA T, Hirai S, Horii Y, Yamauchi T
Granular cell tumor of the urinary bladder.
Int J Urol 2001; 8: 29-31
Abstract Related articles

ATAUS S, Yaycioglu O, Demirkesen O, Uygun N, Yalcin V, Solok V
Retrovesical leiomyosarcoma.
Int J Urol 2000; 7: 467-9
Abstract Related articles

UYGUR MC, Tan MO, Altug U, Yilmaz C, Erol D
Clinical, urodynamic and endoscopic characteristics of the stanford pouch ileal neobladder constructed with absorbable staples.
Int J Urol 2000; 7: 440-6
Abstract Related articles

TAKAGI Y, Takashi M, Koshikawa T, Sakata T, Ohshima S
Immunohistochemical demonstration of cyclin D1 in bladder cancers as an inverse indicator of invasiveness but not an independent prognostic factor.
Int J Urol 2000; 7: 366-72
Abstract Related articles

HANADA T, Nakagawa M, Emoto A, Nomura T, Nasu N, Nomura Y
Prognostic value of tumor-associated macrophage count in human bladder cancer.
Int J Urol 2000; 7: 263-9
Abstract Related articles

BALTOGIANNIS D, Tasos A, Voutsinas G, Dauaher H, Chambilomatis P, Giannakopoulos X
Bladder cancer mortality in the Epirus district population (Greece).
Int Urol Nephrol 2001; 32: 377-9
Abstract Related articles

OGE O, Atsu N, Kendi S, Ozen H
Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer.
Int Urol Nephrol 2001; 32: 367-70
Abstract Related articles

YAGI H, Igawa M, Shiina H, Shigeno K
Concomitant presence of bladder cancer and neurogenic bladder in a patient with HTLV-1 carrier: a case report.
Int Urol Nephrol 2000; 32: 63-5
Abstract Related articles

TEKIN A, Ozen H
Adjuvant chemotherapy for non-organ confined disease after radical cystectomy.
Int Urol Nephrol 2000; 32: 59-62
Abstract Related articles

ALTAY B, Girgin C, Kefi A, Cikili N
The best management of superficial bladder tumours: comparing TUR alone versus TUR combined with intravesical chemotherapy modalities?
Int Urol Nephrol 2000; 32: 53-8
Abstract Related articles

PERIMENIS P, Speakman M
Incidental presentation of leiomyoma of bladder with carincoma of the prostate.
Int Urol Nephrol 2000; 32: 279-80
Abstract Related articles

OZDEMIR BH, Ozdemir G, Sertcelik A
The nested variant of the transitional cell bladder carcinoma: a case report and review of the literature.
Int Urol Nephrol 2000; 32: 257-8
Abstract Related articles

STRAUB B, Muller M, Schrader M, Goessl C, Heicappell R, Miller K
Concomitment spread of a renal cell carcinoma beyond the kidney and a transitional cell carcinoma beyond the bladder.
Int Urol Nephrol 2000; 32: 249-50
Abstract Related articles

OZBEY I, Aksoy Y, Bicgi O, Polat O, Okyar G
Transitional cell carcinoma of the bladder in patients under 40 years of age.
Int Urol Nephrol 1999; 31: 655-9
Abstract Related articles

MILLIKAN R, Dinney C, Swanson D, Sweeney P, Ro JY, Smith TL et al
Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant m-vac versus cystectomy with both preoperative and postoperative m-vac.
J Clin Oncol 2001; 19: 4005-13
Abstract Related articles

STERNBERG CN, Parmar MK
Neoadjuvant chemotherapy is not (yet) standard treatment for muscle- invasive bladder cancer.
J Clin Oncol 2001; 19 : 21S-6S
Abstract Related articles

BAJORIN DF
Plenary debate of randomized phase iii trial of neoadjuvant mvac plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.
J Clin Oncol 2001; 19 : 17S-20S
Abstract Related articles

MELUCH AA, Greco FA, Burris HA 3rd, O’Rourke T, Ortega G, Steis RG et al
Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network.
J Clin Oncol 2001; 19: 3018-24
Abstract Related articles

HUSSAIN M, Vaishampayan U, Du W, Redman B, Smith DC
Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer.
J Clin Oncol 2001; 19: 2527-33
Abstract Related articles

COHEN MH, Rothmann M
Gemcitabine and cisplatin for advanced, metastatic bladder cancer.
J Clin Oncol 2001; 19: 1229-31
Abstract Related articles

STEFANADIS C, Chrysochoou C, Markou D, Petraki K, Panagiotakos DB, Fasoulakis C et al
Increased temperature of malignant urinary bladder tumors in vivo: the application of a new method based on a catheter technique.
J Clin Oncol 2001; 19: 676-81
Abstract Related articles

STEIN JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S et al
Radical cystectomy in the treatment of invasive bladder cancer: long- term results in 1,054 patients.
J Clin Oncol 2001; 19: 666-75
Abstract Related articles

RABBANI F, Perrotti M, Russo P, Herr HW
Upper-Tract Tumors After an Initial Diagnosis of Bladder Cancer: Argument for Long-Term Surveillance.
J Clin Oncol 2001; 19: 94-100
Abstract Related articles

HERR HW
Transurethral resection of muscle-invasive bladder cancer: 10-year outcome.
J Clin Oncol 2001; 19: 89-93
Abstract Related articles

VON DER MAASE H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ et al
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.
J Clin Oncol 2000; 18: 3068-77
Abstract Related articles

GOHJI K, Nomi M, Niitani Y, Kitazawa S, Fujii A, Katsuoka Y et al
Independent prognostic value of serum hepatocyte growth factor in bladder cancer.
J Clin Oncol 2000; 18: 2963-71
Abstract Related articles

YAMANAKA M, Kanda K, Li NC, Fukumori T, Oka N, Kanayama HO et al
Analysis of the gene expression of sparc and its prognostic value for bladder cancer.
J Urol 2001; 166: 2495-9
Abstract Related articles

SAINT F, Patard JJ, Maille P, Soyeux P, Hoznek A, Salomon L et al
T helper 1/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus calmette- guerin for superficial bladder cancer.
J Urol 2001; 166: 2142-7
Abstract Related articles

PLNA K, Hemminki K
Familial bladder cancer in the national Swedish family cancer database.
J Urol 2001; 166: 2129-33
Abstract Related articles

ZAAK D, Frimberger D, Stepp H, Wagner S, Baumgartner R, Schneede P et al
Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection.
J Urol 2001; 166: 1665-9
Abstract Related articles

MURAISHI O, Mitsu S, Suzuki K, Koshimizu T, Tokue A
A technique for resection of small bladder tumors using a flexible cystoscope on an outpatient basis: bladder tumor resection with newly designed hot cup forceps.
J Urol 2001; 166: 1817-9
Abstract Related articles

MORALES A, Chin JL, Ramsey EW
Mycobacterial cell wall extract for treatment of carcinoma in situ of the bladder.
J Urol 2001; 166: 1633-7
Abstract Related articles

JOHN H, Hauri D
RE: NERVE AND SEMINAL SPARING RADICAL CYSTECTOMY WITH ORTHOTOPIC URINARY DIVERSION FOR SELECT PATIENTS WITH SUPERFICIAL BLADDER CANCER: AN INNOVATIVE SURGICAL APPROACH.
J Urol 2001; 166: 1402
Abstract Related articles

O&RSQUO;DONNELL MA, Krohn J, DeWOLF WC
SALVAGE INTRAVESICAL THERAPY WITH INTERFERON-alpha2B PLUS LOW DOSE BACILLUS CALMETTE-GUERIN IS EFFECTIVE IN PATIENTS WITH SUPERFICIAL BLADDER CANCER IN WHOM BACILLUS CALMETTE-GUERIN ALONE PREVIOUSLY FAILED.
J Urol 2001; 166: 1300-1305
Abstract Related articles

GOMELLA LG, Mastrangelo MJ, McCue PA, Maguire HC JR, Mulholland SG, Lattime EC
PHASE I STUDY OF INTRAVESICAL VACCINIA VIRUS AS A VECTOR FOR GENE THERAPY OF BLADDER CANCER.
J Urol 2001; 166: 1291-1295
Abstract Related articles

GOHJI K, Okamoto M, Kitazawa S, Toyoshima M, Dong J, Katsuoka Y et al
HEPARANASE PROTEIN AND GENE EXPRESSION IN BLADDER CANCER.
J Urol 2001; 166: 1286-1290
Abstract Related articles

SHIGYO M, Sugano K, Tobisu KI, Tsukamoto T, Sekiya T, Kakizoe T
MOLECULAR FOLLOWUP OF NEWLY DIAGNOSED BLADDER CANCER USING URINE SAMPLES.
J Urol 2001; 166: 1280-1285
Abstract Related articles

BERNARDINI S, Fauconnet S, Chabannes E, Henry PC, Adessi G, Bittard H
SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AS A PROGNOSTIC FACTOR IN BLADDER CANCER.
J Urol 2001; 166: 1275-1279
Abstract Related articles

LOSKOG A, Bjorkland A, Brown MP, Korsgren O, Malmstrom PU, Totterman TH
Potent antitumor effects of cd154 transduced tumor cells in experimental bladder cancer.
J Urol 2001; 166: 1093-7
Abstract Related articles

HSU TH, Klein EA
Subtotal radical cystectomy after radical prostatectomy: a source of pelvic recurrence of bladder cancer with life threatening bleeding.
J Urol 2001; 166: 988-9
Abstract Related articles

SHERIF A, De La Torre M, Malmstrom PU, Thorn M
Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer.
J Urol 2001; 166: 812-5
Abstract Related articles

DUGGAN BJ, Maxwell P, Kelly JD, Canning P, Anderson NH, Keane PF et al
The effect of antisense Bcl-2 oligonucleotides on Bcl-2 protein expression and apoptosis in human bladder transitional cell carcinoma.
J Urol 2001; 166: 1098-105
Abstract Related articles

CASSEL A, Rahat MA, Lahat N, Lindenfeld N, Mecz Y, Stein A
Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise.
J Urol 2001; 166: 841-4
Abstract Related articles

THOMPSON IM
RE: OUTCOME OF PATIENTS WITH GROSSLY NODE POSITIVE BLADDER CANCER AFTER PELVIC LYMPH NODE DISSECTION AND RADICAL CYSTECTOMY.
J Urol 2001; 166: 630
Abstract Related articles

KIELB SJ, Shah NL, Rubin MA, Sanda MG
FUNCTIONAL p53 MUTATION AS A MOLECULAR DETERMINANT OF PACLITAXEL AND GEMCITABINE SUSCEPTIBILITY IN HUMAN BLADDER CANCER.
J Urol 2001; 166: 482-7
Abstract Related articles

GIANNOPOULOS A, Manousakas T, Gounari A, Constantinides C, Choremi-Papadopoulou H, Dimopoulos C
Comparative evaluation of the diagnostic performance of the bta stat test, nmp22 and urinary bladder cancer antigen for primary and recurrent bladder tumors.
J Urol 2001; 166: 470-5
Abstract Related articles

ORLANDO C, Gelmini S, Selli C, Pazzagli M
Telomerase in urological malignancy.
J Urol 2001; 166: 666-73
Abstract Related articles

KIKUNO N, Urakami S, Shigeno K, Shiina H, Igawa M
Urachal carcinoma associated with increased carbohydrate antigen 19-9 and carcinoembryonic antigen.
J Urol 2001; 166: 604
Abstract Related articles

CONSTANTINIDES C, Manousakas T, Chrisofos M, Giannopoulos A
Orthotopic bladder substitution after radical cystectomy: 5 years of experience with a novel personal modification of the ileal s pouch.
J Urol 2001; 166: 532-7
Abstract Related articles

DUTTA SC, Smith JA Jr, Shappell SB, Coffey CS, Chang SS, Cookson MS
Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy.
J Urol 2001; 166: 490-3
Abstract Related articles

SOLOWAY MS
Bladder tumor markers, intravesical therapy and systemic chemotherapy.
J Urol 2001; 166: 488-9
Abstract Related articles

VAN DER MEIJDEN AP, Brausi M, Zambon V, Kirkels W, de Balincourt C, Sylvester R
Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: a European Organization for III trial.
J Urol 2001; 166: 476-81
Abstract Related articles

LEBEDEVA I, Raffo A, Rando R, Ojwang J, Cossum P, Stein CA
Chemosensitization of bladder carcinoma cells by bcl-xL antisense oligonucleotides.
J Urol 2001; 166: 461-9
Abstract Related articles

LEVI AW, Potter SR, Schoenberg MP, Epstein JI
Clinical significance of denuded urothelium in bladder biopsy.
J Urol 2001; 166: 457-60
Abstract Related articles

CHANG FL, Lai MD
VARIOUS FORMS OF MUTANT p53 CONFER SENSITIVITY TO CISPLATIN AND DOXORUBICIN IN BLADDER CANCER CELLS.
J Urol 2001; 166: 304-10
Abstract Related articles

PONSKY LE, Sharma S, Pandrangi L, Kedia S, Nelson D, Agarwal A et al
Screening and monitoring for bladder cancer: refining the use of nmp22.
J Urol 2001; 166: 75-8
Abstract Related articles

MILLS RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE
Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
J Urol 2001; 166: 19-23
Abstract Related articles

DAHM P, Tuttle-Newhall JE, Nimjee SM, Byrne RR, Yowell CW, Price DT
Indications for admission to the surgical intensive care unit after radical cystectomy and urinary diversion.
J Urol 2001; 166: 189-93
Abstract Related articles

WEINSTEIN RP, Grob BM, Pachter EM, Soloway S, Fair WR
Partial cystectomy during radical surgery for nonurological malignancy.
J Urol 2001; 166: 79-81
Abstract Related articles

PU YS, Chen J, Huang CY, Guan JY, Lu SH, Hour TC
Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells.
J Urol 2001; 165: 2082-5
Abstract Related articles

REIHER FK, Anovich M IV, Huang H, Smith ND, Bouck NP, Campbell SC
THE ROLE OF HYPOXIA AND p53 IN THE REGULATION OF ANGIOGENESIS IN BLADDER CANCER.
J Urol 2001; 165: 2075-2081
Abstract Related articles

HAUTMANN SH, Lokeshwar VB, Schroeder GL, Civantos F, Duncan RC, Gnann R et al
Elevated tissue expression of hyaluronic acid and hyaluronidase validates the ha-haase urine test for bladder cancer.
J Urol 2001; 165: 2068-74
Abstract Related articles

WAIDELICH R, Stepp H, Baumgartner R, Weninger E, Hofstetter A, Kriegmair M
Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer.
J Urol 2001; 165: 1904-7
Abstract Related articles

MCHOWAT J, Creer MH, Rickard A
Stimulation of protease activated receptors on RT4 cells mediates arachidonic acid release via Ca2+ independent phospholipase A2.
J Urol 2001; 165: 2063-7
Abstract Related articles

PIAZZA R, Celia A, Ghidini N, Paterlini M
A technique of transrectal ultrasound guided transperineal percutaneous drainage of pelvic abscess after radical cystectomy.
J Urol 2001; 165: 1973-4
Abstract Related articles

HERR HW, Schneider M
Outpatient flexible cystoscopy in men: a randomized study of patient tolerance.
J Urol 2001; 165: 1971-2
Abstract Related articles

MURPHY WM, Rivera-Ramirez I, Luciani LG, Wajsman Z
Second opinion of anatomical pathology: a complex issue not easily reduced to matters of right and wrong.
J Urol 2001; 165: 1957-9
Abstract Related articles

IZES JK, Dyer MW, Callum MG, Bankes P, Libertino JA, Caffrey JA
Ca 125 as a marker of tumor activity in advanced urothelial malignancy.
J Urol 2001; 165: 1908-13
Abstract Related articles

TURK I, Deger S, Winkelmann B, Schonberger B, Loening SA
Laparoscopic radical cystectomy with continent urinary diversion (rectal sigmoid pouch) performed completely intracorporeally: the initial 5 cases.
J Urol 2001; 165: 1863-6
Abstract Related articles

MOHRENSCHLAGER M, Vocks E, Wessner DB, Nahrig J, Ring J
Tripe palms and malignant acanthosis nigricans: cutaneous signs of imminent metastasis in bladder cancer?
J Urol 2001; 165: 1629-30
Abstract Related articles

DONAT SM, Wei DC, McGuire MS, Herr HW
The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer.
J Urol 2001; 165: 1580-4
Abstract Related articles

HAITEL A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA et al
BILHARZIAL RELATED, ORGAN CONFINED, MUSCLE INVASIVE BLADDER CANCER: PROGNOSTIC VALUE OF APOPTOSIS MARKERS, PROLIFERATION MARKERS, p53, E- CADHERIN, EPIDERMAL GROWTH FACTOR RECEPTOR AND c-erbB-2.
J Urol 2001; 165: 1481-7
Abstract Related articles

ROWLAND RG
Editorial: macroscopic, microscopic and molecular observations of bladder cancer.
J Urol 2001; 165: 1480
Abstract Related articles

SANCHEZ-CARBAYO M, Urrutia M, Silva JM, Romani R, De Buitrago JM, Navajo JA
Comparative predictive values of urinary cytology, urinary bladder cancer antigen, cyfra 21-1 and nmp22 for evaluating symptomatic patients at risk for bladder cancer.
J Urol 2001; 165: 1462-7
Abstract Related articles

DROLLER MJ
Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes.
J Urol 2001; 165: 1811-2
Abstract Related articles

HARA I, Miyake H, Hara S, Arakawa S, Kamidono S
Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
J Urol 2001; 165: 1769-72
Abstract Related articles

FATHIAN-SABET B, Bloch W, Klotz T, Niggemann S, Jacobs G, Addicks K et al
Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder.
J Urol 2001; 165: 1724-9
Abstract Related articles

DELLAGRAMMATICAS D, Bryden AA, Collins GN
Regression of metastatic transitional cell carcinoma in response to tamoxifen.
J Urol 2001; 165: 1631
Abstract Related articles

PALOU J, Laguna P, Millan-Rodriguez F, Hall RR, Salvador-Bayarri J, Vicente-Rodriguez J
Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors.
J Urol 2001; 165: 1488-91
Abstract Related articles

BYRNE RR, Shariat SF, Brown R, Kattan MW, Morton RA JR, Wheeler TM et al
E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
J Urol 2001; 165: 1473-9
Abstract Related articles

YOSHIMURA R, Sano H, Mitsuhashi M, Kohno M, Chargui J, Wada S
Expression of cyclooxygenase-2 in patients with bladder carcinoma.
J Urol 2001; 165: 1468-72
Abstract Related articles

WALL BM, Dmochowski RR, Malecha M, Mangold T, Bobal MA, Cooke CR
Inducible nitric oxide synthase in the bladder of spinal cord injured patients with a chronic indwelling urinary catheter.
J Urol 2001; 165: 1457-61
Abstract Related articles

ABOL-ENEIN H, Ghoneim MA
Functional results of orthotopic ileal neobladder with serous-lined extramural ureteral reimplantation: experience with 450 patients.
J Urol 2001; 165: 1427-32
Abstract Related articles

YACHIA D, Erlich N
The Hadera continent reservoir: a new appendico-umbilical continent stoma mechanism for urinary diversion.
J Urol 2001; 165: 1423-6
Abstract Related articles

DUREK C, Richter E, Basteck A, Rusch-Gerdes S, Gerdes J, Jocham D et al
The fate of bacillus Calmette-Guerin after intravesical instillation.
J Urol 2001; 165: 1765-8
Abstract Related articles

CRESSWELL J, Roberts JT, Neal DE
Urethral recurrence after radical radiotherapy for bladder cancer.
J Urol 2001; 165: 1135-7
Abstract Related articles

RIEDL CR, Daniltchenko D, Koenig F, Simak R, Loening SA, Pflueger H
Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer.
J Urol 2001; 165: 1121-3
Abstract Related articles

DONAT SM, Genega EM, Herr HW, Reuter VE
Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance.
J Urol 2001; 165: 1117-20
Abstract Related articles

DALBAGNI G, Genega E, Hashibe M, Zhang ZF, Russo P, Herr H et al
CYSTECTOMY FOR BLADDER CANCER: A CONTEMPORARY SERIES.
J Urol 2001; 165: 1111-1116
Abstract Related articles

CRESSWELL J, Roberts JT, Neal DE
URETHRAL RECURRENCE AFTER RADICAL RADIOTHERAPY FOR BLADDER CANCER.
J Urol 2001; 165: 1135-1137
Abstract Related articles

RIEDL CR, Daniltchenko D, Koenig F, Simak R, Loening SA, Pflueger H
FLUORESCENCE ENDOSCOPY WITH 5-AMINOLEVULINIC ACID REDUCES EARLY RECURRENCE RATE IN SUPERFICIAL BLADDER CANCER.
J Urol 2001; 165: 1121-1123
Abstract Related articles

DONAT SM, Genega EM, Herr HW, Reuter VE
MECHANISMS OF PROSTATIC STROMAL INVASION IN PATIENTS WITH BLADDER CANCER: CLINICAL SIGNIFICANCE.
J Urol 2001; 165: 1117-1120
Abstract Related articles

LOUGHLIN KR, Manson K, Cragnale D, Wilson L, Ball RA, Bridges KR
The use of hydrogen peroxide to enhance the efficacy of doxorubicin hydrochloride in a murine bladder tumor cell line.
J Urol 2001; 165: 1300-4
Abstract Related articles

SEKULA JJ, Liao RP, Madden J, Price DT
Transitional cell carcinoma in a prostatic remnant 10 years after radical cystectomy.
J Urol 2001; 165: 1222
Abstract Related articles

PARSONS JK, Schoenberg MP
Successful conservative management of perforated ileal neobladder.
J Urol 2001; 165: 1214-5
Abstract Related articles

MENDELSOHN J, Dinney CP
The Willet F. Whitmore, Jr., Lectureship: blockade of epidermal growth factor receptors as anticancer therapy.
J Urol 2001; 165: 1152-7
Abstract Related articles

HOLMANG S, Andius P, Hedelin H, Wester K, Busch C, Johansson SL
Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy.
J Urol 2001; 165: 1124-8
Abstract Related articles

LOKESHWAR VB, Soloway MS
Current bladder tumor tests: does their projected utility fulfill clinical necessity?
J Urol 2001; 165: 1067-77
Abstract Related articles